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Abstract
Bioengineers are in constant pursuit of solutions to problems facing the medical and
pharmaceutical field by designing biomaterials that closely mimic the target natural systems. A
unique collection of polymers, known as polymeric actuators, have been devised with the ability
to convert an external stimulus to a change in shape, size or permeability. The current options
within polymeric biomaterials with multi-functionality include matrices that are biocompatible,
biodegradable, quick transitioning / shape changing, and mechanically tunable. These properties
have been harnessed for application such as stents, valves, semi permeable membranes, and
dynamic cell culture substrates. For such applications quick and uniform actuator response that
does not need to be sustained for more than a few hours is desired. However there exist other
areas of biomedical applications, such as wound closure/healing and nerve regeneration, where
polymeric actuators have been underutilized. These applications however call for a polymer
system that can actuate at controlled slow speeds and sustain this actuation for several days. At
present there is a lack of such slow actuating polymer system. Each year over 50,000 peripheral
nerve repair procedures are performed (National Center for Health Statistics, 1995). The total
annual costs in U.S alone exceed $ 7 billion (American Paralysis Association, 1997). The
treatment of a nerve transection is dependent on the size of the injury gap. Similarly, the extent
of regeneration and re-innervation in the PNS is also governed by the size of the gap. For a
smaller gap (<10 mm) the surgeon can pull the severed nerve ends closer and suture them to
repair the injury. For larger gaps autologous nerve transplant is the gold standard treatment
despite the inherent disadvantages. Over the past decades biomaterial researchers have tested
several polymeric nerve conduits as an alternative to autologous nerve grafts. However none
have been able to match the success rates of autologous grafts. There is a lack of an effective

biomaterial solution to the problem of a large gap nerve injury. For many years there has been a
hypothesis that nervous tissue can be successfully elongated via application of an external
mechanical force alone which could be used to treat peripheral nerve gap injuries. Mechanical
actuation studies have been shown to produce successful stretch growth in individual axons and
axonal bundles. This phenomenon is at play in nature during embryonic growth and development
of the body of organisms to adulthood. Applying tensional forces at appropriate rates (< 100
µm/hr) causes sustained axonal stretch growth. The solution we propose in this work is a
biomaterial that can be programmed to perform the function of a mechanical actuator at rates
suitable for axonal stretch growth. We designed, fabricated, and characterized a novel hyaluronic
acid based hydrogel that shrinks over time along a pre-defined axis thereby providing the source
for tension that could be used for sustained axonal stretch growth. The shear thinning property of
hyaluronic acid (HA) enabled us to test if we could store a retractive stress in a rapidly
crosslinked network under shear flow and then controllably release this stress and achieve
shrinkage of the network scaffold along one desired axis. We investigated two strategies to
achieve this goal. The retractive stress trapped in the crosslinked network was released either by
manipulating the main backbone HA chains or by selectively breaking the crosslinks. The
shrinkage rates obtained were within the range of stretching rates that have successfully stretched
neuronal cells. We also confirmed that the material’s cytocompatibility was unaffected by the
chemical modifications that HA was subjected to. This polymer system is a novel addition to the
existing polymeric actuators and is a step towards filling the void of a slow, long term actuating
polymer.
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CHAPTER 1
INTRODUCTION
1.1 Polymeric actuators: Bioengineers are in constant pursuit of solutions to problems facing
the medical and pharmaceutical field by designing biomaterials that closely mimic the target
natural systems. The rapid advancements in microtechnology have created demands of
devices and smart materials that can function as actuators at the micro and macroscale (1, 2).
Fabrication techniques, such as 3D printing, photolithography etc, have tremendously
increased our capabilities of accurate micro-fabrication. In nature, the muscle tissue is the
best example of an actuator where an electrical impulse stimulus causes conversion of ATP
to ADP which is used to produce contraction of the muscle tissue (3). This natural system has
been the inspiration to design artificial actuating polymers that could find use in robotics and
as muscle prostheses (3). Polymeric actuators are defined as materials that can convert some
form of stimulus to a transformation in the material (1, 3-5). This transformation is usually
either a change of shape or size of the material. This change can be harnessed to perform the
function of a mechanical actuator, a valve, optical modulators, or a drug delivery system (14, 6). The stimulus could be a change in temperature, pH, electric field, magnetic field, or
crosslink density. Depending on the design of the polymer these stimuli can lead to reversible
or irreversible swelling/de-swelling, bending, shrinking, or shape recovery of the polymer
matrix. A homogeneous change in the polymer matrix usually leads to the swelling/deswelling or shape recovery. The complex transformations like bending, twisting require an
inhomogeneous change in the polymer matrix (1).
There are three main groups of polymeric actuators that can be used for biomedical
application; hydrogel based actuators, electro active polymers (EAP), and shape memory
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polymers (SMP) (1-3, 5). Hydrogels are three-dimensional matrices that are highly saturated
with water which can reach as high as 99% of the gel mass (7). Thus swelling and deswelling process is the most common way by which hydrogels can be actuators. The most
well studied hydrogel actuator is the thermoresponsive poly (N-isopropylacrylamide)
(PNIPAAm) (1, 5, 8, 9). The change in the properties of PNIPAAm is caused by the change
in conformation above and below a threshold temperature called lower critical solution
temperature (LCST). Above this temperature the expanded coil (soluble chains)
conformation transitions to a compact (insoluble) conformation (2, 5). The LCST of
PNIPAAm is 32°C which can be modulated by copolymerizing with either hydrophobic or
hydrophilic segments (2). Consequently this polymer has been used quite extensively for
drug delivery application.

Crosslinking PNIPAAm in the presence of proteins or drug molecules encapsulates them
in the bulk of the gel. If the drug is hydrophilic then the release can be triggered below LCST
where the gel‟s permeability is greater. However if the drug is hydrophobic then it will be
squeezed out above LCST when the gel collapses (2, 8, 9). Gutowska et al. synthesized
thermoresponsive PNIPAAm gels by copolymerizing with butyl methacrylate (BMA)
(hydrophobic) or acrylic acid (AAc) (hydrophilic) co-monomers (10). The incorporation of
hydrophobic and hydrophilic co-monomers strongly influenced the swelling/shrinking
behavior of the gels. The gels were loaded with heparin below the network LCST. When the
transition temperature was reached the gel demonstrated rapid de-swelling as a result of the
network collapse. This collapse was very rapid and almost all of the transition occurred in
less than an hour. The heparin release from swollen PNIPAAm/BMA and PNIPAAm/AAc
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gels showed that release profiles correlated with de-swelling kinetics of gels. The release
profile showed two distinct kinetics controlled by different mechanisms: an initial rapid
release, due to the network collapse (squeezing effect) and the subsequent slow release
controlled by the rate of solute diffusion within the collapsed matrix. The total network
collapse, triggered by the LCST, occurred in less than 30 mins.

Polymeric actuators that respond to pH changes have also been well documented (1, 2,
5). Polyacids like poly (acrylic acid) and polybases like poly (N,N‟-diethylaminoethyl
methacrylate) are ideal examples of polymers that change conformation due to a change in
their ionic environment. Networks designed using both thermoresponsive and pH responsive
elements provide a multi-responsive actuator that is equipped to respond to subtle changes in
its environment. Such networks can be deployed to release necessary proteins or antibiotics
at an injury or inflammation site where the pH and temperature change based on the level of
inflammation. Brazel et al. (11) synthesized poly (N-isopropylacrylamide-co-methacrylic
acid) hydrogels and investigated pH- and temperature-triggered delivery of antithrombotic
agents, streptokinase and heparin. The gels were triggered in a pulsatile on-off fashion by
changing the temperature and pH. They observed that for hydrogels containing greater than
75 mol% NIPAAm, the pH and temperature sensitivity both influenced the overall swelling
behavior of the networks. The transition as a result of reduction of pH or increase in
temperature or both is rather quick with complete equilibrium swelling occurring within an
hour. Release of the drugs occurred when the gels were in the swollen (expanded coil) state.
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The swelling/de-swelling property of hydrogel based actuators has also been exploited to
cause mechanical motion. Hu et al. fabricated a “bigel strip” out of polyacrylamide (PAAM)
and N-isopropylacrylamide (NIPA) such that the PAAM layer is interpenetrating in to the
NIPA gel block for a few millimeters (12). PAAM was unresponsive to temperature changes
while NIPA changed conformation above its LCST (37°C). When the “bigel strip” was
exposed to 37°C, the NIPA layer contracted while PAAM did not thereby causing the gel
block to bend in the direction of the NIPA gel block to almost a complete circle. By making
variations in the position of NIPA regions with respect to PAAM regions, more complex
bending was also achieved. The bending was reversed by changing the solvent from water to
a combination of water and acetone and reducing the temperature below LCST. The authors
posited that such a polymeric actuator can find use as biological grasping tweezers. The total
time for the actuation process to reach its peak was of the order of 10 to 20 mins and the
maximum bending strain was calculated to be 49%. Similar efforts to fabricate bending
hydrogels via pH sensitive route have been undertaken by Topham et al. They synthesized a
pH sensitive triblock polymer gel strip consisting both polyacid and polybases (13). The

polyacid hydrogel comprised of a poly(methyl methacrylate)-block-poly(methacrylic
acid)-block-poly(methyl methacrylate) [PMMA--PMAA--PMMA] triblock copolymer,
synthesized via anionic polymerization and the polybase hydrogel comprised of a poly
(methylmethacrylate)-block-poly(2-(diethylamino)ethyl methacrylate)-block-poly(methyl
methacrylate) [PMMA--PDEA--PMMA] triblock copolymer, synthesized via group
transfer polymerization. At low pH (3.7) the bilayers bent in the direction of the polyacid
as this layer shrunk while the opposite was observed at high pH (7.3). This process was
successfully repeated for several cycles. The bending was very rapid. The authors believe
4

this phenomenon would still function even at much smaller length scale and see the use
of this actuator as a pH sensitive valve in microfluidic devices. Thus the hydrogel based
polymeric actuators have been successfully designed to perform macro and micromechanical actuations. The response time for the trigger to translate to actuation ranges
between instantaneous to several minutes (2, 3, 5, 6, 8, 9, 11, 14).

Polymeric actuators that can produce even faster transition times fall in the class of
electro active polymers. The basic modus operandi for the polymeric EAP‟s, also known as
bioresponsive gels, is a microscopic or macroscopic event (swelling / de-swelling) as a direct
result of an external electric stimulus. EAP‟s have two main categories, electronic EAP‟s
where an electric field causes change in volume of the polymer and ionic EAP‟s where there
is electrically-induced transport of ions and/or solvent (3). Another critical difference
between the two EAP‟s is that the ionic EAP‟s operate in a liquid electrolyte medium, while
the electronic EAP‟s are used in air. The ionic EAP‟s are thus particularly attractive for use
within biological environments. Within each group there are a wide variety of specific
actuation mechanisms. This response is manifested as an optical, chemical or mechanical
signal (3). Electronic EAPs include piezoelectric polymers, electrostrictive polymers,
flexoelectric polymers, and dielectric elastomers. The ionic EAPs include polymer gels,
ionic polymer-metal composites (IPMC), conducting polymers, and carbon nanotubes (3).
For the ionic EAP‟s, modifying chemical crosslinking density is the most common form of
stimulus to cause a change in the property of hydrogels. This can be done by either cleaving
polymer chains (irreversible) or by creating competition at the binding sites (reversible).
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Liang et al. fabricated a poly (vinyl alcohol)/dimethylsulfoxide (PVA/DMSO) hydrogel
which could be driven in air using a DC electric field (15). This gel is an ideal example of an
electronic EAP. The physically crosslinked PVA gels were swollen in DMSO. DMSO is the
component that interacts with the external electric field and is able to transfer the charges to
the gel-substrate interface and act as a whole within the PVA network gel to cause motion.
When the applied field exceeded a threshold value, the gel demonstrated a continuous and
linear locomotion from the anode to the cathode with a maximum velocity of 1.63 mm/sec
when the applied field was 275 V/mm. The locomotion is dependent on the delicate balance
between the threshold field, degree of swelling, and the area of contact between the gel and
the substrate. As the swelling increased, so did the area of contact which increased the
frictional forces at the interface. Thus a higher field was required to produce motion. This
motion behavior (speed and direction) could be well controlled by the external electric field.
The mechanism put forth by the authors attributed this locomotion to the unique structure of
the gel and the strong interaction between external DC field and the accumulated charges on
the surface of the gel. This system could only work in air which may be desired for some
industrial applications.

Miyata et al. fabricated a glucose responsive hydrogel using the formation of crosslinking complexes between poly (glucosyloxy-ethylmethacrylate) poly (GEMA) and
concanavalin-A (16). When there was free glucose present in the aqueous environment that
the hydrogel was placed in, the hydrogel responded by an increase in swelling. The degree of
swelling was predominantly a function of the degree of crosslinking. Thus this bioresponsive
gel functions as a biomolecule recognition device. This can be exploited for a drug delivery
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vehicle that releases insulin based on the concentration of glucose or as a bioresponsive valve
in a microfluidic device. Another example of actuation by a change in cross-linking density
is the system developed by Kim et al. (17). The optical property of spherical poly (Nisopropylacrylamide-co-acrylic acid) hydrogel particles was exploited as flexible
microscopic lenses that change their focus upon changes in swelling. A reaction between the
biomolecule and cross-links in the hydrogel structure led to swelling at the surface of the
material. Hydrogels of poly (N-isopropylacrylamide-co-acrylic acid) were prepared and
functionalized with biotin and aminobenzophenone. These hydrogels were adsorbed onto a
surface. Anti-biotin molecules were photo chemically cross-linked into the structure at the
surface linking the biotin and aminobenzophenone. This cross-linking controlled the degree
of swelling at the surface. When free biocytin, a substitute for biotin, was present in solution
it knocked off the anti-biotin from the anchored hydrogel biotin thus cleaving the cross-links
and changing the degree of swelling at the surface. The degree of swelling at the hydrogel
surface controlled the optical properties which when actuated resulted in a change in the
focus of an image projected through the material. This was documented via optical
microscopy.

The final category of polymeric actuators is the shape memory polymers (SMP). SMP‟s
are a class of polymers that are programmed to memorize a less constrained configuration,
then assume a temporary strained configuration followed by returning to the less constrained
form due an external stimulus (14). Traditionally SMP‟s are known for high percentage strain
recovery and high magnitude of stress generation as a result of an external trigger. Usually
this trigger is a thermal transition. The intrinsic mechanism for shape memory behavior in
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thermally responsive SMPs is the reversible freezing and activation of polymeric chain
motion in the network segments below and above a transition temperature, respectively.
Shape memory properties have been reported in a wide range of polymers including, but not
limited to, polyurethanes, epoxies, polyolefins, and polyesters. The driving force for shape
recovery of an SMP is the recoiling of the polymer chains from a temporary state to a lessordered configuration (14). Upon deformation at a higher temperature, termed as transition
temperature (Ttrans), the original orientations of the chain segments get altered, resulting in
new sets of local chain-chain interactions. The temporarily deformed shape can be fixed as
the material cools (T < Ttrans), provided there is no elastic recoiling upon cooling. When
triggered by a temperature greater than the transition temperature, the increased entropy of
chain segments overcomes the constraining local chain-chain interactions, permitting the
recoiling of chain segments to a more disordered state. The net-points of an SMP network,
which maintain its dimensional stability, could be either covalent or physical crosslinks. The
switching components that reversibly respond to temperature changes can be either
amorphous or semi-crystalline. Thus the transition temperature could be glass transition
temperature (Tg) characteristic of the amorphous regions or melting temperature (Tm)
representative of the crystalline regions.

A majority of early SMP‟s that found use in biomedical applications were not designed
primarily for those applications (14, 18).The very first SMP polymer system for biomedical
application was adapted by Hiyashi et al. (19) in the form of a polyurethane SMP based
catheter which softened at body temperature to minimize any tissue damage during surgical
delivery. Since then various other systems have been devised for applications such as
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coronary grafts, drug eluting stents, tissue engineering scaffolds, and dynamic cell culture
substrates (14, 20). Maitland et al. (21, 22) designed a novel thermoset polyurethane (MP
5510) SMP-based micro-actuator for treating strokes by making a blend of hexamethylene
diisocyanate (HDI), N,N,N‟,N‟-tetrakis (2-hydroxypropyl) ethylenediamine (HPED), and
triethanolamine (TEA) and encapsulating a nitinol backbone wire. The micro-actuator was
coupled to an optical fiber and was set in a straight configuration for easy surgical insertion.
Once the target clot site was reached, laser heating was applied to heat the polymer to a
temperature between 65°C and 85°C to activate the SMP to form a pre-cast corkscrew shape
to facilitate the capturing of the thrombus. Due to the high transition temperature there was
concern about local damage to the blood vessels.

The transition temperatures for most of the SMP‟s are well above body temperature (14,
18). To make the polymer relevant for biomedical application, the transition temperatures in
the 30° – 40° C range are necessary and have been achieved by optimizing the network
composition (20, 23). A new branch of SMP‟s combining the properties of near body
temperature Ttrans and incorporation of degradable segments have enabled a whole new set of
applications (18, 18, 24, 25). By conjugating biodegradable poly (lactic-co-glycolic acid)
PLGA oligomers with shape memory component polyhedral oligosilsesqioxane (POSS),
Knight et al. designed an organic-inorganic crosslinked SMP network (24). By controlling
the degree of crystallinity (% POSS), the rate of degradation of the polyester segments was
modulated. Both Tg and Tm were investigated for the Ttrans. The temperature at which the
temporary shape was fixed and the method of fixing the shape governed the success of shape
fixing and the degree of strain recovery. If the cooling process after shape fixing was
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performed slowly then that provided POSS chains time to crystallize and thus retain the
temporary shape better. However the strain recovery was only 20% when Tg was used as the
Ttrans. PLGA has a Tg close to body temperature which gets further lowered in aqueous state
as is common with polyesters (18, 24). When the SMP was immersed in PBS buffer at 37°C,
shape recovery based on Tg trigger was observed. After the initial Tg based 20% strain
recovery, further shape recovery occurred as the network degraded and the crystalline POSS
was unable to hold the temporary shape. The network degraded completely on a timescale
between three to fourteen weeks depending on the concentration of POSS in the network. As
the POSS concentration increased, the hydrophillicity of the network decreased which also
slowed the rate of PLGA degradation. This organic-inorganic crosslinked SMP network is a
significant step towards increasing applicability of SMP‟s for biomedical applications.

An example of SMP‟s designed specifically for soft tissue application is surgical sutures.
Langer et al. synthesized a degradable block copolymer by coupling oilgo(εcaprolactone)diol

(OCL)

and

oligo(p-dioxane)diol

(ODX)

with

2,2,(4),4-

trimethylhexanediisocyanate (25). They fabricated sutures that were programmed by
elongation and fixing the elongated state. The transition temperature for this SMP was 41°C.
The sutures could be elongated up to 1000% before failure. When the shape memory was
triggered, the force generated as the material rapidly shrunk was of the order of 1.6 N in vitro
while in vivo this force was detected as 0.1 N. The degradation of the L-lactide polyesters
was linear and the degradation products were cytocompatible. Thus they were able to
demonstrate a possible alternative to basic sutures and a way to reduce the subjective
variability in the force used to tie the knots while applying sutures. Near body temperature
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transitions have also made it possible to perform fundamental science studies in order to
understand behavior of cells. Substrate stiffness and topography play a major role in
processes like cell division, migration, and phenotype (26, 27). Using the property of shape
memory transition, substrates have been designed to understand how a dynamic change in
morphology can affect the cell. Davis et al. designed polyurethane based SMP by
crosslinking Norland Optical Adhesive-63 (NOA-63) and temporarily fixed a ridge and
groove geometry (20). The transition temperature was between 30°C-37°C which was
achieved by lowering of the Tg via fabrication conditions. The Tg of wet NOA-63 normally
is 51°C. C3H/10T1/2 mouse embryonic fibroblasts were seeded on these substrates at 30°C
and after 10 hours the temperature was raised to 37°C to trigger the transition. The SMP
activation triggered a rapid change in morphology and almost the entire pattern was lost
within an hour. The cells that had aligned to the pattern now lost their directional orientation.
Despite this the cell viability still remained high (95%).

1.2 Limitations of polymeric actuators for biological applications
When it comes to biological application of polymeric biomaterials it is critical to match
the mechanical properties of the polymer matrix with that of the native tissue (26-29).
Hydrogels offer a good solution to this by having the property of mechanical tunability. As a
mechanical actuator, the swelling/de-swelling behavior of the gel has to be used to perform
actuation/locomotion. There are several design and conceptual challenges in this area,
primary one being the delicate relationship between swelling phenomenon, strength of the
gel, and the ability to generate forces. This relationship is also known as the force vs stroke
behavior (4). Stroke is defined as the displacement achieved by the actuator. Hydrogel based
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actuators like PNIPAAm generate strokes by swelling or de-swelling around the transition
temperature. For a high value of stroke the swelling needs to be large which would suggest
low crosslink density. This also translates to a weaker gel matrix which will be unable to
produce high value of force. Thus force and stroke are inversely related. To obtain sufficient
force potential, the stiffness of the ideal gel material falls outside the range of most biological
soft tissues (3). The bioresponsive gels in the form of EAP‟s can produce high force
generating displacements as a direct consequence of an external DC electric field or change
in ionic makeup of the direct environment (3, 15). EAP‟s have found tremendous use in
microfluidic devices and lab-on-chip strategies (3). However from a biomedical application
perspective, their use is limited due to the requirement of maintaining a steady electric field
or ionic concentration (16, 17, 30).

SMP‟s have been designed to be degradable, biocompatible, with transition temperatures
close to body temperature, and most importantly generate high strains during the shape
recovery phase. The transformation of the SMP networks after the transition temperature is
reached is very rapid, usually ranging between 1.8% to 5% per minute depending on the size
of the monomer used to form the crosslinked network (14, 23). The focus of a majority of
investigations of polymeric actuators is in relation to microscopic applications such as
sensitive valves in a microfluidic device or for localized delivery vehicles for drugs or
macroscopically as coronary stents and novel tissue culture scaffolds (2, 5, 14, 18, 22, 25).
For such applications quick and uniform actuator response is desired (1, 4, 5). Thus the focus
of this field currently is towards designing faster responding materials. There exist other
areas of biomedical applications where polymeric actuators have been underutilized. For
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many years there has been a hypothesis that nervous tissue can be successfully elongated via
application of an external mechanical force alone (31-34). Recently this hypothesis has been
proven in vitro by several researchers using mechanical motors (31, 35). The principal
requirement for sustained elongation of nervous tissue is a controlled slow rate of extension.
In theory polymeric actuators could provide an alternative to the mechanical motors and lead
to in vivo therapies to treat peripheral nerve gap injuries. When we inspect the current library
of polymeric actuators that can be used on the macroscopic scale for such a soft tissue
application there is a serious lack of available options. The rapid displacements that the
current library of polymeric actuators possess, necessitate investigations into designing a new
category of degradable, biocompatible, slow actuating polymer systems that can sustain
actuation for several days.

1.3 Motivation for this Dissertation
Based on the discussion of the current options within polymeric actuators, it is clear that
there is a lack of a slow actuating polymer system that can be used in biological environment
for prolonged stress application. Our goal was to design a polymeric biomaterial that can be
used in vivo to impart tensile force to cells akin to an in vitro micromotor controlled
apparatus. The critical requirements for a suitable biomaterial included biocompatibility, ease
of chemical modification, cell attachment, ability to generate tensile force, and
biodegradation. The rationale for this work, as shown in Figure 1.1, is simple yet involves
careful balancing of several parameters. We propose a system that enables us to store a
retractive stress in a crosslinked network along a pre-defined axis during fabrication. Storing
a retractive stress in essence means storing energy in the system. By gradually releasing this
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stress we hypothesize that the crosslinked network will shrink in dimension along the predefined axis. Any object attached to the ends of this shrinking matrix would be similar to a
micromotor applying tensile stress on that object. We chose high molecular weight, shear
thinning hyaluronic acid to form our crosslinked networks. The following sections discuss
the advantages of selecting this natural polysaccharide to design the polymeric actuation
matrix.

Fig.1.1. Schematic showing the rationale for fabricating hyaluronic acid based hydrogels that
have retractive stress stored in the network
1.3.1 Hyaluronic Acid
Hyaluronic acid (HA) was first discovered in the vitreous humor of the eye in the year
1934 (36). The main subunit of HA is a disaccharide composed of alternating 1, 4- linked
units of 1, 3-linked glucoronic acid and N-acetylglucosamine. HA is a naturally derived, nonadhesive, non-immunogenic, non-sulfated, linear viscoelastic glycosaminoglycan. HA is well
known for its wound healing properties (36, 37). It exists in the human body predominantly
in the synovial fluid and acts as a lubricating and shock absorbing component (37, 38). In
recent past it has been used as a successful viscosupplement in eye surgeries and to relieve
pain in arthritic joints (36, 37, 39). Despite its relatively high molecular weight (~ 106 Da) it
gets degraded or turned over at a rapid pace. To counter this, researchers have crosslinked
HA via different strategies (40). One of the common strategies is to attach a
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photocrosslinkable moiety to the HA chain and crosslink it, thereby slowing down the
degradation and considerably increasing the residence time in body. HA can be modified
chemically at the hydroxy groups on both the glucoronic and N-acetylglucosamine units or
the carboxyl group on the glucoronic acid unit. There has been a growing interest in the
tissue engineering community for HA based scaffolds (41). HA is synthesized at the cell
level without a protein core; however it interacts with many extracellular matrix molecules
and cells (39). HA provides the benefit of having structural conservation, meaning there will
be minimal or no immunogenic response when injected into the human body despite the
source of HA.

The HA molecule in its native state is in a random coil conformation. The high molecular
weight of this molecule poses some problems with ease of solubility. A solution containing
HA at concentration of 1x106 Da saturated the solution at a concentration of 0.4 wt% (37,
39). Beyond this, any new polymer chains dissolved in the solution causes entanglement of
the coils. HA solutions are highly viscoelastic in nature. High frequency perturbations cause
the solution to act like an elastic material while lower frequency forces elicit a viscous
response. This is the main mechanism by which HA acts as a shock absorber in the synovial
fluid in the joints. HA molecules have the advantage of being shear thinning (38, 39). Under
the influence of shear flow the random coils slowly disentangle to varying degrees and align
along the direction of flow. This enables even highly concentrated solutions to be injectable.
The basis of this work lies in exploiting this property. If a solution of highly concentrated HA
were to be sheared and then rapidly crosslinked before all the molecular chains are able to
relax back to random coil conformation, then a residual retractive stress could be stored in
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the network. Furthermore, if this stress were to be slowly released then we believe the
process would cause the gel matrix to shrink along the original flow axis.

We investigated the shrinking mechanism by either selectively degrading the crosslinks
that hold the network together or by selectively degrading the long HA backbone chains. A
schematic of the two pathways used to study this crosslinked gel system is shown in Figure
1.2. To study the effect of selectively degrading the HA chains, we crosslinked the network
using a nearly non-degradable crosslinker poly(ethylene glycol) diacrylate (PEGDa). In the
human body HA is broken down predominantly by the enzyme hyaluronidase. The cleavage
occurs

at

the

β-N-acetyl-D-glucosaminidic

linkages

to

yield

fragments

of

N-

acetylglucosamine at the reducing terminus and glucoronic acid at the non reducing end (36,
37, 42, 43). We used this enzyme at physiologic and elevated concentrations to simulate in
vivo degradation at the site of injury. The breakdown products of HA have been shown to
modulate wound healing (36, 37, 39). This would be an added advantage of this polymer
network system that would aid in repairing the injury site while providing mechanical
stimulus to the neurons to grow. To study the shrinkage induced by degrading crosslinks, we
crosslinked the network using a hydrolytically degradable crosslinker poly(ethylene glycol)poly(lactic acid) diacrylate (PEGPLADa). The degradation products are non toxic in this case
as well.
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Fig.1.2. Flowchart detailing the experimental rationale

Another advantage of the HA molecule is its favorability for cell attachment. CD44 is a
major cell surface receptor for HA (44). It is expressed on many different cells including
neuronal cells where it is over expressed following any trauma (45). CD44 has many
functions depending on the cell type. For neuronal cells it is said to be involved in directed
migration. CD44 along with a receptor for hyaluronan mediated mobility (RHAMM) provide
opportune sites for attachment of the crosslinked HA hydrogel to neuronal ends (46). HA has
been documented as enhancing peripheral nerve regeneration (47). Rats with a sciatic nerve
gap injury were implanted with a nerve guide consisting of ports to inject HA solutions. It
was observed that HA helped in organizing the fibrin matrix making it more porous and
favorable for regenerating axons to cross over. We believe that the versatility of HA
molecule makes it an ideal candidate for application as a nerve regeneration matrix.
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1.4 Targeted Application for HA Based Slow Polymeric Actuator System
1.4.1 Peripheral Nervous System
The Peripheral Nervous System (PNS) consists of cranial nerves coming out of the brain,
the spinal nerves from spinal cord, and sensory nerve cell bodies and their processes (48-50).
The peripheral nerves act as the cables transferring excitatory signals from and to the spinal
column from the muscle tissues. Peripheral nerves are generally classified as motor or
sensory nerve. However no nerve is purely sensory or purely motor. The motor nerves are
myelinated while sensory are largely unmyelinated. The ratio of number of sensory nerves to
number of motor nerves is around 4:1 (50). The anatomy of a peripheral nerve is shown
below in Figure 1.3. A peripheral nerve is akin to a coaxial electrical cable consisting of
many individual axons bundles together and insulated from each other. Individual axons are
surrounded by Schwann cells that provide the necessary support for transmission of
excitatory signal through the axons. Endoneurium surrounds individual axons and their
ensheathing Schwann cells. The endoneurium is primarily composed of oriented collagen
fibers. A group of these axons is surrounded by perineurium to form fascicles. The
perineurium is composed of many layers of flattened fibroblasts. Finally, a fibrous and
collagenous layer called epineurium binds many of these fascicles together to form the nerve
fiber or the trunk.
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Fig.1.3. Anatomy of a peripheral nerve showing the basic architecture of a nerve (50)

1.4.2 Peripheral Nerve Injury
There are several causes for a PNS injury including but not limited to mechanical,
chemical, biological, or thermal sources. The most common source is mechanical injury
ranging from simple cuts to amputations. The effect of such injuries from the perspective of
the nervous system is the transection of peripheral nerves. Following an injury several natural
processes occur that determine the fate of the recovery from the injury. The crucial difference
between a peripheral and a central nervous system (CNS) injury is that the native
environment facilitates axonal regrowth for PNS, where as it is inhibitory in the case of CNS
(48, 51-54). Following a complete transection nerve injury, the nerve ends move away from
each other due to the inherent tension in the nervous system. Next there is retrograde
degeneration of the nerve ends and the Schwann cells lose their myelin and degrade as well.
The macrophages that enter the site of injury then start phagocytotic clearance of the cell and
myelin debris. This also triggers release of cytokines that promote sprouting of new neurites.
In the CNS the astrocytes and fibroblasts enter a hypertrophic state and form an astroglial
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scar which is a physical barrier for the axonal sprouts to grow across the injury. In the PNS
injury the absence of this scar tissue causes the neurites to re-grow and form connections to
the distal end of the severed nerve or the target tissue.

Fig.1.4. Schematic showing the sequence of events that occur at the site of a peripheral nerve
injury. After a severance injury, the proximal end of the nerve starts to degrade while the
Schwann cells give up their myelin coat and become phagocytic. Along with macrophages,
they clear the debris at the site of injury and trigger release of cytokines which promote
axonal sprouting (50)

1.4.3 Current treatments for PNS injury
The treatment of a nerve transection is dependent on the size of the injury gap. Similarly,
the extent of regeneration and re-innervation in the PNS is also governed by the size of the
gap. For a smaller gap (<10 mm) the surgeon can pull the severed nerve ends closer and
suture them to repair the injury (36, 49). Aligning the internal fascicles into motor or sensory
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components helps to improve the outcome. Researchers and neurosurgeons have observed
that if the nerve gap is larger than 10 mm, the success of the re-innervation is low. To
mitigate this issue, the current gold standard treatment is an autologous nerve graft. This
means harvesting a nerve, usually sural or sensory nerves from upper extremities, and
suturing it in the gap to bridge it. The recovery rate is around 80 % which is the best achieved
across all available traditional and experimental treatments. Generally the surgical repair is
not done immediately after the injury to reduce any unknown damage.

The main disadvantages of the surgical treatment include the availability of donor nerve
tissue, multiple surgeries, and the loss of function at the donor site. Alternatives to
autologous nerve grafts include allogenic or xenogenic nerve grafts, but they possess the risk
of an immune reaction. Using immunosuppressant drugs is not always possible in cases
involving trauma or cancer. Engineered nerve conduits were the next alternative that has
been studied for the past several decades. The main requirements for a nerve conduit are easy
availability, biodegradability, easy vascularization, low antigenicity, ease of oxygen
diffusion, and avoiding long-term compression (49, 55). Using naturally derived materials
like laminin, fibronectin to form guidance conduits have demonstrated exciting results. Batch
to batch variability in these naturally derived molecules hamper their wide spread application
(49). Synthetic engineered conduits provide the ability to alter the mechanical properties,
biocompatibility, degradation, porosity etc. Researchers have tested constructs fabricated out
of degradable biocompatible polymers like poly(lactic-co-glycolic acid) (PLGA) and poly(Llactic acid) (PLLA) with controlled porosity (49, 56-58). Over time PLGA constructs
demonstrated diminished structural rigidity leading to nerve compression. However PLLA
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constructs did not show any nerve compression (49, 57). The critical limitation faced by
nerve conduits is the ability to sustain axonal regeneration for gaps larger than 15 mm (49,
55). Despite promising results from all the alternate experimental forms of treatment for large
gap neuronal injuries, none have managed to match the autologous nerve graft success rate.

1.4.4 Mechanical stimulation of neuronal cells
How does an axon grow? In vitro and in vivo axonal growth have slight differences in
their progression, however the main framework for growth is same for both cases. In vitro,
topographic or chemical cues guide the growth cone and cause the axonal growth. In vivo,
the axonal growth is a two stage process where the growth cone follows the topographic and
chemical cues and binds to its target and then the axon elongates grows as a result of the
growth and movement of the target. The microstructural makeup of the axon, consisting of
actin cytoskeleton and microtubules, is what allows the sustained and stable elongational
growth of the axon. The actin cytoskeleton and microtubules exist in a balanced tensioncompression environment (31, 59). As a result of various growth cues the cell secretes
extracellular matrix and add new membrane along the axon. As the growth cone explores the
substrate or when the target that the growth cone is attached to traverses, new actin
polymerizes to sustain the movement of the growth cone. Simultaneously the addition of
microtubules counters increasing tension from the actin. The transport of nutrients to sustain
the addition of new membrane needs to match with the growth rate or else axonal growth is
not possible and leads to retraction of the axon. Over the past several decades, in vitro
neuronal studies have confirmed that the growth cone is the component that drives the axonal
growth and elongation on a substrate (33, 60). The growth cone explores the substrate that it
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is attached on and based on the chemical or mechanical guidance signals it traverses in the
favorable direction. Unlike non-neuronal cells which migrate in response to favorable cues
(61, 62), neuronal cell bodies generally remain stationary while the growth cone migrates and
pulls the axon along with it. As for the in vivo growth it occurs in two phases. In the
embryonic state the growth cones are in their sensing mode searching for its target. Thus the
growth cone in response to matrix cues is the causative agent in the axonal growth in this
phase. Once it reaches its target it no longer in control of the axonal growth/elongation. As
the target moves away, on account of growth of the body, it pulls along with it the attached
axons. This is a naturally occurring phenomenon. Weiss described it in 1941 (34) as a three
stage process. Figure 1.5 shows a schematic of those three stages of axonal growth in vivo.

Fig.1.5. Schematic showing the three phases of in vivo neuronal growth as described by Paul
Weiss. It was posited that „„the nerve is drawn out by the growth and dislocations of its
terminal tissues‟‟ (34) (reprinted with permission from Elsevier Publishing)

The “towing” phase presents a fascinating hypothesis that mechanical stimulation might
just be enough for promoting axonal growth. It wasn‟t until 1984 that this was
experimentally proven by Bray (31). He designed a device called a “cell puller” that
consisted of a glass microelectrode attached to a micromotor. Neuronal cells obtained from
dissociated chick dorsal root ganglia (DRG) were plated on glass coverslips. The
microelectrodes were coated with laminin or collagen and laid in the path of growth cones.
Once the growth cone attached to the microelectrode the micromotor was switched on and
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the growth cone was pulled at rates ranging from 40 µm/hr to 170 µm/hr for the duration of 3
hrs to 24 hrs. What he observed was that growth cones that were extended at the rate of 100
µm/hr or less showed a net growth ranging from 100 µm to 960 µm. At higher rates the
neurites initially thinned out and then detached from the glass microelectrode. Figure 1.6
shows a micrograph from one of these experiments. The cytoplasm of the extended axons
appeared to be normal and an increase in volume of the axon was observed. Furthermore if
the growth cone was detached and returned to the coverglass the axon continued to thrive and
grow. Moreover, Bray was able to generate axons de novo (31). He attached the
microelectrode to a round neuronal cell body devoid of any processes and by just the
application of a tensile stress was able to coax the cell to generate a neurite. This extension
appeared similar to a neurite but was devoid of a growth cone like structure at its point of
attachment with the microelectrode. This further provided proof that towed growth did not
need the growth cone.

Heidemann and Baxubaum (60), and Lamoureux et. al (63) further elaborated on this
study and confirmed that mechanical tension by itself can be a potent cue for enhancing
axonal growth. In towing neurites from pheochromocytoma cell (PC12 cells) and chick
sensory neurons, they observed that there was a direct correlation between axonal
elongational rate and tension rate and magnitude and that it was threshold dependent. They
also noted that loss of tension caused retraction of the neurites. By attaching glass
microspheres coated with polyethyleneimine (PEI) they were able to confirm that the new
membrane gets added interstitially throughout the neurite as opposed to near the growth cone
during a growth cone mediated axonal growth. They concluded that tension acts as a
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regulator for axonal elongational growth by modulating the polymerization and depolymerization of the cytoskeletal elements (60, 63).

Fig.1.6. Optical micrographs showing (c) a single neuron shortly after attachment of its
growth cone to a microelectrode; (d) the same neuron after being towed at 60 µm/hr for
1.9hrs (31). The process induced stretch growth of the axon. There did not seem to be any
reduction in the overall thickness of the axon. (reprinted with permission from Elsevier
Publishing)

The pioneering studies mentioned above came to the conclusion that the limiting rate for
axonal stretching was about 100µm/hr for individual axons and DRG explants and it
correlated with the rate at which nutrient transport vesicles can travel to support this growth.
In the early 2000‟s, Smith et. al published a series of papers describing the effect of
mechanically stretching a bundle of neurites from DRG explants (34, 35, 64, 65). Their
device consisted of precision engineered overlapping Aclar membranes, one stationary and
other attached to a micromotor. DRG explants were plated on the membranes and the
neurites were permitted to crossover. After sufficient number of neurites had crossed over
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they started to move the membranes apart using the micromotor at varying speeds. The
results they obtained were astonishing. Through a controlled process of stress
acclimatization, they were able to stretch the neurites at rates as high as 10 mm/day or 400
µm/hr. However they determined that at least for the first day of the stretch, the maximum
rate that could successfully elicit sustained axonal elongation was 100 µm/hr. If stretched
beyond this rate on the first day the neurites delaminated or appeared to have a reduced
volume. Figure 1.7 shows a picture of their device with an overlaid micrograph of the
stretched neurites. The neurite bundles (~10cm) they were able to get from this extreme
stretching process were elctrophysiologically functional. Stretch-growth did not alter sodium
(Na) channel activation, inactivation, and recovery or potassium (K) channel activation. In
addition, neurons generated normal action potentials that propagated across stretch-grown
axons. However, Na and K channel density showed an increase due to stretch-growth, which
was hypothesized as representing a natural response to preserving the fidelity of neuronal
signaling.
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Fig.1.7. Schematic showing the mechanical device used for extreme stretch of neurite
bundles. Neurons were plated on two adjoining substrates and sufficient time was given for
axons to bridge the two substrates and integrate with other neurons on both sides. The
membranes were pulled apart thereby stretching the interconnecting axons. The stretch rate
were gradually increased to 1 cm/day leading to stretch growth to lengths of at least 10 cm.
(65) (reprinted with permission from Elsevier Publishing)
1.5 Significance of this work
The current options within polymeric biomaterials with multi-functionality include
matrices that are biocompatible, biodegradable, quick transitioning / shape changing, and
mechanically tunable. These properties have all been combined in the form of actuator polymers
(EAP‟s and SMP‟s) that have found application as stents, valves, semi permeable membranes,
and dynamic cell culture substrates. However these matrices are not appropriate for applications
requiring a slower transition and long term application of force. This work will hopefully be a
step towards filling that void. We propose to design, fabricate, and characterize a novel
hyaluronic acid based hydrogel actuator that shrinks over time along a pre-defined axis thereby
providing the source for displacement/force. In terms of the intended application for such a
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matrix, the goal is to provide an alternative to current autologous nerve transplant treatment.
Each year over 50,000 peripheral nerve repair procedures are performed (National Center for
Health Statistics, 1995). The total annual costs in U.S alone exceed $ 7 billion (American
Paralysis Association, 1997). Despite the inherent disadvantages of autologous nerve
transplantation, it is the most preferred treatment for a large gap peripheral nerve injury.
Alternative therapies have been unable to match the success rate of this treatment. Nerve
conduits have the limitation of being unable to sustain axonal growth for gaps larger than 15 mm
(55). There is a lack of an effective biomaterial solution to the problem of a large gap nerve
injury. The in vitro studies discussed in the previous sections confirm and simulate the natural in
vivo process of tensile regulation of axonal elongation. The solution we propose is a biomaterial
that can be programmed to perform the function of a mechanical actuator at rates suitable for
axonal stretch growth. The inherent neuronal cell adhesive property of HA makes it an attractive
scaffold for axonal regeneration. We foresee such a successful system being used inside a nerve
conduit in a large gap peripheral nerve injury to stimulate and enhance axonal growth by the
towed growth mechanism. Due to a finite amount of energy that can be stored in the system that
translates into shrinkage, this material will transition from an active stimulator to a passive
degrading bridge over the course of regeneration and recovery. The potential of shortening the
gap even by a few millimeters would vastly improve the success of nerve conduit based
treatments and increase their efficacy for treating large gap PNS injuries.
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CHAPTER 2
SPECIFIC AIMS AND HYPOTHESES

Specific Aim I: To investigate effect of crosslinker concentration on the molecular chain
alignment and network properties of Poly(ethylene glycol)-diacrylate (PEGDa) crosslinked
hyaluronic acid (HA) hydrogels
Hypothesis 1: Increasing the crosslinker concentration increases the degree of alignment of
molecular chains in the crosslinked HA hydrogels. This is manifested as an increase in
orientation birefringence (Δn) of the sample.
Hypothesis 2: As the crosslinker concentration increases, a higher degree of molecular
chain alignment will be retained, resulting in increased retractive stress in the HA network.
Rationale: The HA molecular chains align along the axis of flow, to varying degrees, during the
process of injecting the pre-crosslinking solution into the mold. This chain alignment can be
retained to some extent by crosslinking the chains rapidly. This process traps a retractive stress in
the crosslinked network. The extent to which this chain alignment is retained is a function of the
crosslinker concentration.

Polarized optical microscopy experiments will be performed to

explore this relationship and rubber elasticity theory will help us quantify the stress that can be
stored in the HA network via rapid crosslinking of the shear flow oriented HA molecular chains.
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Specific Aim II: To investigate effect of glycidyl methacrylated hyaluronic acid (HAGMa)
concentration on the molecular chain alignment and network properties of Poly(ethylene
glycol)-poly (lactic acid)-diacrylate (PEGPLADa) crosslinked HA hydrogels
Rationale: The pre-crosslinking solution consisting of HAGMa, crosslinker, and photoinitiator
is sheared while being injected into the mold. HA random coils disentangle and align along the
axis of flow to varying degrees. This state of the chains can be prevented from relaxing back to
random coils by rapidly crosslinking the system with excess crosslinker. The extent of retractive
stress stored in the network is a function of the concentration of HAGMa chains. We hypothesize
that there is a direct correlation between the concentration of HAGMa and the magnitude of
stress stored in the network.
Hypothesis 1: Increasing the HAGMa concentration decreases the degree of alignment of
molecular chains in the PEGPLADa crosslinked HA hydrogels. This is manifested as a
decrease in orientation birefringence (Δn) of the sample.
Rationale: Shearing pre-crosslinking solution aligns the HAGMa chains to varying degree. If
the shearing force is kept constant, then increasing the HAGMa concentration will decrease the
extent of chain disentanglement. This would cause fewer chains to align to the flow direction.
Hypothesis 2: Increasing the HAGMa concentration increases the magnitude of retractive
stress stored in the network.
Rationale: The HA molecular chains align along the axis of flow, to varying degrees, during the
process of injecting the pre-crosslinking solution into the mold. This chain alignment can be
retained to some extent by crosslinking the chains rapidly. This process traps a retractive stress in
the crosslinked network. The extent of stress stored in network is a function of the HAGMa
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concentration. Polarized optical microscopy experiments will be performed to explore this
relationship and rubber elasticity theory will help us quantify the stress that can be stored in the
HA network via rapid crosslinking of the shear flow oriented HA molecular chains.
Specific Aim III: To understand the behavior of HA hydrogel networks during degradation
and measure the force generated by the networks during the degradation process.
Rationale: Crosslinking the HA chains while they are disentangled and aligned to varying
degrees results in entrapment of a retractive stress in the network. This stress can be released by
manipulating the network, specifically either by breaking the HA molecules or selectively
cleaving the crosslinks that hold the network. The two crosslinkers selected for the study provide
opportunity to independently study the two mechanisms of releasing the stress in the network.
The enzymatic degradation of gels crosslinked with non-hydrolysable PEGDa will help us to
study the effect of breaking the HA chains on shrinkage, while hydrolytic degradation of
crosslinks in gels crosslinked with PEG-PLA-Da will help us to study the effects of cleaving just
the crosslinks on shrinkage behavior.
When such a shrinking hydrogel is connected to a neuronal bundle, it will be applying a
force on the bundle, in essence performing work on the tissue. We intend to study and quantify
the force that the shrinking hydrogel network is capable of generating while degrading/shrinking
and compare with studies that have used mechano-stimulation to elicit stretch growth in neurons.
We expect to understand the effect of the species of crosslinker, its concentration in the gel, and
the method of degrading the network on the shrinking behavior of the hydrogels. Comparing the
results from the theoretical calculation of retractive stress in the gel network from specific aim 1
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with the results from the stress measurement device, will help us to understand the limits of the
shrinkage process.
Hypothesis 1: Increasing PEGDa concentration in the hydrogel increases the magnitude of
shrinkage and force generated by the shrinking hydrogel.
Rationale: Higher PEGDa crosslinker concentration will increase the probability of trapping a
higher volume of HAGMa molecular chains in their disentangled conformation. A higher degree
of this retained alignment amounts to a higher magnitude of retractive force being stored in the
network. This translates to a higher potential for the network to shrink under the influence of the
enzyme hyaluronidase which causes a reorganization of the network.
Hypothesis 2: Increasing hyaluronidase concentration increases the rate of shrinkage and
the rate of force generated by the shrinking PEGDa crosslinked hydrogel.
Rationale: The rate at which the crosslinked HAGMa network is reorganized due to degradation
is a function of the concentration of degradation source, the enzyme. A higher concentration of
the enzyme hyaluronidase should potentially speed up the rate of degradation and thus the rate of
shrinkage and rate of force generated during the shrinkage.
Hypothesis 3: Increasing HA concentration in the PEGPLADa crosslinked hydrogel
increases the magnitude of shrinkage and force generated by the shrinking hydrogel.
Rationale: Higher HAGMa concentration will increase the probability of trapping a higher
magnitude of retractive force being stored in the network. This translates to a higher potential for
the network to shrink while releasing this stored retractive stress.
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Hypothesis 4: Degradation process reduces the degree of alignment of molecular chains in
the crosslinked HA hydrogels.
Rationale: The basic hypothesis for this hydrogel system is that the long chain HAGMa polymer
is able to disentangle under shear flow and then relax when this flow or any obstruction to relax
is removed. This relaxation process in a crosslinked network causes a reorganization of the
network. Hence we hypothesize that the degree of alignment will reduce as the network gets
reorganized. Molecular chain alignment in a network leads to a phenomenon called
birefringence. We aim to verify the above hypothesis by measuring the birefringence of the
network prior and post degradation.
Specific Aim IV: To study the interaction between crosslinked hydrogel and neuronal cells
using mechanical stretching device and assess the cytocompatibility of the crosslinked
hydrogels
Hypothesis 1: Chemical modification and crosslinking of HAGMa will not affect the
cytocompatibility of HAGMa based hydrogels.
Technical goal: To design a cell culture chamber with capability to be a mechanical
stretching device.
Hypothesis 2: The potential of the shrinking hydrogels to cause axonal stretch growth can
be tested using the custom-built mechanical stretching device.

Rationale: The size difference between the hydrogels crosslinked in the mold and the neuronal
ends on a 2D surface, along with the issue of clamping the hydrogel under fluid without
restricting its shrinking ability, make designing of a direct experiment to test the stretch growth
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capability of the gel networks unfeasible. To circumvent these problems we custom-built a cell
culture chamber where a micromotor can separate an interface in a controlled fashion. Score
cracked glass slides can be mounted on the holders in the chamber such that one side bears a
covalently crosslinked hydrogel, of desired composition, and the other slide with primary
neurons cultured on adhesion protein lanes growing towards the interface of the two slides. After
sufficient time has been provided for interface interaction, micromotors would separate the
interface at rates corresponding to the shrinkage rate of the hydrogels in question. We aim to
shed light on the following questions; can a strong bond be formed at the interface to sustain the
separation motion and do the rates of separation corresponding to shrinkage rates of the hydrogel
produce axonal stretch growth.
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CHAPTER 3
3.1 Introduction
Polymeric actuators are a special class of materials that respond to an external trigger and
undergo a transformation that can be used to perform mechanical work (1-3). Such polymers
have found use in industrial applications like coatings (1) as well as biomedical applications
as drug delivery devices (2, 4-6), micro-valves/switches in microfluidic devices (7, 8) and
sutures (9). However their potential has been grossly underutilized. The focus of researchers
with respect to actuators is reducing the response time for the polymer matrix. Certain soft
tissue applications that could benefit from use of polymeric actuators include areas like
wound closures and nervous tissue regeneration. The cellular processes can benefit from
application of slow tensile forces at rates that the natural cell growth/division can keep up
with (10-12). The inverse relation between the displacement produced by in the actuator and
the resulting force generated consequently, present the greatest challenge in designing
actuators for soft tissue applications (13). The polymer system should possess
biodegradability, a biologically relevant trigger, controlled actuating potential that can be
sustained for several days and be mechanically similar to soft tissue (10-100kPa). Presently
none of the polymeric actuators can deliver all these requirements in one system. We aim to
design a degradable polymeric biomaterial that can be used in vivo to impart tensile force to
cells akin to an in vitro micromotor controlled apparatus. The strategy was to store a retractive
stress in a crosslinked network along a pre-defined axis during fabrication. By gradually
releasing this stress over time by degradative processes, we hypothesize that the crosslinked
network will shrink in dimension along the pre-defined axis and produce controlled long
term actuation over the course of several days.
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Treatment of large gap (> 1 cm) peripheral nerve injuries has posed a significant
challenge to the medical and biomedical engineering community (14-16). The nervous
system is always under some degree of tension. For small gap injuries (< 1 cm) the
neurosurgeon can surgically suture the nerve ends. For larger gaps the current gold standard
treatment is a surgical autograph (15, 16). However this method of treatment has it pitfalls
which include need for harvesting a functional nerve from somewhere else in the body, risk
of infection, and loss of functionality for the donor site. The functional recovery rate is
around 80% (1). Allografts and xenografts have been used as alternatives; however there is
always a chance of rejection and an immune reaction. Biomaterial strategies have explored
the application of polymeric conduits supplemented with growth factors or support cells like
Schwann cells with promising results (14-16). However they have not been able to match the
success rate of autografts.

Understanding how an axon grows could provide some guidance in improving
biomaterial strategies to enhance their axonal growth. The growth cone is considered a key
player in axonal growth in vitro (11, 17). In vivo however, there are two main mechanisms of
axonal elongation. The first is via growth cone extension, while the second occurs after the
growth cone has synapsed with its desired target and the neuron elongates as the target
relocates and pulls the neuron with it (12, 18). The latter mechanical stimulation mechanism
is called “stretch growth” or “towed growth”. In vitro studies in the past decades have used
calibrated micro-needles and mechanical micromotors to simulate and manipulate this
phenomenon (10, 12, 19-21). The goal of such studies was to understand this mechanism and
determine the limits of stretch growth. We aim to develop a hydrogel that can perform the
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same function as a micromotor and “tug” on the neuron it is attached to, thereby providing
mechanical stimulation to enhance their growth.

This work describes a crosslinked network system wherein retractive stress was stored
along a pre-defined axis during fabrication and later by gradually releasing this stress we
hypothesize that the crosslinked network will shrink in dimension along the same pre-defined
axis. If nerve endings are attached to the ends of this shrinking matrix, it would be similar to
a micromotor applying tensile stress on the neurons. Unlike the mechanized studies
mentioned above, the polymer network system developed here will have a limit to its
potential of being an actuator. We believe that this system will exist in two stages. During the
first stage the hydrogel network will release the stored retractive stress and shrink, while in
the second stage once the hydrogel has stopped shrinking it will exist as a passive scaffold
that will act as a bridge for the neurites to cross over.

In order to be able to store a retractive stress in a network we needed to select a long
chain biocompatible polymer. Some of the other requirements included ease of chemical
modifications for the purpose of crosslinking, being a natural ligand for neuronal cells, and
being naturally degradable to non-toxic byproducts. HA is a naturally occurring
glycosaminoglycan that has been shown to enhance peripheral nerve regeneration (22, 23). It
is a natural ligand for cell surface receptors like CD44 and RHAMM (24-27). The shear
thinning property of HA would allow the molecular chains in even a highly concentrated
solution to disentangle and align to the direction of flow. Rapid crosslinking of the chains in
this state would allow us to store a retractive stress in the network. Releasing this stress may
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lead to shrinkage of the network. We investigated the shrinking mechanism by either
selectively degrading the crosslinks that hold the network together or by selectively
degrading the long HA backbone chains. This chapter details our efforts at characterizing the
hydrogel shrinkage as a result of degrading the HA network. To study the effect of
selectively degrading the HA chains, we crosslinked the network using a almost nondegradable crosslinker poly(ethylene glycol) diacrylate (PEGDa). In the human body HA is
broken down predominantly by the enzyme hyaluronidase (27-31). Enzyme concentrations
simulating normal and post injury over-expression were tested. The hydrogel was
characterized for its capability to shrink and to generate force in the process.

3.2 Materials and Methods
Sodium salt of HA (MW 1.6 MDa), bovine testicular hyaluronidase, poly(ethylene glycol)
diacrylate (PEGDa), and glycidyl methacrylate (GMa) were purchased from Sigma Aldrich.
GMa and PEGDa were filtered to remove MEHQ inhibitor. Irgacure 2959 was purchased
from BASF chemicals. All other solvents and chemicals were purchased from Sigma unless
stated otherwise and used without further purification.

3.2.1 Methacrylation of HA: Sodium salt of HA derived from Streptococcus equi, MW
1.6MDa, was used in the derivatization reaction. The functional unit of an HA molecule
is a disaccharide consisting of N-acetylglucosamine and glucoronic acid. There are two
main sites on an HA disaccharide suitable for modification, namely the pendant hydroxyl
group on the N-acetylglucosamine and carboxylate on the glucoronic acid component.
The derivatization method was adapted from previous work by Bader et al. with
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poly(vinyl alcohol) gels (32). An excess of GMa was used to covalently attach the
methacrylate moiety onto the HA disaccharide. Briefly, HA was dissolved in deionized
water (DI H2O) at a concentration of 3 mg/ml. A 20 molar excess of GMa was then
dissolved in the HA solution, the pH was adjusted to 1.5, and the reaction was carried out
at 50 °C for 2 days. Following this, the reaction mixture was dialyzed against DI H2O for
2 days, after which the product was lyophilized and refrigerated until needed. The
reaction chemistry is shown in Figure 3.1.

The degree of modification was quantified using proton NMR spectroscopy
performed using a Bruker Avance-III 300 MHz spectrometer. Peaks (δ = 5.8, 6.2)
representing the two protons on the methacrylate chain were used to calculate the degree
of modification. The reference peak (δ = 2.0) was the peak representing protons from the
methyl group on HA and methacrylate segment. The solvent used for NMR was
deuterated water. The degree of methacrylation can be altered by varying the molar
concentration of GMa in the reaction, and the duration of the reaction.
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Fig.3.1 Schematic showing the reaction mechanism for methacrylation of hyaluronic
acid. The reduction in pH triggered the ring opening of glycidyl methacrylate which
covalently attached to the HA disaccharide.
3.2.2 Rheological characterization: To ensure that rapid crosslinking is able to restrain the
shear flow disentangled HA molecular chains, it is imperative to know the relaxation
behavior of the solution. An oscillatory strain sweep was conducted on a TA ARG2
stress-controlled rotational rheometer using parallel-plate geometry and a Peltier plate at
room temperature to determine the linear viscoelastic regime. The strain was ramped
from 0.1% to 10% at 25 °C. Step-strain stress relaxation experiments were conducted,
where shear stress was monitored following application of a small shear strain. The
diameter of the plate was 40 mm with a solvent trap and moisture chamber enclosure to
prevent drying of the test solution. The strain values selected were 5%, 7%, 10% and
12%. Various compositions of HA pre-crosslinking solutions minus the photoinitiator
were subjected to the stress relaxation test.
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3.2.3 Fabrication of crosslinked hydrogels: Pre-crosslinking solutions were made consisting
of methacrylated HA, PEGDa crosslinker, and 1% Irgacure 2959 (I2959).
Cytocompatibility studies have showed that I2959 is one of the most cytocompatible
photoinitiators (33). Irgacure 2959 is an α-cleavable type I photoinitiator or α-hydroxy
phenyl ketone. It is a partially water soluble, non-yellowing compound which forms
colorless solutions. The excitation frequency is 320 nm and photo-excitation produces a
benzoyl and a ketyl radical of which the former is the major reactive species. One of the
many advantages of this particular photoinitiator is that the excited triplet state is too
short to be scavenged by oxygen, so the polymerization reaction can be carried out in air
inside a fume hood (34). Experimental samples were fabricated using a mold created
using glass slides as shown in Figure 3.2. The pre-crosslinking solution was injected into
the mold via a 20 gauge needle at a rate of 0.5 ml/min. Rapid crosslinking was initiated
by exposing the mold to a 100 W, 365 nm UV light source. The experimental samples
were crosslinked immediately following injection. To make negative control samples, a
delay was introduced between the injection and UV exposure to facilitate relaxation of
the HA chains. Figure 3.3 shows the reaction schematic of the crosslinking chemistry.
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Fig.3.2. Image of the glass slide mold used to crosslink HA hydrogels. The needle shows
the channel where the pre-crosslinking solution was injected prior to UV exposure.

Fig.3.3. Schematic showing the crosslinking chemistry of the hydrogel. Two ratios of
PEGDa (3:1 and 4:1) were used to crosslink methacrylated HA. The crosslinking solution
turned from clear to opaque indicating success of crosslinking chemistry.
3.2.4 Birefringence experiment: Birefringence is a property that can provide evidence of a net
molecular chain orientation in the crosslinked hydrogel due to rapid crosslinking of the
shear aligned HAGMa chains. Crosslinked HA gels were imaged under the polarized
optical light microscope (POM) to study their orientation birefringence. Since the
samples were opaque in hydrated conditions, they were air dried following which they
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became clear and transparent. The dried gel samples of each composition were placed
between crossed polarisers and the sample stage was rotated to observe the change in
optical birefringence. Since the polarisers are crossed, no light can pass through to the
sensors. When an anisotropic material with some degree of net orientation is introduced
between the crossed polarisers, some of the light is able to pass through the second
polariser onto the sensors. The maximum intensity of this orientation induced
birefringence signal can be observed when the optical axis of the sample is at 45° to the
polariser. The extent of orientation in the hydrogel is a function of the how efficiently the
crosslinker can arrest relaxation of the chains during crosslinking. The intensity of light
was captured using a visible spectrometer and the spectral content analyzed via ocean
optics OOIBase software. The raw intensity spectrum was normalized to obtain the
transmittance spectrum using the following formula;
𝑇 𝜆 = [𝐼 𝜆 − 𝐼𝑑 𝜆 ]/[𝐼0 𝜆 − 𝐼𝑑 𝜆 ]
Where I is the intensity spectrum of the sample, I0 is the reference bright spectrum and Id
is the dark spectrum. The transmittance spectrum, as shown in Figure 3.4, follows the
relation;
𝑇(𝜆) = 𝑆𝑖𝑛2 𝜋

𝛥𝑛ℎ
𝜆
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𝑆𝑖𝑛2 (2𝜒) ........(35)

Fig.3.4. Representative transmittance spectrum from a sample within the visible light
frequencies captured using the spectrometer. The black curve is from a crosslinked
hydrogel sample while the red curve shows the standard equation fit curve obtained from
non-linear regression.

where χ is orientation angle of sample reference axis (45°) with respect to the polariser,
and h is the sample thickness. Using non-linear regression, the experimental data was fit
to the above equation to get the retardance (Δnh) value. Two sets of experiments were
performed to answer two different questions about this hydrogel system. Samples
crosslinked with different crosslinker concentrations were compared for their retardance
to determine the effect of crosslinker concentration on the degree of alignment. The
second set of experiments compared the retardance of samples before and after a 48hr
shrinkage experiment to confirm that the shrinkage is a result of reorganization of the
molecular chains in the hydrogel network. The compositions tested were 60 mg/ml
HAGMa crosslinked with 3:1 or 4:1 ratio of PEGDa. Each sample was imaged at three
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separate locations representing the two ends and the middle of the sample. This was done
to observe if there is any significant difference in the molecular orientation across the
sample. The enzyme concentration for the degradation experiment was 10 µg/ml of
hyaluronidase which simulates the over expression of the enzyme at the injury site.
3.2.5 Calculation of predicted retractive stress in the network using rubber elasticity
theory: In order to predict the retractive stress stored in the hydrogel network, we needed
to first calculate certain network parameters. Swelling experiments were performed on
samples of each composition to calculate the swelling coefficient (Qm) and crosslink
density (n). HA hydrogels consisting of 60 mg/ml HAGMa were crosslinked with 3:1 and
4:1 ratio of PEGDa in the injection mold as described earlier. The gels were swollen in
PBS overnight and weighed to find the wet weight (Mw). The samples were dried in a
desiccator and weighed again to find the dry weight (Md). Qm was calculated using these
masses.

𝑄𝑚 =

𝑀𝑤
𝑀𝑑

Using the swelling coefficient we calculated the volumetric swelling ratio (Qv). It is
related to Qm as follows,

𝑄𝑣 = 1 +

𝜌𝑝
𝜌𝑠

(𝑄𝑚 − 1)

where ρp = density of dry polymer = 1.229 gm/cm3, and ρs = density of solvent = 1
gm/cm3. Applying Flory-Rehner equilibrium swelling theory (36), the crosslink density
was calculated from the following equation:
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𝑛=

− ln 1 − 𝜗 + 𝜗 + 𝜒𝜗 2
1
𝜗
𝑉 𝜗 3−2

where ʋ = volume fraction of polymer in swollen mass = 1/Qv, V = Molar volume of
solvent = 18 cm3/mol, and χ = Flory polymer-solvent interaction parameter = 0.473. As
the crosslinker concentration in the hydrogel increases, Qm will decrease.
We adapted the rubber elasticity principles to calculate the predicted maximum retractive
stress (𝝈Pr) that can be stored in the crosslinked hydrogel network. Under normal
convention when a crosslinked network is stretched by a factor α, the retractive stress in
the network can be calculated using the following relation (36);

𝜍𝑃𝑟 = 𝑛𝑅𝑇 𝛼 −

1
𝛼2

where α = extension ratio = L/L0, R = Gas constant, and T = Temperature. In this current
system we are storing a retractive stress in the network via rapid crosslinking of the
oriented HA chains. So the extension ratio (α) in this case can be assumed to be the
extent by which the disentangled molecular coils are retained in that state.

Pre-

crosslinking solution was injected into the glass mold and crosslinked to form a hydrogel.
The length of this hydrogel (L) was measured. Next the same composition and volume of
pre-crosslinking solution was injected into the mold but this time it was not exposed to
the UV source and crosslinked. This allowed for the relaxation of the molecular chains
that were previously aligned due to the shear flow. The length of the solution column in
the mold channel in the absence of crosslinking provided us with L0. The extension ratio
was the ratio of the two lengths. A minimum of three samples were used for each
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composition. As the crosslinker concentration in the system is increased, the restriction of
chain relaxation should increase. As a result, the degree of retractive stress in the network
should also increase. This predicted calculation of retractive stress was compared with
the actual measured value of stress that was generated by the shrinking sample in the
mechanical setup.
3.2.6 Enzyme driven shrinkage experiment: HA hydrogels consisting of 60 mg/ml HAGMa
crosslinked with 3:1 and 4:1 ratio of PEGDa were subjected to two different
concentrations of the enzyme hyaluronidase to characterize the network‟s ability to
shrink. The concentrations we selected for this work were 5 µg/ml and 10 µg/ml. Rapidly
crosslinked PEGDa hydrogels were fabricated in an injection mold as described
previously. These gels were swollen in DI water overnight before testing. The hydrogels
were exposed to 0 µg/ml, 5 µg/ml, and 10 µg/ml hyaluronidase for a period of 48 hrs in a
37 °C shaker. The enzyme was replenished every 4 hrs to compensate for the loss of
activity. At each of these time points, images of the samples were captured, which were
later measured using Image J. To confirm that the shrinkage was a result of the
reorganization of polymer microstructure, we also fabricated negative control samples
where we did not expect to have any stored retractive stress. This was achieved by
providing the HA chains in the pre-crosslinking solution ample time to relax before being
exposed to UV light source. The negative control samples were exposed to the same
concentration of enzyme for the same duration and their dimensions were measured.
Three samples of each composition were tested. We also conducted a 1 week long term
experiment to determine how long the shrinkage continues. For this experiment, 3:1 and
4:1 ratio PEGDa crosslinked hydrogels were exposed to the over expression
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concentration of 10 µg/ml of hyaluronidase for 1 week. Sample images were captured
every 4hr and measured to plot the shrinkage profile. To also ensure that degradation was
not a result of erosion, relative position of surface features was observed in all the images
captured.

3.2.7 Effect of solvent diffusion on shrinkage: Diffusion is a key aspect that could affect the
rate and manner of shrinkage. To ensure that the enzyme was diffusing through the bulk
of the hydrogel and producing the shrinkage, samples were fabricated as described
previously and then sliced longitudinally to reduce the thickness by one half. The
rationale behind this was that if the enzyme was not diffusing into the bulk of the sample
then the shrinkage magnitude and profile would be different than the regular samples.
Three samples each of 60 mg/ml HAGMa crosslinked with 3:1 or 4:1 ratio of PEGDa
were used for this experiment. The samples were exposed to 10 µg/ml of hyaluronidase at
37 °C for a period of 48 hrs. The enzyme was replenished every 4 hrs and images
captured at each time point were measured using Image J.

3.2.8 Measurement of hydrogel stiffness: In order to determine the force generated by the
shrinking hydrogel, we designed a mechanical test setup that relies on a flexible
cantilever and its associated sensor. To make sure that we can accurately determine the
forces, the hydrogel samples and the cantilever had to be stiffness matched. We
performed surface indentation using the mesoindentation system to calculate the stiffness
of the hydrogel (37). At the beginning of each indent, the tip was positioned some
distance away from the sample surface and then driven into the sample until a predefined
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maximum load was reached, as detected by the deflection of the cantilever towards the
differential variable reluctance transducer (DVRT). Once the predefined load was
reached, the tip was retracted from the sample until it reached its initial position. The
force and displacement data were acquired during this entire process. The tip moved at a
speed of 33 µm/sec. A liquid cell in the form of a Plexiglas container was incorporated in
the setup along with a sample holder to submerge the sample, tip, cantilever and the
DVRT. The samples were indented to a maximum load of 60 µN. Each sample was
indented in at least three random locations to gauge the bulk stiffness. The stiffness was
calculated from the slope of the loading portion of the load-displacement curve. Samples
were tested before and after exposure to 10 µg/ml of hyaluronidase to determine the
effect of degradation on hydrogel stiffness.

3.2.9 Force measurement: A device consisting of a flexible aluminum cantilever-DVRT pair,
as shown in Figure 3.5, was custom built for measuring the force generated by HA
hydrogels during the process of shrinking. The principle concept behind the design is that
a shrinking hydrogel attached between a flexible calibrated cantilever and a fixed stage
will deflect the cantilever. The non-contact DVRT will record this deflection and provide
a way to quantify the force. The cantilever was calibrated for various known loads by
attaching a string to the cantilever and hanging known weights on the other end. The
cantilever was also calibrated for known displacements/deflections of the cantilever by
using a calibrated micromotor. A reservoir was incorporated in the device to house the
gel and keep it hydrated throughout the experiment. The gel was glued onto a fixed stage
on one end and to the calibrated cantilever on the other end using epoxy glue. The non-
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contact DVRT sensed any deflection in the calibrated aluminum cantilever and the data
collected using data acquisition software was plotted as force versus time. The entire
setup was maintained at 37 °C during the experiment by a temperature controlled water
bath. HA hydrogels consisting of 60 mg/ml HAGMa crosslinked with 3:1 and 4:1 ratio of
PEGDa were fabricated as described previously. Three samples of each composition were
exposed to 10 µg/ml of hyaluronidase for a period of 48 hrs. Fresh enzyme was added to
reservoir every 4 hrs. Control samples were not exposed to any enzyme. The raw voltage
data was converted to force (mN) and displacement (µm) using calibration constants. The
cross sectional area of contact of the sample with the cantilever is 1mm2. Using this
information and the calculated force, the stress (F/A) exerted by the shrinking hydrogel
on the cantilever was calculated. The work performed by the shrinking hydrogel was then
calculated by multiplying the stress and the corresponding cantilever displacement.

Fig.3.5. Images showing the device used to measure the force generated by the shrinking
hydrogel. (a) The aluminum cantilever-DVRT pair (circled in black) is the sensing end of
the device. (b) The sample is attached on one end to the calibrated flexible cantilever and
to a fixed stage on the other end. The sample is kept submerged via the enclosed reservoir
chamber.

3.2.10 Statistical analysis: For all statistical analyses, ANOVA with Tukey post-hoc analysis or
a students t-test were employed as applicable using Origin Pro 8.0, with a significant
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difference reported for p < 0.05. Image analysis was performed using Image J software
(NIH, USA). All values are reported as mean ± standard deviation.

3.3 Results
3.3.1 Methacrylation of HA: Sodium hyaluronate was successfully modified and a pendant
methacrylate group was added on the disaccharide thus forming methacrylated HA
(HAGMa). The coupling of GMa to HA was accomplished via epoxide ring-opening
mechanism. Figure 3.6 shows the NMR of the HA molecule before and after
derivatization. The ratio of normalized area under either peak with the reference methyl
peak shows that 79% of the potential sites on the HA molecule were successfully
modified. This reaction was successfully repeated several times with the modification
percentage ranging from 75% to 82%. The extent of methacrylation was controlled via
the concentration of HAGMa (see appendix). A reaction consisting of 10 molar excess of
glycidyl methacrylate resulted in approximately 50% methacrylation of the HA molecule.
The molecular weight of the resulting HAGMa was verified using gel permeation
chromatography (GPC) and was found to be 1.3 MDa.
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Fig.3.6. (a) Proton NMR of HA showing the peak representing methyl group (δ = 2.0) of
the N-acetylglucosamine. (b) Proton NMR of methacrylated HA molecule. The two
peaks (δ = 5.8, 6.2) representing the two protons on the methacrylate chain were used to
calculate the degree of modification. The reference peak is a result of protons
representing the methyl group on the HA backbone and the methyl group on the
methacrylate segment. The solvent used was deuterated water (δ = 4.8). The degree of
methacrylation was 79%.
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3.3.2 Rheological characterization: Figures 3.7 and 3.8 show the stress relaxation plots for
the compositions 60mg/ml HAGMa with 3:1 PEGDa and 60 mg/ml HAGMa with 4:1
PEGDa respectively. At time = 0 the specimen was suddenly deformed homogenously.
The deformation created a stress which gradually relaxed with time. The shear stress
could return to zero once the strain induced stress relaxes. Due to the high molecular
weight of the HA polymer, the molecular chains may not return to the same random
configuration once the stress relaxes. Instead of zero shear stress the sample could plateau
out at a non-zero value as the chains may obstruct each other to prevent complete
relaxation. Complete relaxation of shear stress was not observed within the test duration
for any of the strain conditions. We also did not observe any plateau condition either.
From pilot crosslinking tests the crosslinking time was observed to be between 45 and 55
seconds. The rheological tests indicated that the neither of the compositions, 60 mg/ml
HAGMa crosslinked with 3:1 or 4:1 PEGDa, would have relaxed before the solution gets
completely crosslinked. Thus these compositions would be ideal candidates for testing
our hypothesis of storing a retractive stress in the crosslinked networks.
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Fig.3.7.Stress relaxation curves for pre-crosslinking solutions of the composition
60mg/ml HAGMa with 3:1 PEGDa. The % strain conditions used were 5%, 7%, 10%,
and 12%. The shear stress did not return to zero or plateau out within testing duration
limits indicating that total molecular chain relaxation did not occur. This meant that if
this solution were to be crosslinked post shearing then the crosslinking reaction would be
able to trap some of the chains in the shear aligned conformation.
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Fig.3.8.Stress relaxation curves for pre-crosslinking solutions of the composition
60mg/ml HAGMa with 4:1 PEGDa. The % strain conditions used were 5%, 7%, 10%,
and 12%. The shear stress did not return to zero or plateau out within testing duration
limits indicating that total molecular chain relaxation did not occur. This meant that if
this solution were to be crosslinked post shearing then the crosslinking reaction would be
able to trap some of the chains in the shear aligned conformation.

3.3.3 Birefringence study: The degree of orientation was quantified using polarized optical
microscopy. Under crossed polarizers, a sample with no specific molecular orientation
will appear dark while a sample possessing molecular orientation will appear bright or
colorful depending on the extent of orientation and the type of the material. The
brightness level is directly proportional to degree of orientation. Figure 3.9 shows optical
micrographs for samples of the composition 60 mg/ml HAGMa crosslinked with 3:1 ratio
of PEGDa prior to exposure to 10 µg/ml hyaluronidase. When the optical axis of the
60

sample was at 45° to the polarizers, birefringence was observed indicating presence of
orientation. We calculated the retardance (Δnh) values for all the samples at three distinct
locations across the sample, the middle and the two ends. After comparing the retardance
values from the three locations, amongst themselves and across the samples, we
concluded that there was no significant difference (p >> 0.05) in the retardance values.
This indicated that the crosslinking was rapid enough to preserve the shear induced
molecular orientation and this orientation was nearly homogenous. The average
retardance was calculated from the nine values obtained from the three samples. The
average retardance for the composition 60 mg/ml HAGMa crosslinked with 3:1 PEGDa
prior to enzymatic degradation was 39.71 ± 12.41 nm.
Three samples of the same composition were then exposed to 10 µg/ml
hyaluronidase for a period of 48 hrs. This concentration of the enzyme was selected to
simulate the over expression of the enzyme following PNS injury. The enzyme was
replenished every 4 hrs. After the test duration, the samples were air dried and observed
under the polarized optical microscope (POM). Figure 3.10 shows the captured
micrographs. The observable brightness was significantly reduced as compared to the
pre-enzyme exposure samples. This demonstrated that the enzymatic degradation caused
decrease in molecular orientation within the samples. Once again we compared the
retardance values along length of the sample and between samples. There was no
statistically significant difference observed (p >> 0.05). The magnitude of overall sample
shrinkage was not measured during this experiment. The average retardance for this
composition following enzymatic degradation was 8.15 ± 2.44 nm.
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Fig.3.9. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels crosslinked
with 3:1 ratio of PEGDa prior to their exposure to hyaluronidase. Images were captured
at the two ends and the middle of the sample. The arrow indicates the direction of flow of
the pre-crosslinking solution in the glass mold prior to rapid crosslinking. The retardance
for this composition calculated from the captured spectra was 39.71 ± 12.41 nm. The
magnification was 20X.
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Fig.3.10. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels
crosslinked with 3:1 ratio of PEGDa after exposure to 10 µg/ml hyaluronidase for 48hrs.
Images were captured at the two ends and the middle of the sample. The arrow indicates
the direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 8.15 ± 2.44 nm. The decrease in the retardance compared to the value obtained
before enzymatic degradation indicated loss of molecular orientation in the sample. The
magnification was 20X.

Similarly the second composition, 60 mg/ml HAGMa crosslinked with 4:1 ratio
of PEGDa, was observed under the POM prior to and after exposure to 10 µg/ml
hyaluronidase. Figure 3.11 shows the optical micrographs for the 4:1 ratio PEGDa
samples prior to enzyme exposure. Each sample was imaged at the two ends and the
middle to determine the homogeneity of any molecular orientation. The brightness
verified the existence of molecular orientation. The average retardance was 50.06 ± 10.95
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nm. Samples of the same composition were then exposed to 10 µg/ml hyaluronidase for
48 hrs and imaged to observe effect of degradation on molecular orientation. Figure 3.12
shows the polarized optical micrographs for the enzymatically degraded samples. The
retardance values and the observable brightness significantly decreased (p << 0.05), as
compared to values obtained from prior to degradation, indicating loss of molecular
orientation. The average retardance value post enzyme exposure was 15.28 ± 1.25 nm.
The magnitude of overall sample shrinkage was not measured during this experiment.

Fig.3.11. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels
crosslinked with 4:1 ratio of PEGDa prior to their exposure to hyaluronidase. Images
were captured at the two ends and the middle of the sample. The arrow indicates the
direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 50.06 ± 10.95 nm. The magnification was 20X.
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Fig.3.12. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels
crosslinked with 4:1 ratio of PEGDa after exposure to 10 µg/ml hyaluronidase for 48hrs.
Images were captured at the two ends and the middle of the sample. The arrow indicates
the direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 15.28 ± 1.25 nm. The decrease in the retardance compared to the value obtained
before enzymatic degradation indicated loss of molecular orientation in the sample. The
magnification was 20X.

Figure 3.13 summarizes the results from the birefringence study for the HAGMa
hydrogels crosslinked with two different ratios of PEGDa. There was a significant
reduction in molecular orientation following enzymatic degradation. The retardance
values, and hence the molecular orientation, scaled with an increase in crosslinker
concentration. To confirm that enzymatic degradation was the sole contributor to
reduction in molecular orientation, we also performed a negative control experiment
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where samples were submerged for 48 hrs in PBS not containing any hyaluronidase.
Figure 3.14 shows retardance results from this control experiment. There was no
significant difference (p >> 0.05) between the retardance of the samples before and after
the 48 hr PBS soak. The average values for this batch of samples were slightly lower than
those described earlier, however they were within the range. The lower values could be
attributed to batch variability. The lack of any significant reduction in retardance values
proved that enzyme activity is required for the molecular reorganization which leads to
the loss of molecular orientation.

Fig.3.13. Bar graph summarizing the retardance values calculated for the PEGDa
crosslinked HAGMa hydrogel samples prior to and following enzymatic degradation.
The significant decrease in the retardance for the two compositions following enzymatic
degradation indicated that the process of degradation reduced the molecular orientation in
the hydrogels. (n=3)
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Fig.3.14. Bar graph summarizing the results from the negative control samples of PEGDa
crosslinked HAGMa hydrogels. The negligible change in the retardance values of the
samples after 2 days indicated that the reduction in molecular orientation seen in the
samples exposed to the enzyme was truly on account of the degradation. (n=3)

3.3.4 Estimation of retractive stress in the hydrogel: To calculate the crosslink density of
the hydrogels, swelling experiments were performed to calculate the swelling ratios. The
gels with lower concentration of crosslinker showed higher average swelling; however
there was no statistically significant difference in the swelling coefficients. We adapted
rubber elasticity theory to estimate the retractive stress stored in a rapidly crosslinked
hydrogel. Table 3.1 and Figure 3.15 show the results from these calculations. Increasing
the crosslinker concentration did not significantly increase the predicted retractive stress
stored in the hydrogel network.
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Table 3.1. Results from the swelling experiments and retractive stress estimation study

Fig.3.15. Bar graph showing the predicted values of retractive stress stored in the two
compositions of PEGDa crosslinked HAGMa hydrogel samples. There was no
statistically significant difference observed between the two compositions although the
averages seemed to scale with the increase in PEGDa concentration. (n=3)

3.3.5 Enzyme driven shrinkage: Rapidly crosslinked HAGMa samples demonstrated
shrinkage when they were exposed to hyaluronidase. We exposed the samples to three
concentrations of hyaluronidase; 0 µg/ml, 5 µg/ml, and 10 µg/ml. The images obtained at
each enzyme replenishment time point were measured and the sample lengths were
normalized and plotted against time. Figure 3.16 shows the shrinkage profile for each
composition. In the case of 60 mg/ml HAGMa crosslinked with 3:1 ratio of PEGDa, the
control samples showed negligible reduction in their length (3%) as compared to those
exposed to hyaluronidase (12%). The majority of shrinkage occurred along the long axis
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of the sample which was also the axis of flow prior to crosslinking. Increasing the
enzyme concentration increased the total average magnitude of shrinkage by 2%. The
profile of the shrinkage indicated that majority of the shrinkage occurred within 30hrs.

Fig.3.16. Graph showing enzyme driven shrinkage profile for PEGDa crosslinked
HAGMa hydrogel samples exposed to hyaluronidase for 48 hrs. The controls were not
exposed to the enzyme. Panels a, c, and e show the profiles for 3:1 ratio PEGDa samples
while panels b, d, and f show profiles for 4:1 ratio PEGDa crosslinked samples. Increase
in concentration of the enzyme increase the magnitude of shrinkage. The composition 60
mg/ml HAGMa crosslinked with 4:1 ratio PEGDa demonstrated a linear shrinkage
profile when exposed to 10 µg/ml hyaluronidase. (n=3)

Samples of the second composition, 60 mg/ml HAGMa crosslinked with 4:1 ratio
of PEGDa, also underwent shrinkage along their long axis when subjected to enzymatic
degradation. Compared to the controls (2%), the experimental samples shrunk on an
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average about 11% - 12%. Increasing the enzyme concentration did not increase the
magnitude of shrinkage; however it made the shrinkage profile almost linear. The
samples indicated potential to shrink beyond 48 hrs. To test when the shrinkage stops we
extended the duration of the experiment to 1 week. For each concentration of enzyme
exposure, increasing the crosslinker concentration in the samples decreased the
magnitude of net shrinkage achieved in 48hrs. We hypothesize that as the crosslink
density increases in the gels, the freedom of motion in the network for the chains to
rearrange themselves is lower as hyaluronidase cleaves the larger HA molecule into
smaller segments. This led to lower shrinkage in spite of having higher retractive stress
stored in the network. Samples of the composition 60 mg/ml HAGMa crosslinked with
3:1 PEGDa demonstrated the most shrinkage (2 ± 0.09 mm or 12.33 ± 0.66 %) when
exposed to10 µg/ml hyaluronidase.

Enzymatic degradation caused the samples to shrink. Degradation at the surface
could result in erosion of sample presenting as sample shrinkage along with the
molecular reorganization. We tracked distinct features (surface asperities, visible pores)
and their relative location on the sample throughout the degradation process and
concluded that erosion was not responsible for the reduction in the length of the sample.
To further verify the mechanism of shrinkage, we fabricated negative controls that should
be devoid of any retractive stress in their crosslinked matrix. These samples made using
the two PEGDa concentrations were exposed to 5 µg/ml and 10 µg/ml of hyaluronidase
for 48 hrs. Figure 3.17 shows the shrinkage profiles for such samples. Comparing the
results of the 48 hr shrinkage of the rapidly crosslinked samples as described above to the
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negative controls it is quite evident that the latter show significantly lower shrinkage (2%
- 4%) which was actually in the range of the control sample shrinkage. We attribute the
shrinkage seen to the incapability of the chains to completely relax in the time provided
prior to crosslinking due to physical entanglements. Thus we ascertained that the
shrinkage we observed was due to the enzymatic cleavage of shear aligned backbone HA
molecular chains that had their disentangled conformation preserved by rapid
crosslinking process.

Fig.3.17. Average sample length profiles for the negative control samples. (a, c) When
the 3:1 PEGDa crosslinked HAGMa samples were exposed to hyaluronidase for duration
of 48 hrs, the shrinkage was on par with control samples which were not exposed to any
enzyme. (b, d) The 4:1 ratio PEGDa negative control samples showed similar
insignificant shrinkage when exposed to hyaluronidase. (n=3)
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The long term experiment to study how long the shrinkage can be sustained showed a
direct dependence on crosslinker concentration in the hydrogels. Figure 3.18 shows the
average sample length profile plotted against time. For the gels crosslinked with 3:1 ratio
of PEGDa, the shrinkage stopped by the end of day 2, where as for the gels crosslinked
with 4:1 ratio of PEGDa the shrinkage stopped around day 3. These results verified our
initial hypothesis that the gel would exist in two phases; phase 1 where it is an active
stimulator and phase 2 where it is a passive scaffold. The limiting factor controlling the
duration and magnitude of the shrinkage is the extent to which the molecular chains
disentangle during shear flow.
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Fig.3.18. Graph showing enzyme driven shrinkage profile for PEGDa crosslinked
HAGMa hydrogel samples exposed to hyaluronidase for 1 week. The controls were not
exposed to the enzyme. Panels a, c, and e show the profiles for 3:1 ratio PEGDa samples
while panels b, d, and f show profiles for 4:1 ratio PEGDa crosslinked samples. Increase
in the concentration ratio of PEGDa seemed to slow down the shrinkage rate. The 4:1
ratio PEGDa samples sustained shrinkage for 2.5-3 days where as the 3:1 ratio PEGDa
samples stopped shrinking after 1.5 days. (n=3)

We selected two concentrations of the enzyme to selectively study shrinkage
induced by degradation of the backbone HAGMa chains. We observed some evidence of
dependence of the rate and magnitude of shrinkage on the enzyme concentration from the
overall profile of the change in sample length. We were curious if we could increase the
magnitude of shrinkage by further increasing the enzyme concentration. We exposed
PEGDa crosslinked samples to extremely high concentration (500 µg/ml) of
73

hyaluronidase and observed that the rate of shrinkage does increase quite dramatically.
As shown in figure 3.19, almost all of the shrinkage occurred within the first 8 hours of
exposure to the enzyme. However the net magnitude of sample length change remained
similar to samples exposed to 5 µg/ml or 10 µg/ml hyaluronidase. This indicated that
magnitude of shrinkage is dependent on the extent to which molecular orientation was
retained during crosslinking, while the rate of shrinkage is dependent on the
concentration of hyaluronidase and the concentration of the crosslinker. Table 3.2
summarizes the results from the constrained shrinkage experiments.

Fig.3.19. Graph showing enzyme driven shrinkage profile for PEGDa crosslinked
HAGMa hydrogel samples exposed to large excess (500 µg/ml) of hyaluronidase for 48
hrs. The samples appeared to have achieved the maximum magnitude of shrinkage within
the first 4-8 hours indicating that the rate of shrinkage is governed by the concentration of
hyaluronidase. (n=3)
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Table.3.2. Summary of the average sample shrinkage for the PEGDa crosslinked
HAGMa samples

In vitro studies that have tested the effect of applying mechanical tension via
micromotors or microneedles on neuronal elongation have unanimously observed that at
least for the first day the rate of displacement has to be limited to 100 µm/hr (4, 7-11).
Figure 3.20 shows the shrinkage rates per day for all of the compositions tested here.
Increasing the enzyme concentration increased the shrinkage rates. Hydrogels of the
composition 60 mg/ml HAGMa crosslinked with 3:1 and 4:1 ratio of PEGDa when
degraded with hyaluronidase, generated shrinkage induced displacements at rates below
the 100 µm/hr. Hydrogels exposed to 10 µg/ml hyaluronidase produced the highest
magnitude of shrinkage and shrinkage rates. In contrast to a micromotor which is able to
produce consistent displacements over time, our hydrogel system can cause
displacements only for a finite period of time and these displacements will decrease over
time due to a finite amount of energy stored in the system. However this novel concept
provides the advantage of possible in vivo application. Further optimizations to sustain
the shrinkage for an extended period of time would certainly elevate the applicability of
this hydrogel system for enhancing the axonal regeneration via stretch/towed growth.
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Fig.3.20. Profile of the shrinkage rates for the PEGDa crosslinked HAGMa hydrogels
exposed to hyaluronidase for a period of 1 week. The shrinkage rates ranged from 25
µm/hr to 60 µm/hr for the first day. The shrinkage gradually ceased by day 3 for all the
compositions. (n=3)
3.3.6 Effect of solvent diffusion on shrinkage: Degradation can occur either in the bulk or on
the surface. To verify which mode was responsible for the results we observed, we chose
to study if the enzyme was diffusing in the bulk or eroding the surface. The rationale
behind using samples that were half (1 mm x 0.5 mm) the thickness of the standard
samples (1 mm x 1 mm) tested was that if the degradation was occurring in the bulk we
would observe similar rate of shrinkage. However if the degradation were a function of
enzyme diffusion then a thinner sample would shrink faster. As shown in Figure 3.21, the
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shrinkage profile was similar to standard thickness samples. The 3:1 PEGDa crosslinked
samples stopped shrinking around 32 hr mark while the shrinkage for 4:1 PEGDa
crosslinked samples seemed to plateau out by 48 hrs. This verified that there was no
hindrance to the diffusion of the enzyme in the sample and that bulk degradation was the
method by which the molecular chains were being broken down and reorganized.

Fig. 3.21. Graph showing the enzymatic degradation driven shrinkage of PEGDa (a, b –
3:1PEGDa; c, d – 4:1 PEGDa) crosslinked hydrogels comparing effect of sample
thickness on nature of sample shrinkage. The samples were exposed to 10 µg/ml
hyaluronidase. The overall magnitude and the general profile of shrinkage were not
affected by the thickness of the sample. (n=3)
3.3.7 Hydrogel stiffness: Crosslinked HAGMa samples were indented at random locations
prior to and following exposure to 10 µg/ml hyaluronidase. The load-displacement curves
indicated a linear elastic behavior where the loading and unloading curves overlapped.
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The stiffness was calculated from the loading portion of the curve. Prior to exposure to
the enzyme the stiffness of gels with the composition 60 mg/ml HAGMa crosslinked with
3:1 PEGDa was 3.97 ± 0.09 N/m. After exposure to hyaluronidase for 48 hrs, the
stiffness dropped to 2.96 ± 0.18 N/m. Similarly the stiffness of gels made using 60 mg/ml
HAGMa and 4:1 PEGDa before enzyme exposure was 5.47 ± 0.17 N/m. After exposure
to the enzyme, the stiffness decreased to 3.56 ± 0.87 N/m. Figure 3.22 summarizes the
results from this experiment. The stiffness values helped us in designing the aluminum
cantilevers with stiffnesses specifically matched to the hydrogel composition.

Fig. 3.22. Graph showing the measured stiffness of HAGMa hydrogels crosslinked with
PEGDa before and after exposure a 48hr exposure to 10 µg/ml hyaluronidase.
Degradation caused the stiffness of samples of both compositions to decrease
significantly. (n=3)

3.3.8 Measurement of shrinkage force: Based on the stiffness values of the hydrogels before
and after degradation, flexible aluminum cantilevers were fabricated to be used in the
mechanical device. To ensure that we capture the entire potential of the shrinking
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hydrogel to deliver tensile force on an attached body, it was imperative that the stiffness
of cantilever be somewhere between the pre and post degradation stiffness values of the
hydrogel. To test the samples made using 60 mg/ml HAGMa crosslinked PEGDa, we
selected an aluminum cantilever with the stiffness 3.47 N/m. The cantilever was
calibrated using known loads and known displacements (see appendix). The test was run
in increments of 4 hrs for a total duration of 48 hours to ensure replenishment of the
enzyme. The raw voltage values were converted to appropriate force and displacement
values using the calibration constants (see appendix). Even though the DVRT signal was
recorded at the rate of one point per second, the final plot only shows one data point per
hour for the purpose of clarity. The cross-section of the hydrogel was 1 mm2. The force
values were then converted to their respective stress (kPa) values to compare with the
previously calculated 𝝈Pr to estimate what percent of the stored predicted stress was
recovered. Figure 3.23 (a, c, e) shows the force, displacement, and recovered stress
curves for hydrogel samples of the composition 60mg/ml HAGMa crosslinked with 3:1
PEGDa. The average cantilever displacement measured by the end of 48 hrs for control
samples was 0.5 mm which translated to a net average force of 1 mN. This is equal to
14% of the predicted stored retractive stress. We attribute the small amount of shrinkage
seen in control samples to rearrangement of the gel matrix due to swelling. The cantilever
displacement value was within the range of shrinkage observed for the control samples
(0.48 ± 0.02 mm) of this composition during the unconstrained shrinkage experiments.

Exposing the same composition to 10 µg/ml hyaluronidase demonstrated
interesting results. The average cantilever displacement achieved at the end of 48 hrs was
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0.4 mm which was less than half (2.00 ± 0.09 mm) of what we observed in the
unconstrained shrinkage experiments.

The curves for samples of the composition 60 mg/ml HAGMa crosslinked with
4:1 PEGDa are shown in Figure 3.23 (b, d, f). Once again we observed that the cantilever
displacement values for control samples were similar to the unconstrained shrinkage
experiments (~0.3 mm). The controls generated an average of 1.5 mN of force which
correspond to a recovered stress value of 1.5 kPa or 16% of the predicted stored stress.
The samples that were exposed to 10 µg/ml hyaluronidase on the other hand showed a
much more significant recovery of the stored retractive stress. By the end of 48hrs, the
samples applied an average of 3.47 kPa of tensile stress on the cantilever. That amounts
to 37.5% of the predicted stored retractive stress. The total cantilever displacement was 1
mm which was slightly less than what was observed for the unconstrained shrinkage
magnitude (1.4 ± 0.22 mm). This indicated that as the sample got weaker on account of
degradation, it lost the “tug of war” battle and was no longer able to counter the resisting
cantilever. The overall effect was the appearance of slowing down of the shrinking
process and a lower magnitude for total recovered stress. However since the samples
crosslinked with 4:1 ratio of PEGDa are stiffer than those crosslinked with 3:1 ratio of
PEGDa, we did not see as large a gap between the sample shrinkage values between the
constrained and the unconstrained shrinkage experiment.
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Fig.3.23. Graphs showing the force, cantilever displacement, and recovered stress curves for the
HAGMa samples crosslinked with 3: 1 ratio of PEGDa (a,c,e) and 4:1 ratio of PEGDa (b,d,f).
The hyaluronidase concentration used was 10 µg/ml. The control samples showed minimal
shrinkage which was on par with the unconstrained shrinkage experiments. The enzymatically
degraded samples that were crosslinked with 4:1 ratio of PEGDa showed the greatest recovery of
the stored retractive stress (37.5%) as compared to samples crosslinked with 3:1 ratio of PEGDa
(22.6%). Degradation decreased the ability of samples to continue shrinking in the constrained
environment. It was more evident in case of the samples crosslinked with 3:1 ratio of PEGDa.
(n=3)

Figure 3.24 shows the comparison between the predicted stored retractive stress and the
measured recovered stress. It is apparent that not all of the stored stress is recovered.
There is a disparity of 50 % or greater between the values.
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Fig.3.24. Bar graph showing the predicted and recovered values of the retractive stress
stored in the two compositions of PEGDa crosslinked HAGMa hydrogel samples. The
recovered stress values were significantly lower than the predicted stored retractive
stress. (n=3)
3.4 Discussion
The unique properties of HA enabled us to fabricate a novel hydrogel that could be
designed to shrink, via molecular reorganization, on a time scale relevant for application as a
mechanical stimulator of neuronal cells. Water soluble HA has a very short half life in the
body if it is injected as a solution. Derivatizing HA and crosslinking solves this problem by
slowing down the degradation process. One of the clinically used HA derivatives is a solid
hydrated gel called hylan-B which is implanted in soft tissues (26, 27). A 1% solution of HA
when injected under the rabbit skin had a half life of 24 hours. In comparison, a 0.5% hylanB had a half life greater than 9 months in the same scenario (26). The disaccharide subunit
can be easily modified to add pendant crosslinkable moieties. We chose to methacrylate HA
using GMa, as the reaction is water based and the conditions do not damage the HA molecule
itself. By controlling the concentration of GMa in the reaction, we were able to affect the
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extent of modification. We used several molar excesses of GMa to counter for the
inaccessibility of -OH target areas on some HA molecules on account of their coiled
conformation. Our main goal of storing retractive stress in the network demanded the highest
modification levels and we achieved that (~82%) by using 20 molar excess of GMa.

The rheological properties of polymers are of general interest since they provide
important information for designing and optimizing processing conditions. In networks made
of long linear polymers, network chains impose topological constraints on each other called
entanglements. HA in its ground state is in a random coil conformation. Due to its shear
thinning property, under shear flow these entangled coiled chains disentangle and align to the
direction of flow making it easier for even highly concentrated solutions to be injectable. Our
goal for performing the rheological characterization was to observe the relaxation behavior
and select compositions that relaxed slower than the time it took for the crosslinking reaction
to finish. Based on the relaxation curves we selected two compositions, 60 mg/ml HAGMa
with 3:1 ratio of PEGDa and 60 mg/ml HAGMa with 4:1 PEGDa. The results indicated that
the solutions of these compositions would not have relaxed by the time crosslinking reaction
completes. This was critical in restricting the chain conformation and storing a retractive
stress in the crosslinked network.

Birefringence enabled us to verify the success of arresting the shear flow induced
molecular chain alignment. Increasing the crosslinker concentration from a 3:1 ratio to 4:1
ratio increased the average retardance from 39.71 nm to 50.07 nm. The range of values we
observed compare well with values reported for viscoelastic polymer solutions studied under
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shear flow (38). The lack of any significant difference in retardance values calculated across
the sample suggested that the crosslinking chemistry is rapid enough to trap molecular chains
in similar stages of disentanglement. In order to prepare samples to be imaged under the
polarized optical microscope the opaque samples needed to be air dried. This was essential to
make the samples optically clear. This process shrinks the samples and may lead to under
estimation of the molecular orientation. However by treating all the samples the same way,
the trends we observed are a true representation of the effects of experimental conditions. To
selectively study the shrinkage brought about by enzymatic degradation, we exposed the
samples to the primary degradation enzyme for HA, hyaluronidase. For both compositions of
samples tested we observed a significant decrease in retardance values indicating significant
loss of molecular chain alignment.

The trend observed in the birefringence correlated well with our estimation of retractive
stress in the crosslinked network. Traditionally when a crosslinked network is stretched by a
factor α, it creates a retractive force in the network that can be calculated using rubber
elasticity principles. The two states this network exists during such an experiment are the
resting state and the stretched state. Drawing a parallel with our hydrogel system, we could
equate the rapidly crosslinked hydrogel to the stretched state, while the resting state would be
if the pre-crosslinking solution were allowed to relax in the mold without crosslinking. We
measured the lengths of both these stages to calculate extension ratio α. The confinement of
the mold channel and the high concentration of the solution may have hampered complete
relaxation of the chains in the solution. Swelling experiments provided us an understanding
of the behavior of the network in hydrated condition. Assimilating all this information, we
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were able to generate an estimation of the magnitude of retractive stress that might get stored
in the network. It is this stress that was the source of the potential energy that we planned on
harnessing in order to use the network as an actuator. The results indicated that increasing the
crosslinker ratio increased the average retractive stress stored in the network.

Enzymatic degradation of the rapidly crosslinked HAGMa hydrogels brought about
shrinkage of the gel along its long axis, which as per the design was also the axis of flow
prior to crosslinking. We observed that the crosslinker concentration and the hyaluronidase
concentration affected the sample shrinkage the most. Increasing the crosslinker
concentration increased the average molecular orientation and the average retractive stress
stored in the network. This meant there was more potential for the network to shrink as it
degraded. Enzymatic cleavage of the network increases the free volume within the network
providing an opportunity for the chains to reorganize and in the process dissipate the stored
retractive stress. Increasing the hyaluronidase concentration increased the magnitude of
shrinkage. However increasing the crosslinker concentration also slowed down the rate at
which the samples underwent change in their lengths. The denser the crosslinked network,
the harder the enzymes had to work to create free volume for the network chains to
reorganize. The negative control samples confirmed that molecular orientation, followed by
the loss of it, was the source of sample shrinkage. The net shrinkage for all of the
compositions tested was less than or equal to 1mm per day which was the upper limit of
displacements that researchers have demonstrated to be successful in eliciting enhanced
axonal growth (10, 12, 17, 39). The average rates of shrinkage for the first 24 hours ranged
between 25 µm/hr and 60 µm/hr. These rates are well within the favorable maximum rate
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100 µm/hr that have been shown to elicit enhanced axonal elongation (10, 12, 15, 21).
Exposure to extremely high concentrations of enzyme failed to significantly increase the
magnitude of shrinkage, although it did speed up the time it took for the sample to shrink.
This result indicated that the limiting factor of this system is the degree of molecular chain
alignment of the HA molecule. There is a direct correlation between the degree of orientation
and the magnitude of retractive stress stored in the network, as seen from our results, and
thus the magnitude of sample shrinkage. Looking at results from the mechanical device
designed to measure the force generated by the shrinking hydrogel, it is evident that we are
unable to recover all of the predicted stored retractive stress. As the sample gets degraded by
hyaluronidase, the mechanical properties of the sample decrease. Indentation test showed that
the stiffness of samples of the composition 60 mg/ml HAGMa crosslinked with 3:1 PEGDa
when exposed to 10 µg/ml hyaluronidase decreased by 25%. Hence as the sample weakens,
its stiffness is equal to or less than that of the aluminum cantilever. This could explain why
the displacement in case of the unconstrained experiment is higher than when the samples
were constrained. The net average force generated by the end of 48 hrs was 1.6 mN. This
equals 22.6% of 𝝈Pr, but the process did not appear to have ceased as seen in the
unconstrained shrinkage experiment. On the contrary it appeared that due to the physical
confinement and the fact that the hydrogel was now actually performing work on another
body which was trying to resist it, the shrinkage profile of the sample was more gradual than
the unconstrained shrinkage. The method we used to recover the stored retractive stress from
the hydrogel network was by enzymatically cleaving the HAGMa chains, which are the
source of the retractive stress. Hence by cleaving them in multiple locations we think that
true potential of the chain to relax could not be entirely exploited. Thus the experimentally
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measured recovered stress would be lower than the predicted values of retractive stress stored
in the network. The hydrogel compositions we tested here performed work on the flexible
cantilevers by applying tensile stress. The 3:1 PEGDa crosslinked HAGMa hydrogel when
exposed to 10 µg/ml hyaluronidase applied a net stress of 1.6 nN/µm2, while the 4:1 PEGDa
crosslinked HAGMa hydrogel generated a net stress of 3.4 nN/µm2 in the 48hr test period.
Franze et al. (40) experimentally calculated an upper threshold limit for applied stress on
growth cones of individual neurons that could sustain extensional growth. The value they
reported was 274 ± 47 pN/µm2, (mean ± SE). Neurite bundles are able to sustain extreme
stretch rates (µm/hr) which would usually lead to detachment and retraction of individual
neurites (12, 19, 21). We could draw a parallel and predict that the neurite bundles may be
able to sustain higher stresses than the threshold reported for individual neurites.

In degrading the HA chains to bring about sample shrinkage we are truly not using the
entire potential of the HA chain. The HA molecule is the driving force of this shrinkage
phenomenon. If we observe a single HA molecule we would find it in a random coiled
conformation in its ground stage. Under shear flow conditions this coil disentangles and
aligns to the flow thus storing some energy. When the flow ceases to exist, the molecule
starts losing this stored energy in order to return to its ground state. A shorter chain would
need less energy to disentangle compared to a longer chain. Thus a longer chain would need
higher energy to disentangle and will have higher potential energy that it has to lose to return
to ground state. We proposed to use this principle in a crosslinked network consisting of
several of such long chained HA molecules. The mechanism we explored here to make the
HA molecules lose their orientation and the stored retractive stress was cleaving the HA
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molecule itself. We did observe shrinkage; however we do not believe that this is the most
efficient way. When we cleaved the HA molecule to shorter segments we also decreased the
overall potential for shrinkage as we now have shorter segments of the HA molecule getting
reorganized in the network matrix. In the next chapter we explore another technique for
shrinking the crosslinked HAGMa hydrogel where we do not cleave the HA molecule but
instead selectively cleave the crosslinks that hold the network together. This we believe will
allow the HA molecule to expend more of its stored potential energy/retractive stress and
cause a higher magnitude of hydrogel shrinkage.

At the outset of this study our main goal was to create a polymeric network based
actuator to enhance axonal elongation drawing inspiration from the in vitro studies that used
mechanical actuators. In contrast to a micromotor which is able to produce consistent
displacements over time, our hydrogel system can cause displacements only for a finite
period of time and these displacements decrease over time due to a finite amount of energy
stored in the system. However this novel concept provides the advantage of possible in vivo
application. Further optimizations to sustain the shrinkage for an extended period of time
would certainly elevate the applicability of this hydrogel system for enhancing the axonal
regeneration via stretch/towed growth.

3.5 Conclusion
Novel crosslinked hyaluronic acid based hydrogels were designed to possess the property
of controlled shrinkage for the purpose of use as a potential axonal growth enhancer. The
samples were characterized for their ability to shrink and ability to exert a force while
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constrained during shrinkage. The composition 60 mg/ml HAGMa crosslinked with 3:1 ratio
of PEGDa demonstrated the highest magnitude of shrinkage in 48 hrs (12.33%) when
exposed to 10 µg/ml of hyaluronidase. However, the most linear and longest sustained
shrinkage was shown by samples of the composition 60 mg/ml HAGMa crosslinked with 4:1
PEGDa (11%), when exposed to 10 µg/ml of hyaluronidase. The latter composition also
allowed us to recover the highest percentage (37.5%) of the retractive stress stored in the
network. This hydrogel system could prove to a viable alternate treatment for bridging large
gap peripheral nerve injury.
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CHAPTER 4
4.1 Introduction
The severity of a peripheral nerve gap injury is dependent on the extent of the gap created
as a result of the injury. (1-3). Larger the gap, the greater is the challenge to repair it. The
constant tension that the nerves exist in, make it difficult for neurosurgeons to surgically
suture the nerve ends. The current gold standard treatment for large gap injury is a surgical
autograph (2, 3). However there are several disadvantages of using this treatment which
include need for harvesting a functional nerve from somewhere else in the body, risk of
infection, and loss of functionality for the donor site. The functional recovery rate for the
primary injury site is around 80% (1). The alternative strategies for autografts that have been
explored over the past decades include allografts and xenografts; however the risks of
rejection and an immune reaction outweigh the benefits. Biomaterial strategies have explored
the application of polymeric conduits supplemented with growth factors or support cells like
Schwann cells with promising results (1-3). However so far they have not been able to match
the success rate of autografts.

The growth cone is a key player in axonal growth in vitro (4, 5). In vivo however, there
are two main mechanisms of axonal growth. The first is via growth cone extension, while the
second occurs after the growth cone has synapsed with its desired target and the neuron
elongates as the target relocates and pulls the neuron with it (6, 7). The latter mechanical
stimulation mechanism is called “stretch growth” or “towed growth”. Bray in 1984 (8)
demonstrated that short neurites could be elongated by mechanically pulling them at a
limiting rate of 100 μm/hr. That study was later substantiated by Heidemann and Buxbaum
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(4). Both of the studies used calibrated glass micro-needles to attach to growth cones and
apply tension. Smith et al. showed experimentally that rat dorsal root ganglion (DRG) neurite
bundles could be stretched successfully using micromotors at rates as high as 8 mm/day
without breaking (7). They have been successful in stretching axon bundles to lengths up to 5
cm in vitro. The stretched axons showed normal morphological appearance and
ultrastructure. These studies explored the limits of this mechanism (7-11).

There exist a group of polymers that under the influence of an external stimulus undergo
a change in their shape or size (12-14). This transformation could be used to simulate the
micromotors and possibly develop a therapy that can be used in vivo to mechanically
stimulate neuronal cells. There are three main groups of polymeric actuators that have been
used for biomedical application; hydrogel based actuators (13), electro active polymers
(EAP) (12), and shape memory polymers (SMP) (15, 16). Hydrogel based actuators have
been successfully used as drug delivery vehicles (17, 18) and as valves in microfluidic
devices (19, 20). Thermoresponsive PNIPAAm gels synthesized by Gutowska et al. by
copolymerizing with butyl methacrylate (BMA) (hydrophobic) or acrylic acid (AAc)
(hydrophilic) co-monomers are an ideal example of utilizing the actuating mechanism to
deliver drugs (21). Heparin was loaded into the gels below the network lower critical solution
temperature when the gel permeability is high. When the transition temperature was reached
(37°C), the gel demonstrated rapid de-swelling as a result of the network collapse. This
collapse was very rapid and almost all of the transition occurred in less than an hour. Some of
the most significant biomedical applications of polymeric actuators include surgical sutures
and self-deploying stents. Langer et al. synthesized a novel degradable block copolymer by
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coupling oilgo(ε-caprolactone)diol (OCL) and oligo(p-dioxane)diol (ODX) with 2,2,(4),4trimethylhexanediisocyanate (22). They fabricated sutures that were programmed by
elongation and fixing the elongated state. The transition temperature for this SMP was 41°C.
When the triggering temperature was applied the sutures deployed and closed the incision in
a mouse model. Thus they were able to demonstrate a possible alternative to basic sutures
and a way to reduce the subjective variability in the force used to tie the knots while applying
suture. However the response times that have been reported for polymeric actuators in the
literature range between instantaneous to a few hours (12, 14, 16, 18, 19, 21-29).
Predominantly the applications for these polymeric materials required quick, almost
instantaneous response to the external stimulus. There is an absence of category of
degradable, biocompatible, slow actuating polymer systems that can keep on actuating for
several days which could benefit applications like axonal regeneration and wound healing.

This work describes a crosslinked network system wherein retractive stress was stored
along a pre-defined axis during fabrication. Storing a retractive stress in essence meant
storing energy in the system. By gradually releasing this stress we hypothesize that the
crosslinked network will shrink in dimension along the pre-defined axis over the course of
several days. If nerve endings are attached to the ends of this shrinking matrix, it would be
similar to a micromotor applying tensile stress on the neurons. Unlike the mechanized studies
mentioned above, the polymer network system developed here will have a limit to its
potential of being an actuator. We believe that this system will exist in two stages. During the
first stage the hydrogel network will release the stored retractive stress and shrink, while in
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the second stage once the hydrogel has stopped shrinking it will exist as a passive scaffold
that will act as a bridge for the neurites to cross over.

In order to be able to store a retractive stress in a network we needed to select a long
chain biocompatible molecule. Some of the other requirements included ease of chemical
modification for the purpose of crosslinking, property of being a natural ligand for neuronal
cells, and being naturally degradable to non-toxic byproducts. HA is a naturally occurring
glycosaminoglycan that has been shown to enhance peripheral nerve regeneration (30, 31). It
is a natural ligand for cell surface receptors like CD44 and RHAMM (32-35). We
investigated the shrinking mechanism by either selectively degrading the crosslinks that hold
the network together or by selectively degrading the long HA backbone chains. In the
previous chapter, we discussed our attempt at crosslinking HAGMa chains using PEGDa, a
non-degradable crosslinker. We were able to demonstrate controlled hydrogel shrinkage by
degrading the hydrogels using the enzyme hyaluronidase. The shrinkage ranged from 11% to
12.33% producing a shrinkage force as high as 3.47 mN. The method of recovering the
stored retractive stress was enzymatic which cleaved the HAGMa chains. This method did
not allow us to use the maximum recoiling potential of an entire uncleaved chain. This
chapter details our efforts at selectively degrading the crosslinks to produce shrinkage of
HAGMa hydrogels. We synthesized a hydrolysable crosslinker polyethylene glycol
poly(lactic acid)-diacrylate (PEGPLADa) which helped us achieve our goal. The hydrogel
was characterized for its capability to shrink and to generate force in the process.
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4.2 Materials and Methods
Sodium salt of HA (MW 1.6 MDa), bovine testicular hyaluronidase, poly(ethylene glycol)
diacrylate (PEGDa), and glycidyl methacrylate (GMa) were purchased from Sigma Aldrich.
GMa and PEGDa were filtered to remove MEHQ inhibitor. Irgacure 2959 was purchased
from BASF chemicals. All other solvents and chemicals were purchased from Sigma unless
stated otherwise and used without further purification.
4.2.1 Methacrylation of HA: Sodium salt of HA derived from Streptococcus equi, MW 1.6
MDa, was used in the derivatization reaction. The functional unit of an HA molecule is a
disaccharide consisting of N-acetylglucosamine and glucoronic acid. There are two main
sites on an HA disaccharide suitable for modification, namely the pendant hydroxyl
group on the N-acetylglucosamine and carboxylate on the glucoronic acid component.
The derivatization method was adapted from previous work by Bader et al. with
poly(vinyl alcohol) gels (36). An excess of GMa was used to covalently attach the
methacrylate moiety onto the HA disaccharide. Briefly, HA was dissolved in deionized
water (DI H2O) at a concentration of 3 mg/ml. A 20 molar excess of GMa was then
dissolved in the HA solution, the pH was adjusted to 1.5, and the reaction was carried out
at 50°C for 2 days. Following this, the reaction mixture was dialyzed against DI H 2O for
2 days, after which the product was lyophilized and refrigerated until needed. The
reaction chemistry is shown in Figure 4.1.

The degree of modification was quantified using proton NMR spectroscopy
performed using a Bruker Avance-III 300 MHz spectrometer. Peaks (δ = 5.8, 6.2)
representing the two protons on the methacrylate chain were used to calculate the degree
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of modification. The reference peak (δ = 2.0) was the peak representing protons from the
methyl group on HA and methacrylate segment. The solvent used for NMR was
deuterated water. The degree of methacrylation can be altered by varying the molar
concentration of GMa in the reaction, and the duration of the reaction.

Fig.4.1. Schematic showing the reaction mechanism for methacrylation of hyaluronic
acid. The reduction is pH triggered ring opening of glycidyl methacrylate. The extent of
successful modification is a function of the concentration of GMa.

4.2.2 Synthesis of PEGPLADa: Hydrolysable PEGPLADa crosslinker was synthesized by
modifying a method previously described by Sawhney et al. (37). Figure 4.2 shows the
schematic of the reaction. Stage 1 of the reaction entailed adding dl-lactide moieties onto
the α and ω hydroxyl end of PEG molecule via ring opening polymerization. Stage 2 of
the reaction added photoactive acrylate terminal end to the PEG-dl lactide molecule. Poly

98

(ethylene glycol) (MW: 1500 Da), dl-lactide (MW: 180 Da) and stannous octoate were
charged in a round bottom flask under nitrogen environment. The reaction mixture was
stirred under vacuum for 4 hours at 200°C and 2 hours at 160°C. The reaction product
was then cooled to room temperature and dissolved in methylene chloride followed by
precipitation in large excess of chilled anhydrous diethyl ether. The precipitate was then
dried in a vacuum dryer for 2 days. Proton NMR was used to confirm the success of the
reactions. Next the PEG-dl-lactide molecule was dissolved in dichloromethane along
with triethylamine (TEA) and acryloyl chloride. The reaction mixture was cooled to 0°C
using an ice bath for 2 hours and then the reaction mixture was stirred at room
temperature for an additional 22 hours. The reaction product was washed with 1M HCl
and water to remove the triethanolamine hydrochloride. Methylene chloride was rotary
evaporated and then the product was further dried in a vacuum oven at 70°C for 2 days.
Again the reaction was confirmed using proton NMR. The solvent used for NMR was
deuterated chloroform.
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Fig.4.2. Schematic showing the synthesis of PEGPLADa. During stage 1 dl-lactide was
reacted with PEG in the presence of tin hexanoate to obtain PEG-dl lactide. In stage 2,
acrylate photo-reactive group was covalently attached to the ends of PEG-dl lactide
monomer. The success of the reaction was verified using 1H NMR.
4.2.3 Rheological characterization: To ensure that rapid crosslinking will be able to restrain
the shear flow disentangled HA molecular chains, it was imperative to know the
relaxation behavior of the solution. An oscillatory strain sweep was conducted on a TA
ARG2 stress-controlled rotational rheometer using parallel-plate geometry and a Peltier
plate at room temperature to determine the linear viscoelastic regime. The strain was
ramped from 0.1% to 10% at 25 °C. Step-strain stress relaxation experiments were
conducted, where shear stress is monitored following application of a small shear strain.
The diameter of the plate was 40 mm with a solvent trap and moisture chamber enclosure
to prevent drying of the test solution. The strain values selected were 5%, 7%, 10% and
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12%. Various compositions of HA pre-crosslinking solutions minus the photoinitiator
were subjected to the stress relaxation test.

4.2.4 Fabrication of crosslinked hydrogels: Pre-crosslinking solutions were made consisting
of methacrylated HA, crosslinker, and 1% Irgacure 2959 (I2959). Cytocompatibility
studies have showed that I2959 is one of the most cytocompatible photoinitiators (38).
Irgacure 2959 is an α-cleavable type I photoinitiator or α-hydroxy phenyl ketone. It is a
partially water soluble, non-yellowing compound which forms colorless solutions. The
excitation frequency is 320 nm and photo-excitation produces a benzoyl and a ketyl
radical of which the former is the major reactive species. One of the many advantages of
this particular photoinitiator is that the excited triplet state is too short to be scavenged by
oxygen, so the polymerization reaction can be carried out in air inside a fume hood (39).
Experimental samples were fabricated using a mold created using glass slides as shown
in Figure 4.3. The pre-crosslinking solution was injected into the mold via a 20 gauge
needle at a rate of 0.5 ml/min. Rapid crosslinking was initiated by exposing the mold to a
100 W, 365 nm UV light source. The experimental samples were crosslinked
immediately following injection. The control samples were crosslinked following a delay
was introduced between the injection and UV exposure to facilitate relaxation of the HA
chains. The samples were allowed to swell in DI water at 4 °C for 2 hours before any
tests. The lowered temperature was utilized to minimize hydrolytic degradation. Figure
4.4 shows the reaction schematic of the crosslinking chemistry.
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Fig.4.3. Image of the glass slide mold used to crosslink HAGMa hydrogels. The needle
shows the channel where the pre-crosslinking solution was injected prior to UV exposure.

Fig.4.4. Schematic showing the hydrogel crosslinking chemistry. Two concentrations of
HAGMa (60 mg/ml and 70 mg/ml) were crosslinked using 1:1 ratio of PEGPLADa. The
pre-crosslinking solution turns from translucent yellow to opaque white indicating
success of crosslinking chemistry.

4.2.5 Birefringence experiment: Birefringence is a property that can provide evidence of a net
molecular chain orientation in the crosslinked hydrogel due to rapid crosslinking of the
shear aligned HAGMa chains. Crosslinked HAGMa gels were imaged under the
polarized optical light microscope (POM) as described in section 3.2.4 to study their
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orientation birefringence. Two sets of experiments were performed to answer two
different questions about this hydrogel system. Samples crosslinked with different
HAGMa concentrations were compared for their retardance to determine the effect of
HAGMa concentration on the degree of alignment. The second set of experiment
compared the retardance of samples before and after a 48hr degradation experiment to
confirm that the shrinkage is a result of reorganization of the molecular chains in the
hydrogel network. The compositions tested were 60 mg/ml HAGMa crosslinked with 1:1
ratio of PEGPLADa and 70 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa.
The sample was imaged at three separate locations representing the two ends and the
middle of the sample. This was done to observe if there is any significant difference in
the molecular orientation across the sample.

4.2.6 Calculation of predicted retractive stress in the network using rubber elasticity
theory: In order to estimate the retractive stress stored in the hydrogel network, we need
to first calculate certain network parameters. Swelling experiments were performed on
samples of each composition to calculate the swelling coefficient (Qm), and crosslink
density (n). The compositions tested were 60 mg/ml HAGMa crosslinked with 1:1
PEGPLADa, and 70 mg/ml HAGMa crosslinked with 1:1 PEGPLADa. The gels were
swollen in PBS at 4°C for a couple of hours and weighed to find the wet weight (Mw).
The samples were then dried in a descicator and weighed again to find the dry weight
(Md). The swelling parameters (Qm, Qv, n) and the predicted maximum retractive stress in
the network (𝝈Pr) were calculated as described in section 3.2.5.
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4.2.7 Hydrolysis driven shrinkage experiment: HA hydrogels were crosslinked with
PEGPLADa as described earlier. The sample concentrations used were 60 mg/ml
HAGMa crosslinked with 1:1 ratio of PEGPLADa and 70 mg/ml HAGMa crosslinked
with 1:1 ratio of PEGPLADa. Crosslinked hydrogel samples were swollen to equilibrium
in DI water for 2 hours at 4°C in a refrigerator to slow down any hydrolysis that may
occur during the swelling process. Rapidly crosslinked hydrogel samples were then
transferred into a 37°C shaker for a period of 48 hrs. As the shrinkage process is
hypothesized to occur due to hydrolysis, the only form of control samples fabricated were
ones with negligible retractive stress stored in the network. This was achieved by
providing ample time for the HA chains in the pre-crosslinking solution to relax inside
the injection mold before exposing to UV light source. Sample images were captured
every 4 hrs and measured using Image J. As a long term study to determine how long the
shrinkage continues to occur, samples of the above mentioned composition were kept in a
37°C shaker for a week and sample dimensions were measured form the images captured
every 8 hrs.

The experiment described above tested in a controlled manner the shrinkage that
is only caused by the hydrolysis process. To simulate the actual conditions at the injury
site, where there would be hydrolytic as well as enzymatic degradation, PEGPLADa
crosslinked hydrogels were also exposed to 10 µg/ml of hyaluronidase for duration of 48
hrs. The enzyme was replenished every 4 hrs. This experiment provided evidence of any
synergistic effect that may happen on account of having both the processes occurring
simultaneously.
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4.2.8 Effect of solvent diffusion on shrinkage: Diffusion is a key aspect that could affect the
rate and manner of shrinkage. To ensure that PBS was diffusing through the bulk of the
hydrogel efficiently and producing the shrinkage, samples were fabricated as described
previously and then sliced longitudinally to reduce the thickness by one half. The
rationale behind this was that if the solvent was not diffusing into the bulk of the sample
then the shrinkage magnitude and profile would be different than the regular samples.
Three samples each of 60 mg/ml HAGMa crosslinked with 1:1 PEGPLADa and 70
mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa were used for this experiment.
The samples were placed in a 37°C shaker for a period of 48 hrs. Images captured at each
timepoint were measured using Image J.

4.2.9 Measurement of hydrogel stiffness: In order to determine the force generated by the
shrinking hydrogel, we designed a mechanical test setup that relies on a flexible
cantilever and its associated sensor. To make sure that we can accurately determine the
forces, the hydrogel samples and the cantilever had to be stiffness matched. We
performed surface indentation using the mesoindentation system, as described in section
3.2.8, to calculate the stiffness of the hydrogel

4.2.10 Force measurement protocol: Figure 4.5 shows the custom-built device consisting of a
flexible aluminum cantilever- (DVRT) pair. This device enabled us to measure the force
generated by HAGMa hydrogels during the process of shrinking as described in section
3.2.8. The compositions tested were 60 mg/ml HAGMa crosslinked with 1:1
PEGPLADa, and 70 mg/ml HAGMa crosslinked with 1:1 PEGPLADa. Control samples
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were made with a delay between injection into the mold and crosslinking to ensure
negligible retractive stress is stored in the gel network. The raw voltage data was
converted to force (mN) and displacement (µm) using calibration constants. These values
were then used to determine the work performed by the shrinking hydrogel.

Fig.4.5. Images showing the device used to measure the force generated by the shrinking
hydrogel. (a) The aluminum cantilever-DVRT pair (circled in black) is the sensing end of
the device. (b) The sample is attached on one end to the calibrated flexible cantilever and
to a fixed stage on the other end. The sample is kept submerged via the enclosed reservoir
chamber.

5.2.10 Statistical analysis: For all statistical analyses ANOVA with Tukey post-hoc analysis or
a students t-test were employed as applicable using Origin Pro 8.0, with a significant
difference reported for p < 0.05. Image analysis was performed using Image J software
(NIH, USA). All values are reported as mean ± standard deviation.

4.3 Results

4.3.1 Methacrylation of HA: Sodium hyaluronate was successfully modified and a pendant
methacrylate group was added on the disaccharide thus forming methacrylated HA
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(HAGMa). This reaction was successfully repeated several times with the modification
percentage ranging from 75% to 82%.

4.3.2 Synthesis of PEGPLADa: PEG oligomer with hydroxyl end group in the form of
lactidyl moiety was synthesized by ring opening of the cyclic dl-lactide at 200°C in the
presence of the stannous octoate as the transesterification agent. The ring opening
polymerization of the lactones was initiated by an alcohol in the presence of the catalyst.
Figure 4.6 and 4.7 show the 1H NMR of the PEG and PEG-dl lactide respectively. The
lactone was added stepwise to the α and ω terminal hydroxyl group of the PEG. This
resulted in a BAB copolymer having terminal hydroxyl group. The degree of
polymerization depended on the ratio of the lactone concentration to the concentration of
the PEG. Two mol dl-lactide / mol PEG resulted in a degree of polymerization of 1.9. Fig
4.8 shows the 1H NMR of the stage 2 product, PEGPLADa. The terminal hydroxyl
groups in the PEG-dl lactide precursor were end capped with acrylate groups by reacting
with acryloyl chloride. Since the precursor has two hydroxyl end groups per molecule,
the number of acrylic groups upon hydroxyl-initiated extension was expected to be two.
The acrylate peaks were observed between 5.5 and 6.6 ppm.
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Fig.4.6. 1H NMR of Poly(ethylene) glycol with molecular weight of 1500Da. The peak at
4.3 ppm represents the (-CH2O) group. The solvent used was deuterated chloroform.
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Fig.4.7. 1H NMR of stage 1 product. The lactide was added onto the PEG molecule at the
hydroxyl end terminals. The degree of polymerization was calculated using the reference
(-CH2O = 4.3 ppm) from the PEG and the (-CH3 = 1.3 ppm) of the lactide. The degree of
polymerization obtained varied between 1.9 - 2.9, which was essential to synthesize a
water soluble end product (19).
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Fig.4.8. 1H NMR of PEGPLADa, the end product of stage 2 reaction. The peaks seen
between 5.5 and 6.6 confirmed the successful addition of the acrylate groups.
4.3.3 Rheological characterization: Figure 4.9 and 4.10 show the stress relaxation plots for
the compositions 60mg/ml HAGMa with 1:1 PEGPLADa and 70 mg/ml HAGMa with
1:1 PEGPLADa respectively. At time = 0 the specimen was suddenly deformed
homogenously. The deformation created a stress which gradually relaxed with time. The
shear stress could return to zero once the strain induced stress relaxes. Due to the high
molecular weight of the HA polymer, the molecular chains may not return to the same
random configuration once the stress relaxes. Instead of zero shear stress the sample
could plateau out at a non-zero value as the chains may obstruct each other to prevent
complete relaxation. Complete relaxation of shear stress was not observed within the test
duration for any of the strain conditions. We also did not observe any plateau condition
either. From pilot crosslinking tests the crosslinking time was observed to be between 45
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and 55 seconds. The rheological tests indicated that the molecular chains in neither of the
compositions, 60 mg/ml HAGMa crosslinked with 1:1 PEGPLADa or 70 mg/ml HAGMa
crosslinked with 1:1 PEGPLADa, would have relaxed before the solution gets completely
crosslinked. Thus these compositions would be ideal candidates for testing our hypothesis
of storing a retractive stress in the crosslinked networks. Another reason we selected this
particular concentration of PEGPLADa was that higher concentrations of the crosslinker
caused phase separation of the pre-crosslinking solution. The hydrophobic lactoyl
moieties in the bifunctional crosslinker interacted with the hydrophilic HAGMa molecule
and lead to the phase separation.

Fig.4.9. Stress relaxation curves for pre-crosslinking solutions of the composition 60
mg/ml HAGMa with 1:1 PEGPLADa. The % strain conditions used were 5%, 7%, 10%,
and 12%. The shear stress curves do not return to pre-shearing zero stress or a non-zero
plateau indicating that total molecular chain relaxation did not occur within testing
duration limits.
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Fig.4.10. Stress relaxation curves for pre-crosslinking solutions of the composition 70
mg/ml HAGMa with 1:1 PEGPLADa. The % strain conditions used were 5%, 7%, 10%,
and 12%. The shear stress curves do not return to pre-shearing zero stress or a non-zero
plateau indicating that total molecular chain relaxation did not occur within testing
duration limits.

4.3.4 Birefringence study: Figure 4.11 shows optical micrographs for samples of the
composition 60 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa prior to
hydrolytic degradation. When the optical axis of the sample was at 45° to the polarizers,
birefringence was observed indicating presence of orientation. We calculated the
retardance (Δnh) values for all the samples at three distinct locations across the sample,
the middle and the two ends. After comparing the retardance values from the three
locations, amongst themselves and across the samples, we concluded that there was no

112

significant difference (p >> 0.05) in the retardance values. This indicated that the
crosslinking was rapid enough to preserve the shear induced molecular orientation and
this orientation was nearly homogenous. The average retardance was calculated from the
nine values obtained from the three samples. The average retardance for the composition
60 mg/ml HAGMa crosslinked with 1:1 PEGPLADa prior to enzymatic degradation was
28.60 ± 7.88 nm.

Three samples of the same composition were then immersed in PBS and placed
on a shaker table at 37°C for a period of 48 hrs to facilitate hydrolytic degradation. After
the test duration, the samples were air dried and observed under the polarized optical
microscope (POM). Figure 4.12 shows the captured micrographs. The observable
brightness was reduced as compared to the pre-enzyme exposure samples. However the
retardance values did not show a significant decrease. This demonstrated that the
hydrolytic degradation did not cause a significant decrease in molecular orientation
within the samples. Once again we compared the retardance values along length of the
sample and between samples. There was no statistically significant difference observed (p
>> 0.05). The magnitude of overall sample shrinkage was not measured during this
experiment. The average retardance for this composition following enzymatic
degradation was 21.15 ± 3.43 nm.
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Fig.4.11. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels
crosslinked with 1:1 ratio of PEGPLADa prior to their hydrolytic degradation. Images
were captured at the two ends and the middle of the sample. The arrow indicates the
direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 28.60 ± 7.88 nm. The magnification is 20X.
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Fig.4.12. Polarized optical micrographs of three 60 mg/ml HAGMa hydrogels
crosslinked with 1:1 ratio of PEGPLADa after hydrolytic degradation for 48hrs. Images
were captured at the two ends and the middle of the sample. The arrow indicates the
direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 21.15 ± 3.43 nm. The magnification is 20X.

Similarly the second composition, 70 mg/ml HAGMa crosslinked with 1:1 ratio
of PEGPLADa, was observed under the POM prior to and after being immersed in PBS
at 37°C for 48 hrs. Figure 4.13 shows the optical micrographs for the samples prior to
hydrolytic degradation. Each sample was imaged at the two ends and the middle to
determine the homogeneity of molecular orientation. The brightness verified the
existence of molecular orientation. The average retardance was 23.52 ± 4.57 nm. Samples
of the same composition were then degraded and imaged to observe effect of degradation
on molecular orientation. Figure 4.14 shows the polarized optical micrographs for the
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hydrolytically degraded samples. The retardance values and the observable brightness did
not significantly decrease (p >> 0.05), as compared to values obtained from prior to
degradation, indicating no significant loss of molecular orientation. The average
retardance value post degradation was 24.30 ± 6.54 nm. The magnitude of overall sample
shrinkage was not measured during this experiment. Figure 4.15 summarizes the results
from the birefringence experiment.

Fig.4.13. Polarized optical micrographs of three 70 mg/ml HAGMa hydrogels
crosslinked with 1:1 ratio of PEGPLADa prior to their hydrolytic degradation. Images
were captured at the two ends and the middle of the sample. The arrow indicates the
direction of flow of the pre-crosslinking solution in the glass mold prior to rapid
crosslinking. The retardance for this composition calculated from the captured spectra
was 23.52 ± 4.57 nm. The magnification is 20X.
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Fig.4.14. Polarized optical micrographs of three 70mg/ml HAGMa hydrogels crosslinked
with 1:1 ratio of PEGPLADa post hydrolytic degradation for 48hrs. Images were
captured at the two ends and the middle of the sample. The arrow indicates the direction
of flow of the pre-crosslinking solution in the glass mold prior to rapid crosslinking. The
retardance for this composition calculated from the captured spectra was 24.30 ± 6.54
nm. The magnification is 20X.
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Fig.4.15. Bar graph summarizing the retardance values calculated for the PEGPLADa
crosslinked HAGMa hydrogel samples prior to and following hydrolytic degradation.
There was no significant decrease in the retardance of samples for the two compositions
tested. (n=3)

4.3.5 Estimation of retractive stress in the hydrogel: To calculate the crosslink density of
the hydrogels, swelling experiments were performed to calculate the swelling ratios. The
gels with lower concentration of HAGMa showed significantly higher swelling
coefficient. We adapted rubber elasticity theory to estimate the retractive stress stored in
a rapidly crosslinked hydrogel. Table 4.1 and Figure 4.18 show the results from this
experiment. Increasing the HAGMa concentration did not significantly increase the
predicted retractive stress (kPa) stored in the hydrogel network, although the averages
seemed to scale with the HAGMa concentration.
Table 4.1. Results from the swelling experiments and retractive stress estimation study
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4.3.6 Hydrolysis driven shrinkage: HAGMa samples crosslinked with PEGPLADa were
degraded hydrolytically. Figure 4.16 shows the 48 hr shrinkage profile for samples of the
composition 60 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa. The controls
as well as the experimental samples showed shrinkage. The controls shrunk an average of
0.57 mm or 3.57 % before plateauing out. The experimental samples demonstrated a net
shrinkage of 21.71 % or 3.07 mm. However the shrinkage was rapid and most of it
occurred within the first 4 hrs. Figure 4.17 shows results for the samples of the second
composition 70 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa. We did
observe some shrinkage (6.8 % or 0.9 mm) in the control sample. This control sample
shrinkage could be on account of some residual retractive stress still present in the
network as well as molecular chain reorganization as a result of degradation. The
experimental samples also demonstrated shrinkage along their long axis which was
significantly greater than the control samples. Unlike the samples of the composition 60
mg/ml HAGMa, the 70mg/ml HAGMa samples demonstrated a much more gradual
shrinkage profile. The net shrinkage was 14.21 % or 2.04 mm. The shrinkage did not
seem to stop by the end of 48 hr.
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Fig.4.16. Graph showing hydrolysis driven shrinkage profile for hydrogels of the
composition 60 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa that were
degraded for 48 hrs. The controls were made such that there would be negligible
retractive stress in the network. The experimental samples demonstrated 21% shrinkage,
however almost all of it occurred within the first 4 hrs. The shrinkage ceased after 8 hrs.
In comparison the controls shrunk only 4%. (n=3)

Fig.4.17. Graph showing hydrolysis driven shrinkage profile for hydrogels of the
composition 70 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa that were
degraded for 48 hrs. The controls had negligible retractive stress in the network. The
overall profile of shrinkage was more controlled compared the composition 60mg/ml
HAGMa crosslinked with 1:1 PEGPLADa. The net shrinkage after 48 hrs was 14%. The
controls showed a net shrinkage of 6.8%. (n=3)

To verify if the networks could produce any more shrinkage, we extended the
duration of degradation from 48 hrs to 1 week. Figure 4.18 and 4.19 show the shrinkage
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profile results for samples of the two compositions. The 60 mg/ml HAGMa samples did
not demonstrate shrinkage beyond 8 hrs. The control samples of the composition 70
mg/ml HAGMa did not show any further shrinkage, however the experimental samples
continued to shrink beyond 48 hrs but stopped around 52 hr time point.

We wanted to explore the effect of combining hydrolytic degradation of the
networks with enzymatic degradation. PEGPLADa crosslinked samples were exposed to
10 µg/ml concentration of the enzyme hyaluronidase. Figure 4.20 shows the shrinkage
profile we obtained from those samples. Adding the enzyme had some interesting
synergistic effects on the shrinkage. In case of the 60 mg/ml HAGMa samples, the
shrinkage rate was slowed down but the overall magnitude reduced from 21.71 % to
16.89 %. The duration of shrinkage increased from 8 hrs to 20 hrs. The 70 mg/ml
HAGMa samples on the other hand showed an increase in the net magnitude of shrinkage
from 14.21 % to 20.77 %, however the shrinkage ceased by 52 hrs.

Fig.4.18. Graph showing hydrolysis driven shrinkage profile for hydrogels of the
composition 60 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa that were
degraded for one week. The controls were made such that there would be negligible
retractive stress in the network. The samples did not show any renewed shrinkage after 8
hrs. (n=3)
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Fig.4.19. Graph showing hydrolysis driven shrinkage profile for hydrogels of the
composition 70 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa that were
degraded for one week. The experimental samples continued to shrink till 52 hrs and the
shrinkage profile then seemed to plateau out. (n=3)

Fig.4.20. Shrinkage profile for samples of the composition 60 mg/ml HAGMa and 70
mg/ml HAGMa crosslinked with 1:1 PEGPLADa that were exposed to 10 µg/ml
concentration of hyaluronidase. Combining hydrolytic and enzymatic degradation slowed
down the overall shrinkage profile for the 60 mg/ml composition, while increased the net
magnitude of 70 mg/ml HAGMa composition when compared to the samples that were
only hydrolytically degraded. (n=3)

Figure 4.21 summarizes the shrinkage rates per day that we calculated for the
hydrolytically degraded PEGPLADa crosslinked HAGMa samples. The 60 mg/ml
HAGMa samples stopped shrinking by the end of 8 hrs with a rate greater than 100
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µm/hr during that duration. The 70 mg/ml HAGMa samples stopped shrinking by the end
of day two. The rate calculated for the first day was 70 µm/hr, which is within the
beneficial stretching rate previously reported for axonal elongation (7, 8, 11). Table 4.2
summarizes the degradation induced shrinkage for the PEGPLADa crosslinked samples.

Fig.4.21. Profile of the shrinkage rates for the PEGPLADa crosslinked HAGMa
hydrogels that were degraded hydrolytically for a period of 1 week. The shrinkage rates
for the first day ranged from 70 µm/hr to 125 µm/hr. The shrinkage gradually ceased by
day 2 for all the compositions. (n=3)

Table.4.2. Summary of the average sample shrinkage for the PEGPLADa crosslinked
HAGMa hydrogel samples

4.3.7 Effect of solvent diffusion on shrinkage: Figure 4.22 shows the shrinkage profiles for
the samples that were one half the thickness of the regular samples. We observed that the
overall profile did not change significantly. Samples of the composition 60 mg/ml
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HAGMa still showed rapid shrinkage that lasted 8 hrs. There was a 7% decrease in the
net magnitude of shrinkage. The samples of the composition 70 mg/ml HAGMa showed
an increase of 4% in the net shrinkage. Thus we did see some effect of sample thickness
on the shrinkage. However it was only on the magnitude and not the manner in which
they shrink. Reducing thickness meant reducing the source of the shrinkage. We believe
that in case of 60 mg/ml samples we reduced the overall potential to shrink while in case
of the higher concentration 70 mg/ml HAGMa samples we decreased the density of
chains which was restricting efficient reorganization of chains in the first place.

Fig. 4.22. Graph showing the hydrolysis driven shrinkage of PEGPLADa crosslinked
HAGMa hydrogels (a, b – 60 mg/ml; c, d – 70 mg/ml), comparing the effect of sample
thickness on nature of sample shrinkage. For the 60 mg/ml composition there was a
decrease in overall magnitude of shrinkage but the profile remained unchanged. The 70
mg/ml composition demonstrated a 3% increase in the magnitude of shrinkage. (n=3)
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4.3.8 Hydrogel stiffness: PEGPLADa crosslinked HAGMa samples were indented at random
locations prior to and following hydrolytic degradation. The load-displacement curves
indicated a linear elastic behavior where the loading and unloading curves overlapped.
The stiffness was calculated from the loading portion of the curve. Prior to exposure to
degradation the stiffness of gels with the composition 60 mg/ml HAGMa crosslinked
with 1:1 PEGPLADa was 2.04 ± 0.10 N/m. After degradation for 48 hrs, the stiffness
dropped to 1.14 ± 0.09 N/m. Similarly the stiffness of gels made using 70 mg/ml
HAGMa and 1:1 PEGPLADa before hydrolytic degradation was 2.21 ± 0.19 N/m. After
degradation, the stiffness decreased to 1.44 ± 0.09 N/m. Figure 4.23 summarizes the
results from this experiment. The stiffness values helped us in designing the aluminum
cantilevers with stiffnesses specifically matched to the hydrogel composition.

Fig. 4.23. Graph showing the measured stiffness of HAGMa hydrogels crosslinked with
PEGPLADa before and after 48hr degradation. The stiffness of the samples decreased
significantly (p<<0.05) following degradation. (n=3)
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4.3.9 Measurement of shrinkage force: Flexible cantilevers were fabricated based on the
stiffness values obtained from the indentation experiments. We selected the stiffness
value as 2.01 N/m keeping a fine balance between the stiffness achievable while
acquiring sufficient signal from the DVRT-cantilever pair. The cantilever was calibrated
using known loads and displacements (see appendix). The test was conducted for 48 hrs
and the raw voltage values were converted to appropriate force and displacement values
using the calibrations. The DVRT signal was recorded at the rate of one point per second;
however the plots display only one point per hour for the purpose of clarity. The crosssection of the hydrogels was 1 mm2. The force values were converted to corresponding
stress (kPa) to corroborate with the predicted stress (𝝈pr). This was done to determine
how much of the stored retractive stress was recovered. Figure 4.24 (a, c, e) shows the
force, displacement, and recovered stress curves for hydrogels of the composition 60
mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa. The control samples were able
to displace the cantilever by 0.24 ± 0.05 mm generating a force equivalent to 0.45 ± 0.1
mN. The cantilever displacement can be equated to the sample‟s shrinkage; however the
sample gets weaker as it degrades, so it will be unable to sustain the cantilever
displacement. The sample shrinkage was half that of the unconstrained shrinkage
experiments. The experimental samples demonstrated shrinkage of 1.3 ± 0.6 mm exerting
a net force of 1.4 ± 0.27 mN on the cantilever. This amounted to a net stress of 1.4 kPa or
12.47 % of the predicted stored retractive stress.

Samples of the second composition, 70 mg/ml HAGMa crosslinked with 1:1
PEGPLADa, were tested in the similar fashion. The control samples shrunk 0.51 ± 0.19
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mm with a net force of 0.77 ± 0.26 mN. Once again the shrinkage values were half the
values we measured during the unconstrained experiment. The experimental samples
shrunk 1.46 ± 0.40 mm while applying a force of 1.00 ± 0.23 mN on the cantilever. This
value translated to a net recovered stress of 1 kPa, which was 7.44 % of the predicted
stored retractive stress. The constrained condition of the samples in the test device
affected the shrinking behavior of the hydrogels. Unlike the unconstrained shrinkage
tests, the samples now performed work on another object. Thus even the profile of
shrinkage appeared to be more gradual when compared to the profile obtained from the
unconstrained shrinkage. Another factor that also probably played a role in the plateau
observed in the force and displacement profiles was the fact that the sample strength
decreased on account of the degradation. Thus overtime the cantilever stiffness overtook
the sample stiffness and was able to compensate for the force the sample was applying on
it. Figure 4.25 shows a comparison of between the predicted stored retractive stress in the
networks and the measured recovered stress from this experiment. It was evident that a
significantly smaller percentage of the stored retractive stress could be recovered which
again can be explained by the sample constrainment and loss of sample stiffness.
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Fig.4.24. Graphs showing the force, cantilever displacement, and recovered stress curves
for the PEGPLADa crosslinked HAGMa samples that were hydrolytically degraded
while attached in the force measurement device. The control samples showed very
minimal shrinkage compared to experimental samples. The stress recovered either
composition was significantly lower than what was predicted using rubbery elasticity
principles. (n=3)
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Fig.4.25. Bar graph showing the values of predicted stored and the recovered retractive
stress for the two compositions of PEGPLADa crosslinked HAGMa hydrogel samples.
The magnitude of the recovered shrinkage was significantly lower than the predicted
stored retractive stress. (n=3)

4.4 Discussion
The unique properties of the HA molecule enabled us to design a novel hydrogel that could
be programmed to shrink on a time scale relevant for application as a mechanical stimulator
of neuronal cells. Birefringence enabled us to verify the success of arresting the shear flow
induced molecular chain alignment. Our hypothesis was that increasing the HAGMa
concentration would decrease the extent of molecular orientation in the crosslinked network.
We increased the HAGMa concentration from 60 mg/ml to 70 mg/ml. The average
retardance value decreased from 28.60 nm to 23.52 nm however the standard deviations were
high enough to negate any significant difference between the compositions. The retardance
values were uniform across the samples for either composition indicating that the
crosslinking process maintained similar disentanglement induced state of orientation
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throughout the sample. In our previous work, we hypothesized that enzymatic cleavage of
HAGMa chains was hampering our ability to extract higher degree of shrinkage. Thus we
devised a network where the crosslinks were degraded selectively via hydrolysis. We
examined the birefringence of samples that were degraded for 48 hrs. We did not see any
significant decrease in the molecular orientation despite the fact we observed shrinkage of
the samples. The high concentration of backbone HAGMa chains might be preventing further
relaxation of the chains despite the fact that the hydrolysis cleaves the crosslinks. We did not
observe a complete degradation within our testing duration. An extended degradation study
may be able to shine some light on the duration it takes for the complete network to collapse.

Based on our previous work, we concluded that the magnitude of shrinkage that could be
obtained from the novel HAGMa network is limited by the size and concentration of the
HAGMa chains. The method we adapted to predict this magnitude of retractive stress stored
in the network demonstrated that the retractive stress does seem to scale with the
concentration of HAGMa but we did not see any significant difference between the two
compositions we tested. Our ability to test higher concentrations was limited by the nonhomogenous crosslinking we observed at higher HAGMa concentrations. The higher
concentration of HAGMa restricted diffusion of the free radicals through the samples thereby
producing unevenly crosslinked samples. A solution to this issue would be to increase the
molecular weight of the HAGMa chains which would allow us to reduce the concentrations
and may provide us a wider range of compositions to experiment with.
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Hydrolytic degradation of the rapidly crosslinked HAGMa hydrogels brought about
shrinkage of the gel along its long axis which was also the axis of flow prior to crosslinking.
The magnitude and rate of shrinkage were affected by the concentration of HAGMa. As we
increased the HAGMa concentration the shrinkage was much more gradual. However the
increase in HAGMa concentration also decreased the net magnitude of shrinkage. This result
may seem confusing, considering that higher concentration of the HAGMa chains translate to
higher potential retractive stress in the network, until we inspect how the network chains
behave at the two different concentrations. As the PEGPLADa crosslinks get cleaved, the
free volume within the network increases. So the chains can have some long range motion
and reorganization which translates to shrinkage of the crosslinked sample. But higher the
concentration of the HAGMa, greater is the difficulty for the chains to move past one another
to reorganize. Thus it is easier for samples containing 60 mg/ml HAGMa to release the
retractive stress via reorganization when compared to those with 70 mg/ml HAGMa. Adding
a second mechanism of degradation in the form of an enzyme verified our hypothesis. When
the enzyme worked alongside hydrolysis, the HAGMa chains also got cleaved. Thus we saw
an increase in the net magnitude of shrinkage in the 70 mg/ml HAGMa samples as more
room was created within the network by combining hydrolytic and enzymatic degradation.
Cleaving the chains in lower HAGMa concentration composition samples reduced the total
potential of an intact chain to recoil and relax. Thus the rate and magnitude of shrinkage were
reduced.

The rapid nature of the shrinkage cannot be entirely explained by the hydrolysis alone.
The hydrolysis process is a gradual and slow process. Despite the high hydrophillicity of the
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network due to both HAGMa and PEG, there might be another mechanism at play that may
be responsible for the rapid shrinkage. Prior to the testing of the PEGPLADa crosslinked
samples, they were swollen in PBS for two hours at 4°C. This was done to allow for swelling
while slowing down any hydrolysis. In hindsight this may not have been the optimal
experimental design. The change in temperature from 4°C to the test condition 37°C may
have caused additional network swelling and network reorganization which led to the rapid
shrinkage. To test this hypothesis a shrinkage assay could be performed by completely
getting rid of the two hour swelling duration. Instead, the sample can be subjected to 37°C
conditions straightaway after the crosslinking process and images of the sample captured at
intervals of one hour. The normalized sample length vs time profile will show how the
sample swells, when it reaches equilibrium swelling, and when the shrinkage starts and stops.
The expected outcome profile may show initial swelling followed by shrinkage and maybe
another swelling cycle when the shrinkage stops and hydrolysis increases capacity of the gel
to absorb water.

The rate of shrinkage for the samples of the composition 60 mg/ml HAGMa crosslinked
with 1:1 PEGPLADa for the first day was over the recommended 100 µm/hr rate that is
favorable to elicit axonal elongation by stretch growth (4, 5, 7, 8). Also the shrinkage was
very rapid and lasted only 8 hrs. Samples of the 70 mg/ml composition sustained shrinkage
for 52 hrs and the rates of shrinkage per day were less than 100 µm/hr. We could not elicit
more shrinkage when we extended the degradation to one week indicating that there are still
significant limitations to this hydrogel design. Looking at results from the mechanical device
designed to measure the force generated by the shrinking hydrogel, it is evident that we are
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unable to measure all of the recovered retractive stress. As the samples got weaker on
account of the degradation, the cantilever stiffness exceeded that of the hydrogels and the
hydrogels were unable to sustain the “tug” on the aluminum cantilever. We could not
fabricate cantilevers that were softer than the ones we used. Any further reduction in the size
or flexibility of the cantilever hampered our ability to obtain a high enough DVRT signal that
was devoid of noise generated by vibrations within the reservoir. Simultaneously, the
physical chain entanglements may have prevented complete rearrangement of the network as
it degraded.

Comparing the PEGPLADa crosslinked hydrogels with the PEGDa crosslinked hydrogels
described in the previous chapter, we can start to appreciate the complex processes that result
in the hydrogel network shrinkage. The average retardance of the PEGDa hydrogel
compositions prior to shrinkage was significantly higher than any of the PEGPLADa
crosslinked gels indicating a greater magnitude of retractive stress stored in the network. This
would imply that the former would produce the greatest magnitude of shrinkage. However
the magnitude of shrinkage obtained over a period of 2 days from the PEGPLADa hydrogels
was higher than the PEGDa gels (2.32 – 3.07 mm vs 1.1 – 2.00 mm). The parameter that is
crucial for the intended application of this polymer network is the rate at which the hydrogels
shrink and the efficiency of stress recovery from the network. The profile of shrinkage for the
PEGDa appears to be more gradual and the shrinkage was sustained for a longer duration
when compared with the rapid shrinkage observed with the PEGPLADa hydrogels. Based on
the values reported in the literature on axonal stretching this rapid shrinkage with rates
greater that 100 µm/hr, as seen with the hydrolytically degraded PEGPLADa crosslinked
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gels, could to be detrimental for the application as axonal stretch growth actuators (2, 4, 7, 8,
11, 40). It is crucial to point out that adding a second means of degradation, in the form of the
enzyme hyaluronidase, did slow down the rapid shrinkage of the PEGPLADa gels increasing
their applicability. Thus after critically analyzing and comparing the data from the array of
characterization we performed, the composition 70 mg/ml HAGMa crosslinked with 1:1
PEGPLADa stands out as the most favorable candidate among the PEGPLADa compositions
tested.

There is an emerging need for polymeric actuator materials with applications that range
from artificial muscles to robotic prosthesis (12).

The current technology on actuator

polymers includes hydrogel based actuators, shape memory polymers (SMP) and a class of
polymers called electroactive polymers (EAP). Swelling/de-swelling of hydrogels is the
primary mechanism of hydrogel based actuators and ionic EAP‟s. However the inverse
relationship between the swelling behavior and the ability to generate force presents a
challenge in applying some of the currently described systems for mechanical actuation.
PNIPAAm based gels are able to produce large values (3-4mm) of displacement/shrinkage
due to network collapse (19). Trying to achieve high displacements of the gels invariably
leads to gels with low degree of crosslinking which also means a very fast and short actuation
response. The gel shrinkage for PNIPAAm gels could not be sustained for more than two
hours. Brazel et al. (23) designed a unique PVA based gel that was swollen in DMSO and
was able to produce a constant and directionally controlled locomotion in air using a DC
electric field. This concept, although very promising, would be very difficult to apply in an in
vivo biological environment due the obvious application of high voltage and non-
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biocompatible elements of the gel. SMP‟s tend to have high strain recoveries but at rates that
are as high as 1.8% to 5% per minute (15, 16). A review of the actuation literature reveals
that a majority of current actuator systems have response times that are of the order of
minutes to a few hours (12, 14, 16, 19, 22, 23, 41) which would make them unsuitable for
slow actuation applications.

Recently Chippada et al. (42) described a DNA crosslinked hydrogel that shows some
potential to be a slow actuating polymer system. The DNA-crosslinked polyacrylamide gels
have the ability to dynamically contract or swell by the addition of crosslinks or removal of
strands respectively. The tendency of these loosely crosslinked gels to contract as their
crosslink density was increased is a novel technique to generate a force. The dynamic
modulation of the stiffness of the hydrogels by addition of crosslinks caused the tissue
scaffold to shrink and this could potentially be used to exert traction on the emerging neurites
and physically expand the tissue. The force generated by the DNA crosslinked gel per unit
length was approximately equal to 1050 pN/μm. This force was of the same order of
magnitude as that observed by Heidemann et al. to elicit stretch growth in individual neurites
(4). The PEGPLADa crosslinked hydrogels produced forces that are greater than 90 nN/µm,
which is a few orders of magnitude higher. However unlike singular neurites, a bundle of
neurites may be able to sustain greater forces. The advantage that our crosslinked networks
provide is the ability to produce tensile forces at rates favorable for axonal stretch growth
using a trigger that is not damaging (thermal, electrical) to the already injured neurons.
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The critical limitation evident from our results was obtaining the correct balance between
the concentration of the HAGMa and the crosslinker PEGPLADa to prevent phase separation
of the pre-crosslinking solution. A possible solution we believe that would give us a wider
range of compositions to test is using a higher molecular weight HA molecule. This would
enable us to use lower concentrations of derivatized HA chains while achieving the
rheological conditions favorable for trapping disentangled chains in an ordered structure via
rapid crosslinking. Fabrication conditions like flow rate prior to crosslinking could be altered
to achieve the maximum degree of molecular chain orientation. The hydrogel system needs
to be optimized further for application in its desired application as a mechanical stimulator.
However this system is a significant step towards building a new class of degradable
polymeric actuators that can provide controlled slow and long term actuation.

4.5 Conclusion
Novel PEGPLADa crosslinked hyaluronic acid hydrogels were designed to possess the
property of controlled shrinkage for the purpose of use as a potential axonal growth enhancer
via the mechanism of stretch growth. The samples were characterized for their ability to
shrink and ability to exert a force on account of shrinkage. The composition 60 mg/ml
HAGMa crosslinked with 1:1 ratio of PEGPLADa demonstrated the highest magnitude of
shrinkage in 48 hrs (21.71 %) but could not sustain it for more than 8 hrs. Samples of the
composition 70 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa sustained
shrinkage for 52 hrs and the magnitude of shrinkage was 14.21 %. Despite the lower net
magnitude of shrinkage, the 70 mg/ml HAGMa composition demonstrated shrinkage rate that
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is more conducive for the application of axonal stretch growth. Further optimization of the
hydrogel system is necessary to improve on the duration of shrinkage.

137

References
1. Evans GRD. Peripheral nerve injury: a review and approach to tissue engineered constructs.
Anat Rec. 2001;263:396.
2. Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Annu
Rev Biomed Eng. 2003;5(1):293-347.
3. Wang S, Cai L. Polymers for fabricating nerve conduits. International Journal of Polymer
Science. 2010;2010.
4. Heidemann SR, Buxbaum RE. Tension as a regulator and integrator of axonal growth. Cell
Motil Cytoskeleton. 1990;17(1):6-10.
5. Dennerll T, Lamoureux P, Buxbaum R, Heidemann S. The cytomechanics of axonal
elongation and retraction. J Cell Biol [Internet]. 1989;109(6):3073.
6. Goldberg JL. How does an axon grow? Genes & Development. 2003 April 15;17(8):941-58.
7. Smith DH. Stretch growth of integrated axon tracts: Extremes and exploitations. Prog
Neurobiol. 2009 11;89(3):231-9.
8. Bray D. Axonal growth in response to experimentally applied mechanical tension. Dev Biol.
1984 4;102(2):379-89.
9. Pfister BJ, Iwata A, Meaney DF, Smith DH. Extreme Stretch Growth of Integrated Axons.
The Journal of Neuroscience. 2004 September 08;24(36):7978-83.
10. Pfister BJ, Iwata A, Taylor AG, Wolf JA, Meaney DF, Smith DH. Development of
transplantable nervous tissue constructs comprised of stretch-grown axons. J Neurosci Methods.
2006 5/15;153(1):95-103.
11. Smith DH, Wolf JA, Meaney DF. A New Strategy to Produce Sustained Growth of Central
Nervous System Axons: Continuous Mechanical Tension. Tissue Eng. 2001 04/01;
2011/05;7(2):131-9.
12. Carpi F, Smela E, editors. Biomedical Applications of Electroactive Polymer Actuators. John
Wiley & Sons; 2009.
13. Ionov L. Hydrogel-based actuators: possibilities and limitations. Materials Today.
2014;17(10):494.
14. Ionov L. Polymeric Actuators. Langmuir. 2014;10:1021.
15. Song J, Xu J. Thermal Responsive Shape Memory Polymers for Biomedical Applications. In:
Fazel-Rezai R, editor. Biomedical Engineering - Frontiers and Challenges. ; 2011.
138

16. Sokolowski W, Metcalfe A, Hayashi S, Yahia L, Raymond J. Medical applications of shape
memory polymers. Biomed Mater. 2007;2:S23.
17. Miyata T, Jikihara A, Nakamae K, Hoffman AS. Preparation of poly(2glucosyloxyethylmethacrylate) concanavalin A complex hydrogel and its glucose-sensitivity.
Macromolecular Chem , and Phys. 1996;197:1135.
18. Miyata T, Asami N, Uragami T. A reversibly antigen-responsive hydrogel. Nature.
1999;399:766.
19. Hu Z, Zhang X, Yong L. Synthesis and application of modulated polymer gels. Science.
1995;269:525.
20. Topham PD, Ryan AJ. Antagonistic Triblock Polymer Gels Powered by pH Oscillations.
Macromolecules. 2007;40:4393.
21. Gutowska A, Bae YH, Feijen J, Kim SW. Heparin release from thermosensitive hydrogels
. J Controlled Release. 1992;22:95.
22. Lendlein A, Langer R. Biodegradable, elastic shape-memory polymers for potential
biomedical applications. Science. 2002;296:1673.
23. Brazel ES, Peppas NA. Pulsatile local delivery of thrombolytic and antithrombotic agents
using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. J Controlled Release.
1996;35:57.
24. Cussler EL, Stokar MR, Varberg JE. Gels as size selective extraction solvents. AICHe J.
1984;30:578.
25. Hayashi S, Kondo S, Kapadia P, Ushioda E. Room-Temperature-Functional Shape-Memory
Polymers. Plastics Engineering. 1995;51(2):29.
26. Huffman AS, Afrassiabi A, Dong LC. Thermally reversible hydrogels: II. Delivery and
selective removal of substances from aqueous solutions. J Controlled Release. 1986;4:213.
27. Knight PT, Lee KM, Qin H, Mather PT. Biodegradable thermoplastic polyurethanes
incorporating polyhedral oligosilsesquioxane. Biomacromolecules. 2008;9(9):2458.
28. Kim JS, Singh N, Lyon LA. Displacement-induced switching rates of bioresponsive hydrogel
microlenses. Chem Mat. 2007;19:2527.
29. Mano J. Stimuli-responsive polymeris systems for biomedical applications. Adv Engg Mat.
2008;10(6):515.

139

30. Sakai Y, Matsuyama Y, Takahashi K, Sato T, Hattori T, Nakashima S, et al. New artificial
nerve conduits made with photocrosslinked hyaluronic acid for peripheral nerve regeneration.
Biomed Mater Eng. 2007;17(3):191-7.
31. Wang K, Nemeth IR, Seckel BR, Chakalis-Haley DP, Swann DA, Kuo J, et al. Hyaluronic
acid enhances peripheral nerve regeneration in vivo. Microsurgery. 1998;18(4):270-5.
32. Borland G, Ross J, Guy K. Forms and functions of CD44. Immunology. 1998;93(2):139-48.
33. Lesley J, Hascall VC, Tammi M, Hyman R. Hyaluronan Binding by Cell Surface CD44.
Journal of Biological Chemistry. 2000 September 01;275(35):26967-75.
34. Laurent TC, editor. The Chemistry, Biology and Medical Applications of Hyaluronan and its
Derivatives. 1st ed. London and Miami: Portland Pr; 1998.
35. Laurent TC, Laurent UB, Fraser JR. Functions of hyaluronan. Annals of the Rheumatic
Diseases. 1995 May 01;54(5):429-32.
36. Bader RA, Rochefort WE. Rheological characterization of photopolymerized poly(vinyl
alcohol) hydrogels for potential use in nucleus pulposus replacement. Journal of Biomedical
Materials Research Part A. 2008;86A(2):494-501.
37. Sawhney AS, Pathak CP, Hubbell J. Bioerodible hydrogels based on photopolymerized
poly(ethylene glycol)-co-poly(.alpha.-hydroxy acid) diacrylate macromers. Macromolecules.
1993(4):581.
38. Bryant, S J Nuttelman, C R Anseth,K S. Cytocompatibility of UV and visible light
photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. Journal of biomaterials science.
Polymer edition. 2000;11(5):439.
39. Allen NS, editor. Photopolymerization and photo imaging science and technology. 1st ed.
New York: Elsevier Science Publishers Ltd; 1989.
40. Schmidt CE, Leach JB. NEURAL TISSUE ENGINEERING: Strategies for Repair and
Regeneration. Annu Rev Biomed Eng. 2003;5:293-347.
41. Illeperuma W, Sun J, Suo Z, Vlassak J. Force and stroke of a hydrogel actuator. Soft Matter.
2013;9:8504.
42. Chippada U. Non-intrusive characterization of properties of hydrogels [dissertation]. New
Brunswick, New Jersey: The State University of New Jersey; 2010.

140

Chapter 5
5.1. Background
One of the advantages of hyaluronic acid for the current application as a mechano
actuator for neuronal cells is its inherent ability to be cell adhesive. CD44 is a major cell
surface receptor for HA (1). It is expressed on many different cells, including neuronal
cells where it is over expressed following trauma (2, 3). The cell surface receptors for HA
are CD44 and receptor for hyaluronan mediated mobility (RHAMM) (1, 4). CD44 is by
far the major receptor. CD44 is a ubiquitous multi-structural and multifunctional cell
surface adhesion molecule involved in cell-cell and cell-matrix interactions. It shares a
100-amino acid region of homology with other HA-binding proteins known as the “link
module” or the “proteoglycan tandem repeat” (1, 5). CD44 differs in important ways from
other HA binding proteins. HA binding by CD44 requires sequences outside the common
link module and is regulated by cell-specific factors, and requires multiple CD44/HA
engagements to achieve a functional affinity. The most significant feature that
distinguishes CD44 from other HA-binding proteins is that CD44 binding to HA takes
place at the cell surface, where multiple, closely arrayed CD44 receptor molecules interact
with the highly multivalent repeating disaccharide chain of HA. The affinity of a single
CD44-HA binding domain for HA is likely to be very low (1). It is known that following
injury to the central or peripheral nervous system, cell surface receptors like CD44 are
over expressed (2, 3). It is believed that the excess cell surface receptors help in guiding
the severed or damaged neurites along the matrix to their suitable target for reinnervation
(2). Thus the crosslinked HA network has an inherent binding advantage for the eventual
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application in a peripheral nerve gap injury during both the phases (active mechanostimulator and passive bridging scaffold) the hydrogel will exist at the site.

HA has a very short half-life in the body. To increase the feasability of using HA
based scaffolds, crosslinking process is the preferred way (6-8). HA can be modified
chemically at the hydroxy groups on both the glucoronic and N-acetylglucosamine units
or the carboxyl group on the glucoronic acid unit to add a reactive species that can be used
in the crosslinking process. However this may have adverse effects on the inherent
property of HA to be cell adhesive. Achieving a high degree of derivatization may have
effetcs on the charge density of the molecule. The electronegative nature of the HA
molecule is favorable for cell and ligand binding. Thus it was imperative to study if the
crosslinked hydrogels are still cytocompatible. A live-dead assay was performed to study
the cytocompability.

One of the methods we implemented to cause network shrinkage was degrading the
HAGMa chains in the network. HA is naturally degraded by the enzyme hyaluronidase
(9). The cleavage occurs at the β-N-acetyl-D-glucosaminidic linkages to yield fragments
of N-acetylglucosamine at the reducing terminus and glucoronic acid at the non-reducing
end (6, 7, 10, 11). We used this enzyme at physiologic and elevated concentrations to
simulate in vivo degradation at the site of injury. The breakdown products of HA have
been shown to modulate wound healing (6, 7, 10, 12). This would be an added advantage
of this polymer network system that would aid in repairing the injury site. Hence it was
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critical to know the effect of high concentrations of hyaluronidase on primary cortical
neurons over the 48 hour duration of the shrinkage / degradation experiment.

The crosslinked HAGMa networks described in Chapters 3 and 4 have properties that
would be considered as favorable to be used a mechanical stimulators for axonal stretch
growth. As a preliminary step towards eventual in vivo application, it is crucial to test this
potential in vitro. This required designing an experiment wherein the neurons and the gel
could interact and the gel would be able to exert extensional forces on the axonal ends.
The challenge was of the size scale issue with neurons growing on a 2D substrate and the
gel having to be adhered in a way that it is flush with the axonal ends. Moreover
restricting the gel in a chamber filled with media and still allowing free shrinkage without
any frictional force was a daunting task. To circumvent these problems, we built a
mechanical device to simulate the effect of a shrinking hydrogel on stretch growth of
axons. Mouse primary cortical neurons were used for all experiments involving neuronal
cells. We hypothesize that the crosslinked hydrogel would maintain the inherent
cytocompatibility of HA. The potential of the shrinking hydrogels to cause axonal stretch
growth can be tested using the custom-built mechanical stretching device. The results
from the experiments described in the following sections will allow us to assess if the
interfacial bonding between axonal ends and the crosslinked HA network is strong enough
to sustain axonal stretch growth. This will help us decide if any additional adhesion sites
may be required.
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5.2. Materials and Methods
5.2.1. Effect of Hyaluronidase on primary neurons: PEGDa crosslinked hydrogels were
degraded via the enzyme hyaluronidase to effect shrinkage. The concentrations used
for the study simulate the elevated levels of enzyme at the site of neuronal injury. The
exact concentration of the enzyme post injury is unknown. It is thus imperative to
understand if the hyaluronidase concentration has any effect on the primary neurons.
Primary cortical neurons were generously donated by the Hewett lab. The neurons
were harvested from day 15 gestation mouse pup embryos. The cells were suspended
in serum free primary cortical neuron media and seeded at a density of 200000
cells/well in a tissue culture polystyrene 12 well plate. On day two following seeding,
1 µM solution of anti-mitotic agent Cytarabine (Ara-C) was introduced into the wells
to stop the growth of any non-neuronal cells. The media was changed every two days.
The testing for the effect of hyaluronidase on primary neurons was conducted on
neurons at least six days post seeding. Hyaluronidase at a concentration of 10 µg/ml
was added to the wells every four hours. The cells at the center of the wells were
imaged every four hours to observe any morphological changes or detachment as a
result of the enzyme.

5.2.2. Live-dead assay of HAGMa hydrogels: To test cytocompatibility of the crosslinked
HAGMa hydrogels, a live-dead assay was performed using NIH MC-3T3 fibroblasts.
The gels were crosslinked in the shape of thin cylindrical disks and swollen in DI
water before any tests were conducted. The compositions tested were 60 mg/ml
HAGMa crosslinked with 3:1 and 4:1 ratio of PEGDa, 60 mg/ml HAGMa crosslinked
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with 1:1 ratio of PEGPLADa, and 70 mg/ml HAGMa crosslinked with 1:1 ratio of
PEGPLADa. The samples were sterelized under a 30 W, 254 nm wavelength UV
lamp for 45 mins. Fibroblasts were seeded on to the hydrogels at the concentration of
10000 cells per sample. The cells were grown on the samples for 24 hours before the
live-dead reagents were added. Fluorescent images of the samples were captured to
determine the percentage of live and dead cells.

5.2.3. Cytocompatibility with primary neurons: Primary neurons were seeded on
crosslinked HAGMa hydrogels at density of 400000 cells/sample. Samples were
imaged every 24 hours to observe the morphology of the primary neurons that
attached to the hydrogels. Day 6, the second media change, was selected as the
timepoint to visually observe the shape and arrangement of the neuronal cells. The
compositions tested were 60 mg/ml HAGMa crosslinked with 3:1 and 4:1 ratio of
PEGDa, 60 mg/ml HAGMa crosslinked with 1:1 ratio of PEGPLADa, and 70 mg/ml
HAGMa crosslinked with 1:1 ratio of PEGPLADa.

5.2.4. Axonal stretch device: To test the ability of hydrogels to stretch neuronal bundles
we designed a mechanical device that would allow us to bypass the difficulties related
with a direct in vitro test involving interaction of the hydrogel with the neurite ends.
In order to directly test the capability of the shrinking hydrogel to stretch the neurons
we had to tackle several design challenges. The soft gels needed to be anchored at one
location while keeping one or both ends free to interact with axonal ends. Having the
gels submerged in a liquid caused them to lift off the surface thereby not actually
being on the same plane as the cells. Thus the custombuilt device allowed us to
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simulate gel shrinkage at appropriate rates. Two glass surfaces, one bearing axonal
ends and the other the HAGMa hydrogel, were aligned so that the axonal ends have
an opportunity to interact with the hydrogel on the same plane. The slide bearing the
hydrogel was then slowly moved away using a microstepper motor at rates
corresponding to the shrinkage rates for the hydrogel composition being tested. This
would simulate the situation where the hydrogel shrinks while being attached to
axons. Instead of letting the gel shrink we covalently bonded the gels to glass slides
and moved them at rates corresponding to the composition‟s shrinkage rates using the
microstepper motor.

5.2.5. Design of the device: The axonal stretch device was designed to be a self contained
mini incubator. To maintain sterelity and superior heat conductivity, the chamber in
the device was entirely made out of stainless steel. UV sterelization was chosen to be
the best mode to ensure sterelity. This made it imperative to select all the nonmetallic components to be resistant to UV degradation. All the raw materials were
sourced from McMaster Carr unless stated otherwise. The range of lateral speeds we
anticipated for our experiments ranged from 40 µm/hr to just over 100 µm/hr.The
candidates to produce such slow motions were piezo electric stages and microstepper
motors. The piezo based stage was a custom order design while the microstepper
motor was available off the shelf. After comparing the range of motors and
controllers available, we selected CRK543AKP-PS25 Microstep Stepper Motor
System with Built-in Controller (Stored Program) (24 VDC)

manufactured by

Oriental Motors Corp. This stepper motor when orperated in microstepper
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configuration could produce a linear diaplacement of 1 µm at sufficiently high torque.
The motor came with its own controller and a sophisticated graphical user interface
(GUI) that permitted need based custom programming of the motor movement.
Figure 5.1 shows the GUI.

Fig. 5.1. Screen shot of the GUI provided by Oriental Motor Corp. for controlling the
steppermotor. The program editor option allows writing custom codes to control the motor
movement.
To translate the rotational motion of the motor to linear displacement, we
designed and custom ordered a drive chain system from Applied Industrial Tech. The
hurdle faced with microstepper motors driving any conveyer belt assembly is that of
backlash which is the rotation that the motor shaft undergoes before actually causing
motion in the drive belt. The CRK543AKP-PS25 series motor has a very low
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backlash of 15 arc minutes or 1/21600 of a full shaft rotation. Moreover the tension
on the custom ordered berg drive chain belt was adjustable so that there was no lag
between the transfer of motion from the motor to the drive chain. The next major
component of the motion system was the lead screw. The mobile stage that would
bear the hydrogel slide was mounted on the lead screws that were connected to the
drive chain assembly. To ensure a smooth motion we used two lead screws. Figure
5.2 shows images of the axonal stretching device. For details of the device schematics
please refer the appendix. The input parameters necessary to bring about the motor
movement were the motor speed, the acceleration and deceleration duration, and the
linear displacement magnitude. These parameters were calculated using the following
steps.

Move distance revolutions in Rev = Move distance / (Diameter * 3.14)
Operating Pulses (DIS) = Revs * (pulses/rev)
Pulse speed = Operating pulses / (positioning time – Acceleration time)
TA = Acceleration time
TD = Deceleration time

For micro-stepping function, the maximum gear ratio of 25:1 was selected along with
the option of “High Res” in the system configuration tab of the GUI.
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Fig. 5.2. Side view and top view of the axonal stretching device. The twin lead screws are
turned using a micro-stepper motor. The device is maintained at 37°C with a port to provide
constant flow of 5% CO2.

The device mandated self-contained incubator condition with precise control over the
temperature and CO2 level. The device was maintained at 37 °C using a heater, two
feedback K type thermocouples, and a Model ETR-9090 Microprocessor based
SMARTER LOGIC Auto Tune PID Controller. The PID controller has an in-built
calibration mode which heats up the target at different rates and constantly compares
the desired versus actual temperature detected by the sensors. Thus it determines the
ideal rate at which the device can be heated and maintained at the desired
temperature. The auto calibration was verified using a mercury thermometer. It was
made certain that the temperature at the center and the boundaries of the chamber was
at 37°C. A constant stream of 5 % CO2 was also supplied via the port on the
plexiglass lid. The CO2 was bubbled at a constant speed of two bubbles per second.
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5.2.6. Axonal stretch trials: Glass slides were scored and cracked into two pieces using a
diamond tipped scoring tool. If this process is done correctly the interface of the
cracked slides will align perfectly leaving a negligible gap. SEM analysis of the
interface was performed to quantify the gap. On one half of the slide,
Polyethyleneimine (PEI) was microcontact printed and primary neurons were
cultured on the pattern such that bundles of axons were growing towards the
interface. The silicone stamp had a pattern consisting of rectangular 10 µm ridges and
5 µm deep grooves. The neurites reached the edge of the slide by day four or five
after seeding. The neuronal slides to be used for the experiment were picked on day 6
after the second media change and the corresponding slide of the pair was activated
and the hydrogel was crosslinked on it. The second half of the slide, that would bear
the hydrogel, was treated with 3-aminoproyltrimethoxysilane to create a selfassembled mono layer (SAM) bearing double bonds. These end groups were
covalently crosslinked with the hydrogel during the UV exposure. The activation of
the slide was performed using the method described by Wang and co workers (13)
(See appendix). The pre-crosslinking solution was pipetted on to the slide and a
coverglass was placed on top to reduce exposure to air and minimize oxygen
inhibition of the free radicals. The coverglass was treated with surfasil siliconizing
fluid which made the surface extremely hydrophobic. This assisted in peeling the top
coverslip after the gel was successfully crosslinked. The two slides were firmly
mounted in the holders and the interface was aligned by manually turning the lead
screws. The steppermotor was operated in the micro-stepper mode and was moved in
linear steps of 3.5 µm followed by a pause. By changing the duration of the pause,
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effective linear displacement rates ranging from 42 µm/hr to 100 µm/hr could be
achieved. Fig 5.3 shows the motion profiles of the different linear displacement rates
that the micromotor can produce by incorporation of a pause period between
consecutive motor activation signals.

Fig. 5.3. Graph showing how different stretching rates could be produced by the
microsteppermotor. The y axis is shifted for the purpose of clarity. By varying the
duration of the pause a variety of stretching rates can be achieved.

We tested various conditions to attempt simulated axonal stretching using the
hydrogel. Condition 1 consisted of the neuron slide and the hydrogel slide aligned
such that the axonal ends have an opportunity to interact with the hydrogel on the
same plane. After a 24 hour interaction period, the slide bearing the hydrogel was
slowly moved away using the microstepper motor at 42 µm/hr corresponding to the
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shrinkage rate for the hydrogel composition being tested. In condition 2 the hydrogel
was coated with 10 µg/ml laminin to attract the neurites to cross the interface and
attach to the hydrogel. For condition 3, the hydrogel was fabricated with an additonal
free floating flap that was placed across the interface directly on the neuronal ends.
The hydrogel was coated with 10 µg/ml laminin in this case as well. The neurites at
the interface were allowed to interact with the hydrogel for 24 hours before the motor
was activated to move at 42 µm/hr for 24 hours. Finally, for condition 4
modifications were made to the slide holders in the device. The slide with the cells
was flipped over and placed just at the egde but right on top of the slide with the
hydrogel. Thus the hydrogel and the neurites were sandwiched between two glass
slides. Once again the cells were given 24 hours to interact with the hydrogel before
the motor was moved. The hydrogel composition was 60 mg/ml HAGMa crosslinked
with 4:1 PEGDa. We selected the hydrogel composition that showed the best
neuronal cell attachment results. Once the experiment was stopped after a total 48
hours, the interface was oberved under a stereomicroscope and an inverted
microscope to study the interface.

5.3. Results
5.3.1. Effect of hyaluronidase on primary cortical neurons: Primary neurons were
exposed to 10 µg/ml of hyaluronidase for a period of 48 hours. The enzyme was
replenished every 4 hours. Figure 5.4 shows the optical micrographs for a control
well that was not exposed to any enzyme. The cells demonstrated typical
morphologies as seen with primary neurons in high density environments on TCPS
substrates. It has been observed that when the density of neurons is not sufficient
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these cells tend to form clusters. The density of cells was more than sufficient to
avoid cluster formation. On comparing images of cells from wells exposed to
hyaluronidase (Figure 5.5) to the controls it was evident that there was no
observable difference in the appearance of primary neurons due to the presence of
the enzyme.

Fig.5.4. Representative optical micrographs of primary cortical neurons seeded in a PEI
coated TCPS well that was not exposed to 10 µg/ml hyaluronidase. The images of the
center of the well were captured every 4 hours for a period of 2 days. There was no
visual difference in the morphology of the cells between the time points which was the
expected outcome for these control wells. (n = 3)
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Fig.5.5. Representative optical micrographs of primary cortical neurons seeded in PEI
coated TCPS well that was exposed to 10 µg/ml hyaluronidase. The images of the center
of the well were captured every 4 hours for a period of 2 days. The enzyme was
replenished every 4 hours as well. There was no observable difference in the
morphology of the cells between time points. This indicated that the tested concentration
of hyaluronidase did not have any effect on the primary neurons. (n = 3)

5.3.2. Live- Dead assay of the HAGMa hydrogels: Fibroblasts were seeded on the
crosslinked hydrogels for a period of 24 hours following which a live-dead assay
was performed. Figure 5.6 shows the fluorescent micrographs for the hydrogels of
the compositions 60 mg/ml HAGMa crosslinked with 3:1 and 4:1 ratio of PEGDa
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along with control TCPS wells. The number of cells that remained adhered to the
hydrogels compared to TCPS controls were low. The hydrated state of the hydrogels
may have hampered the attachment of some cells causing them to flow off the
surface when fresh media was first introduced into the wells. However over 82% of
the cells that adhered to the surface were viable. The fibroblasts demonstrated their
typical morphology. There was no significant difference (p>>0.05) in the percent
viability between the PEGDa crosslinked samples when compared to TCPS
controls.
Figure 5.7 shows the fluorescent micrographs of the representative samples
for the PEGPLADa crosslinked HAGMA samples. Similar to tht PEGDa samples,
we observed fewer cells compared to TCPS wells however there was no significant
difference in the viability of fibroblasts that were seeded on the hydrogels when
compared to the TCPS controls. The cell viability results are summarized in Figure
5.8.

The

results

indicated

that

the

crosslinked

hydrogels

maintained

cytocompatibility although the cell density was reduced compared to TCPS control
surface.
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Fig.5.6. Representative fluorescent optical micrographs of the TCPS control wells, and
the PEGDa crosslinked hydrogels following the live-dead assay. Green indicates live
cells while red indicates dead cells. The MC-3T3 fibroblasts demonstrated a high
percentage of viability and the morphology of the cell was typical of this cell line. There
was no significant difference in the cell viability between the hydrogel samples and the
TCPS control surface (p >> 0.05). (n = 6)
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Fig.5.7. Representative fluorescent optical micrographs of the TCPS control well and the
PEGPLADa crosslinked hydrogels following the live-dead assay. Green indicates live
cells while red indicates dead cells. The MC-3T3 fibroblasts demonstrated a high
percentage of viability and the morphology of the cell was typical of this cell line. There
was no significant difference in the cell viability between the hydrogel samples and the
TCPS control surface (p >> 0.05). (n = 6)
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Fig.5.8. Summary of the results for the cell viability experiment conducted on the
crosslinked HAGMa hydrogels. There was no significant difference in the percentage of
live cells when the controls were compared with each of the tested compositions. (n = 6)

5.3.3. Cytocomaptibility study with primary neurons : The cytocompatibility study
performed using the MC-3T3 fibroblasts showed very promising results. The
crosslinked hydrogels were cytocompatible and fibroblasts were still able to attach
to the gels. The next step was to observe how neuronal cells behave on the hydrogel
surface. Figure 5.9 (a) shows representative images of neurons on PEI coated TCPS
surfaces. These were the control wells. The cells formed dense interconnected
networks. The interconnecting neurites were relatively short due to the high density

158

of neurons in the well. Figures 5.9 (b) and 5.9 (c) show micrographs of neurons
seeded on hydrogels of the composition 60 mg/ml HAGMa crosslinked with 3:1 and
4:1 ratio of PEGDa respectively. We observed that the cell bodies were forming
clusters and then sprouting neurites in all directions akin to a dorsal root ganglion.
By day 4 many of these neurites made contact with neighbouring clusters or neurites
and formed thriving inter-connecting networks. Figures 5.10 (a) and 5.10 (b) show
images of hydrogel samples of the composition 60 mg/ml HAGMa crosslinked with
1:1 PEGPLADa and 70 mg/ml HAGMa crosslinked with 1:1 PEGPLADa. Once
again we saw the cell bodies forming clusters and sprouting long neurites which
resulted in interconnected networks. The PEGPLADa crosslined hydrogels were
slightly more opaque compared to PEGDa crosslinked hydrogels. Hence we treated
some samples with the LIVE dye stain calcein to be able to observe the neuronal
cells using the inverted microscope. It is in the nature of primary cortical neurons to
form interconnected networks. In the absence of a sufficient density of neurons in
the near vicinity, these cells have been known to form sattelite clusters and produce
long neurites which explore the surroundings. Our observations fall in line with the
understanding of this primary cell line.
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Fig. 5.9. Representative optical micrographs of primary cortical neurons on (a) PEI coated
TCPS, (b) on gel composition 60 mg/ml HAGMa crosslinked with 3:1 PEGDa, and (c) on
gel composition 60 mg/ml HAGMa crosslinked with 4:1 PEGDa captured on day 6 post
seeding. The density was 0.4 million cells/well. The neurons form dense networks on the
TCPS surface due to close proximity with other neuronal cells, while on the hydrogel
surface they form sparse inter-connected cluster networks due to absence of close
proximity with other neuronal cells. Magnification is 10X.
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Fig.5.10. Representative micrographs of primary cortical neurons on (a) gel composition 60
mg/ml HAGMa crosslinked with 1:1 PEGPLADa, and (b) on gel composition 70 mg/ml
HAGMa crosslinked with 1:1 PEGPLADa captured on day 6 post seeding. The density was
0.4 million cells/well. The neurons formed sparse inter-connected cluster networks similar
to those seen for the PEGDa crosslinked hydrogels due to low density of the adhered cells.
Magnification is 10X.

5.3.4. Axonal stretch device: The custom-built device provided us a way to test the
ability of these novel HA networks to facilitate axonal stretch. The device consists
of a twin lead screw driven slide holder which is moved using a microsstepper
motor. The temperature for the device is maintained using a feedback loop between
the heater element and two thermocouples. The PID controller has a self calibrate
mode which was used to calibrate the temperature within the chamber. The
temperature control was verified using a mercury thermometer. There was a
discrepancy with the actual temperature and what the PID display read. Adjustments
were made to make sure the temperature within the device is always maintained at
37 °C. The 5% CO2 was pumped into the device at a rate of two bubbles/second.
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Figure 5.11 shows the SEM micrographs of the interface created by score
cracking microscope glass slides. Scoring and cracking dislodges material from the
slide which may create some imperfections at the interface. Hence we decided to
use the reverse side of the glass slide and imaged it to measure the gap distance.
Based on the measurements from Image J we observed an average gap distance of
6.7 ± 1.1 µm. This might still seem like a valley for the neurite that approaches the
interface, however the presence of a swollen gel might be sufficient to close this
small gap. Slide pairs were imaged using the Hirox microscope before being
selected for the stretch device experiment. Primary cortical neurons were seeded
close to the edge on the slide bearing the PEI micropattern. Figure 5.12 shows
representative images of the neurites growing towards the edge of one of such
sample slides. The neurites extended from the cell bodies and aligned to the PEI
pattern. We observed that on ocassion the neurites at the edge would interconnect
with each other to form what looked like a thick branch running perpendicular to the
protein pattern. However there were always multiple neurites that were at the
edge.The composition of hydrogel tested was 60 mg/ml HAGMa crosslinked using
4:1 PEGDa. The shrinkage rate for this composition for the first day was 42 µm/hr.
To obtain this lateral movement, the micromotor was triggered repeatedly such that
it turned on for 1 second to cause a 3.5 µm lateral movement followed by a 5 minute
pause.
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Fig. 5.11. Representative SEM micrographs of the score cracked glass slide interface.
The images show the interface is increasing magnification. The gap at the interface was
6.7 ± 1.1 µm.
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Fig. 5.12. Representative optical micrographs showing the edge of the microcontact printed
PEI glass slide at two different magnifications. The primary neurons sprouted neurites that
aligned to the PEI pattern. We did observe some neurites interconnecting just near the edge
forming a long branch. Despite this there were neurites that reached the edge of the slide.

The main difference between the condition 1 and condition 2 test was the
treatment of the hydrogel with 10 µg/ml laminin. Each condition was repeated twice to
confirm the observations. The results from either conditions were similar. Figure 5.13
shows stereo micrograph images of the cell-gel interface following an experiment
testing condition 2. The interface was only separated at the rate of 42 µm/hr after a 24
hour period of contact. For either condions (1 & 2) we did not observe any neurites
spanning the interface. The hydrogels did not show any evidence of neurite attachment
either in the form of snapped neurites or deformed hydrogel surface near the interface.
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Figure 5.14 shows micrographs of the slide bearing the neurons after one of such
experiment. The visual phenotype of the neuronal cells appeared to be normal with no
indication of delamination or retraction.

Fig. 5.13. Stereomicrographs of the gel-cell interface (a-c) after a 48 hour experiment. The
neurites were allowed to interact with the gel at the interface for 24 hours before the motor
was turned on and the interface was separated. The hydrogel was coated with 10 µg/ml
laminin. We did not observe any indication of neurites spanning the separated interface.
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Fig.5.14. Optical micrographs showing the edge of glass slide bearing the primary neurons
after a 48 hour experiment in the stretch device. The cells showed normal visual
phenotype. The neurites were aligned along the PEI micropattern and did not show any
delamination. The magnification was 5X.
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The next variation we tested (condition 3) was having an overlapping flap of gel
directly on top of the neurite ends. Figure 5.15 shows images of the actual experimental
setup in the stretch device. It was a challenge to obtain an extended gel flap extending
the entire expance of the gel slide. The gel and cell interface was allowed to interact for
24 hours before the interface was separated at the rate of 42 µm/hr for 24 hours. Once
more we did not see any stretched neurites spanning the separated interface. The gel
flap however appeared to be still attached to the slide with the neurites. However it had
fractured from its connection with the remainder of the hydrogel. We also imaged the
slide bearing the neurites after the experiment (Figure 5.16). We observed what
appeared to be a boundary created by the gel flap on the area containing the neurites
that it rested on. The failure of the gel flap made it impossible to draw any conclusions
regarding ability of the gels to stretch neurites. The technical difficulty in fabricating
the gel flap led us to test our final variation (condition 4).
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Fig 5.15. Stereomicrgraphs of the experimental setup prior to a stretch experiment for
condition 3, where an extra flap of gel was placed directly over the slide bearing neurites.
The opacity of the gel was a function of the thickness of the gel layer on the glass slide.
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Fig. 5.16. Optical micrographs of the slide bearing neurites prior to (a, b) and post 48
hour stretch experiment (c). Stereomicrographs of the cell-gel interface (d, e) showing the
overlapping gel flap. We observed a boundary that the gel flap created on the patterned
neurites. The gel flap was still connected to the neurite slide when the motor was stopped,
however the gel flap fractured and was pulled apart from the rest of the gel layer.

The final condition we tested (condition 4) entailed flipping of one of the slides
and creating a sandwich of the gel and neurite ends. We made changes to the holders in
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the device to accomodate this configuration. Figure 5.17 shows a schematic depicting
the arrangement of the glass slides. The cell-gel sandwich was motionless for 24 hours
followed by microstepper motor mediated separation at the rate of 42 µm/hr lasting 24
hours. Figure 5.18 shows the actual arrangement inside the device. When the
experiment was stopped we did not observe any neurites extending between the gel and
the flipped cell slide. When the cell slide was imaged under the microscope we
observed the absence of any neurites or cell bodies on the PEI pattern. All that was left
was the PEI pattern itself. Figure 5.19 shows images from such a slide. We observed
the same end result in the two trials conducted for this condition leading to the
hypothesis that either the shearing motion or a lack of sufficient diffusion of nutrients
through the gel may have led to cell detachment or delamination.

Fig. 5.17. Schematic showing the top view and the side view for the glass slide setup inside
the stretch device for condition 4. The slide bearing the neurite ends was flipped and placed
in direct contact with the crosslinked HA gel layer.
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Fig. 5.18. Stereomicrograph of the cell-gel interface prior to start of the stretch device
experiment showing the overlapped glass slides. The cell-gel sandwich was maintianed
motionless for 24 hours before the motor was switched on to separate the interface at 42
µm/hr.
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Fig.5.19. Representative optical micrographs showing the slides bearing the neurites after a 48
hour stretch experiment. After the experiment we did not see any neuronal cells still attached
to the PEI pattern. The shearing motion seems to have triggered cell death which led to
detachment of the cells from the slide surface.

5.4. Discussion: The applicability of the novel crosslinked HAGMa networks as axonal stretch
growth facilitators depends on their ability to be cytocompatible. The HA molecule was
derivatized to incorporate a photoreactive group that was used for crosslinking the
network. Both these processess could affect the conformation of the molecule which may
make it difficult for cell surface receptors to access the inherent binding sites on the HA
molecule. We performed standard LIVE/DEAD assay using MC-3T3 fibroblast and also
performed a cell viability study using mouse primary cortical neurons. The high
percentage of fibroblast survival (≥ 82%) across all compositions verified that the
chemical processess performed on the HA molecule did not affect cytocompatibility of the
crosslinked hydrogels. Despite these high survival numbers it is evident from the optical
micrographs that the number of cells that bound to the hydrogels were fewer than the
control TCPS surface. The hydrophilic nature of hydrogels makes the in vitro cell
adhesion process challenging. Despite the care taken to make sure the gel surface was
172

relatively dry during the seeding process, the capillary wicking action draws more liquid
to the surface. Thus there may be a layer of media in between the cells and the gel surface
making binding difficult. As a consequence when the wells are flodded with media after
30 minutes of binding time, many of them float off the surface into the well. Thus we
observed fewer cells on the samples when compared to the TCPS control, however a very
high percentage of those cells (fibroblast) that adhered to the surface were live. The
primary neurons seeded on the hydrogels showed normal morphology for this cell type on
substrates and created an interconnected network between satellite clusters of neuronal
cell bodies. The high concentration of hyaluronidase enzyme we used to cause shrinkage
of PEGDa gel network did not affect the behavior of the primary neurons that were seeded
in TCPS wells. There was no obervable difference between the control group of cell that
were not exposed to the enzyme and those that were.

The results from the custom built axonal stretch device were not as we expected.
The neurite ends and the hydrogel were allowed to interact on the same plane by precisely
aligning the two glass slide that bore the neurons and the gel. Inspite of providing 24 hours
for the neurite ends to bind to the hydrogel at the interface we did not observe any
evidence of neurite attachment. This may be inferred as either the neurites did not bind at
all or that the strength of binding was insufficient to withstand the separation motion that
followed. Adsorption of adhesion protein laminin on the hydrogels did not alter the
outcome. A possible solution in the future to this issue would be to have a more permanent
binding of adhesion molecules to the hydrogel by covalently linking small peptides to the
HA molecule itself. To increase the probability of the neurites binding to the gel we
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flipped one of the slides so as to have the gel directly on top of the neurites. This trial had
the most unexpected outcome. None of the cells remained adhered to the PEI pattern by
the time the experiment was stopped. The simplest explaination as to what could have
caused this is lack of diffusion of nutrients through the gel. The overlapping of a large
section of gel on the entirety of the neurites may have suffocated them and led to their
retraction or delamination from the protein pattern. Another cause of this outcome may be
the shearing process itself, however there are no studies in the literature at the moment
that can support this hypothesis. The most promising result came from trial 3 where a
small flap of gel was extended across the interface. After the experiment was stopped, the
gel flap was still adhered to the slide with the neurites, however it had almost fractured
from the remaining gel. The media in the chamber sloshed from side to side creating
ripples in the chamber while being trasnported from the vibration isolation table to the
stereo-microscope for imaging after the experiment was stopped. The gel flap adhered to
the slide with the neurites was able to sustain these ripples suggesting the bond strength
was strong. The low stiffness of the gels posed a challenge to successful fabrication of gel
samples with the extended flap. Nevertheless we are hopeful that improvements in
fabrication of these delicate gel films in the future may allow us to successfully test our
hypothesis that these novel hydrogels can promote and sustain axonal stretch growth. A
possible technique that could be beneficial is 3D printing on the glass slide and past the
edge under steady nitrogen flow conditions. This technique would allow for accurate
fabrication of hydrogels with features in different planes. The nitrogen flow would prevent
free radical scavanging by oxygen in the absence of the coverglass sandwich method that
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was used to fabricate the gels described above. Thus the gel flap would not be damaged
during the fabrication and peeling process.
5.5. Conclusions: Derivatization of the HA molecule as well as the crosslinking process did
not have any detrimental effect on the cytocompatibility of the hydrogels, however the
total number of cells that attached to the hydrophilic gel was lower than control TCPS
surface. The high concentration of hyaluronidase enzyme we used to cause shrinkage of
PEGDa gel network did not affect the behavior of the primary neurons. There was no
obervable difference between the control group of cell that were not exposed to the
enzyme and those that were. The observations from the four condtions tested can be
interpretted as either the neurite ends were unable to crossover the interface to attach with
the hydrogel or they were unable to form strong bonds that could sustain the separation
motion. The experiments with the extended gel flap did indicate that the gels was able to
form a bond with the slide bearing neurites, however the fracturing of the gel flap from the
remainder of the gel made drawing any concrete conculsion difficult.

175

References
1. Lesley J, Hascall VC, Tammi M, Hyman R. Hyaluronan binding by cell surface CD44.
Journal of Biological Chemistry. 2000 September 01;275(35):26967-75.
2. Moon C, Heo S, Sim K, Shin T. Upregulation of CD44 expression in the spinal cords of rats
with clip compression injury. Neurosci Lett. 2004 8/26;367(1):133-6.
3. Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, Rosenberg LH, et al. A central role for
the ERK-signaling pathway in controlling schwann cell plasticity and peripheral nerve
regeneration In Vivo. Neuron. 2012;73(4):729.
4. Nagy J, Hacking J, Frankenstein U, Turley E. Requirement of the hyaluronan receptor
RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell
lines. The Journal of Neuroscience. 1995 January 01;15(1):241-52.
5. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis,
and disease. FASEB J. 1993;7(13):1233.
6. Laurent TC, Laurent UB, Fraser JR. Functions of hyaluronan. Annals of the Rheumatic
Diseases. 1995 May 01;54(5):429-32.
7. Laurent TC, editor. The chemistry, biology and medical applications of hyaluronan and its
derivatives. 1st ed. London and Miami: Portland Pr; 1998.
8. Collins MN, Birkinshaw C. Hyaluronic acid based scaffolds for tissue engineering - A review.
Carbo Poly. 2013;92:1262.
9. Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: Biochemistry, biological
activities and therapeutic uses. Cancer Lett. 1998 9/11;131(1):3-11.
10. Price RD, Berry MG, Navsaria HA. Hyaluronic acid: The scientific and clinical evidence.
Journal of Plastic, Reconstructive & Aesthetic Surgery. 2007 10;60(10):1110-9.
11. Zhong SP, Campoccia D, Doherty PJ, Williams RL, Benedetti L, Williams DF.
Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials. 1994 4;15(5):35965.
12. Wakao N, Imagama S, Zhang H, Tauchi R, Muramoto A, Natori T, et al. Hyaluronan
oligosaccharides promote functional recovery after spinal cord injury in rats. Neurosci Lett. 2011
1/25;488(3):299-304.
13. Pelham RJ, Wang Y. Cell locomotion and focal adhesions are regulated by substrate
flexibility. Proc Natl Acad Sci U S A. 1997;94(25):13661.

176

Chapter 6
6.1. Summary: Hyaluronic acid networks were crosslinked using two different bifunctional
crosslinkers. This enabled us to degrade them either enzymatically or via hydrolysis to create
novel slow-shrinking hydrogels. The shear thinning nature of HA made it possible to shear
align the molecular chains of a highly concentrated HA solution. We hypothesized that rapid
crosslinking of this configuration would store a retractive stress in the network. The
crosslinkers we selected were PEGDa (non-degradable) and PEGPLADa (hydrolytically
degradable). Degrading the crosslinked network that had a stored retractive stress afforded
the property of macroscopic shrinkage to the hydrogel network. Cleaving the crosslinks or
the HAGMa chains increased the free volume of the network. The chains had more room to
reorganize or recoil thereby releasing some of the stored retractive stress. The shrinkage was
significant along a preselected axis. The four compositions we tested were 60 mg/ml
HAGMa crosslinked with 3:1 and 4:1 ratio of PEGDa, 60 mg/ml HAGMa crosslinked with
1:1 PEGPLADa, and 70 mg/ml HAGMa crosslinked with 1:1 PEGPLADa. The hydrogels
were characterized using various techniques for their ability to produce shrinkage.

Oriented polymers have the property of optical anisotropy which can be measured as
birefringence. Visually, birefringence is observed as brightness or shades of color depending
on the kind of anisotropic material. The intensity of the brightness is directly proportional to
the degree of molecular orientation. Degrading the network caused the gels to shrink as the
network reorganized. This was manifested as a decrease in molecular orientation and thus the
birefringence. The decrease in the birefringence value was significant for the PEGDa
crosslinked gels when compared to PEGPLADa crosslinked gels. The molecular
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reorganization in case of the enzymatically degraded gels would be higher on account of
directly cleaving the HAGMa chains. Hence the birefringence values post 48 hour
degradation decreased significantly when compared to the degraded PEGPLADa hydrogels.
We adapted rubber elasticity theory to predict the retractive stress that could be stored in the
network. The retractive stress values were in a similar range for all the four compositions.
We did not see a significant effect of PEGDa concentration or HAGMa concentration on the
magnitude of the stored retractive stress.

Shrinkage of the hydrogels was predominantly along the long axis of the sample which
was also the optical axis. The shrinkage along the width of the sample was less than or equal
to 5%. The shrinkage profiles obtained were vastly different for all the compositions. The
concentration of the enzyme and the crosslinker ratio had the most effect on the shrinkage of
the PEGDa crosslinked samples. The shape of the shrinkage profile showed that rate at which
the samples shrunk increased when either the enzyme concentration was increased or the
crosslinker concentration was decreased. The two day profile of shrinkage was almost linear
for samples crosslinked with 4:1 ratio of PEGDa that were degraded with 10 µg/ml
hyaluronidase. The shrinkage for the PEGPLADa crosslinked hydrogels could only last for
two days for the 70 mg/ml HAGMa composition and the profile was not linear. The 60
mg/ml HAGMa samples crosslinked with PEGPLADa demonstrated very rapid shrinkage
within the first 8 hours and thus would not be a good candidate for axonal stretch growth
actuator. The shrinkage rates for the first 24 hours were below the desirable 100 µm/hr
maximum threshold for all but one composition (60 mg/ml HAGMa crosslinked with 1:1
PEGPLADa). Recovered stress was measured in terms of force applied by the shrinking
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hydrogel on a flexible aluminum cantilever paired with a non-contact sensor. It was observed
that there was significant disparity between the predicted stored retractive stress and the
recovered stress. The inability of the flexible cantilever to match with the dynamically
decreasing stiffness of the degrading hydrogel along with any opposition to molecular
reorganization within the network meant that the extent of the measured recovered stress was
significantly lower than the predicted stored stress. The DVRT had a maximum range of 3
mm. Thus even if the cantilever were made more flexible, it would be impossible to test any
shrinking gel with a magnitude of shrinkage beyond this range. A solution to that would be to
adopt a testing strategy described by Chippada et. al (1). They used a thin brass filament
cantilever which was coupled to their shrinking DNA crosslinked gel. Time lapse images
were obtained of the position of the cantilever and then by using cantilever theory the force
per unit length was calculated. This methodology would require negligible changes to our
current setup.
The degradation of the network was performed using two different mechanisms.
Enzymatic degradation cleaved the HAGMa chains to cause the molecular reorganization
which led to the gel shrinkage. However in doing so, the source of the retractive stress i.e. the
long HAGMa chains were cleaved into smaller sections. This reduced the potential that an
extended whole chain might possess to recoil once freed from the element holding it in the
extended conformation. Thus we expected that the hydrolytically degraded PEGPLADa
crosslinked network would produce a greater magnitude of shrinkage and the results
confirmed our hypothesis. What we did not expect was the rapid nature of shrinkage. The 60
mg/ml gels crosslinked with 1:1 PEGPLADa shrunk by 3 mm or 21.71% but all the
shrinkage occurred within the first 8 hours. This behavior mimicked that of thermoresponsive
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or pH responsive gels which contract when the threshold trigger is activated (2). The 70
mg/ml HAGMa gels crosslinked with 1:1 PEGPLADa had a slightly more gradual shrinkage
profile that extended to almost 2 days with a net shrinkage of 2.04 mm or 14.21%. The
concentration of PEGPLADa tested was limited by the hydrophobic-hydrophilic interaction
between the crosslinker and polysaccharide. Even though there was no observable phase
separation of the pre-crosslinking solution, there might be some effect on the conformation of
HAGMa chains that may have an effect on how the gels shrink. Further analysis of the
kinetics of PEGPLADa degradation is required to completely understand the cause of the
rapid shrinkage. In vitro and in vivo degradation studies have investigated how gels made
entirely of PEGPLADA degrade at 37°C (3, 4). Gels consisting of 23% w/v of PEGPLADa
with varying molecular weights of PEG and lactoyl repeat units degraded in vitro between
two days to four months. The degradation rate of PEGPLADA gels depended on the
crosslink density and length of the PEG block. Degradation rate was inversely proportional to
the length of the PEG segment. Gels made from lower molecular weight precursor were more
tightly cross-linked and thus degraded more slowly than gels made from higher molecular
weight precursors. However using the crosslinker to form the HAGMa network may change
how the hydrolysis degrades the crosslinker. The rate of degradation may be increased as
now there are two hydrophilic elements (PEG and HA) that attract water molecules into the
network. This hypothesis may be a possible explanation as to why the shrinkage profile was
so rapid. The gels from the one week long term study did not disintegrate completely,
however their stiffness appeared to be significantly reduced and visually also looked less
opaque. The hydrolysis process is a gradual and slow process. Despite the high
hydrophillicity of the network due to both HAGMa and PEG, there might be another
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mechanism that may be responsible for the rapid shrinkage. Prior to the testing of the
PEGPLADa crosslinked samples, they were swollen in PBS for two hours at 4°C. This was
done to allow for swelling while slowing down any hydrolysis. The change in temperature
from 4°C to the test condition 37°C may have caused additional network swelling and
network reorganization which led to the rapid shrinkage. The new set of swelling
experiments suggested in section 6.4 might shed more light on the exact cause of the rapid
shrinkage.

The HA molecule has inherent sites which allow binding with cell surface receptors like
CD44 and RHAMM. It was inevitable to make chemical modification to the molecule in
order to form crosslinked networks. These processes may alter the conformation of the
molecule in the crosslinked network thereby making it difficult for the cells to bind. Our
observations from the cytocompatibility study with MC-3T3 fibroblasts and primary cortical
neurons assured us that there was no significant effect on the viability of these hydrogels as
cytocompatible materials. However the number of cells that adhered to the hydrogel samples
was severely lower than control TCPS wells. Seeding cells on a wet or semi-dry hydrogel is
always a challenge. If a thin film of liquid exists between the cells and the gel surface, the
cells do not get the opportunity to make contact with the gel surface and bind. Thus on
flooding of the sample wells with media many cells get washed off. However, of the cells
that adhered to the gels, a majority were alive and thriving. The main sites on the HA
molecule that bind to cell receptors like CD44 are the carboxylic (-COOH) groups (5, 6).
Successful derivatization of HA using epoxides like GMa primarily occurs at the (-COOH)
groups along with some reversible methacrylation at the hydroxyl (-OH) groups (5). Besides
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the hindrance in cell binding due to hydrophillicity of the gel, a higher degree of modification
may have decreased the ability of the HA network to present sites for neuronal cells to bind.
We adsorbed laminin on the HAGMa hydrogels in order to promote enhanced binding but
failed to see any benefit. Covalent binding of adhesion molecules like RGD peptides could
provide a boost to the binding capability and strength of the bond.

We custom built a mechanical device that allowed us to indirectly test the binding of the
gels with neurons and the potential of these gels to cause axonal elongation. There was no
indication of neurites binding to the hydrogel across the interface. Despite providing an
additional chemical cue in the form of laminin, it was not possible to get the neurites to bind
to the hydrogel. The only promising observation was made for condition 3 where an extra gel
flap crossed the interface and was laid directly in contact with the neurites. The gel flap
demonstrated bonding with the slide bearing neurites as it was still connected when the motor
was stopped after 24 hours. However the gel flap fractured from the remainder of the gel
which made it difficult to make concrete conclusions regarding the ability of the gels to
facilitate axonal stretch growth. Furthermore there were fabrication challenges with the gel
extension flap. Thus the next progression was to flip one of the slides and sandwich the
neurites and the gel so they are in direct contact. However we observed that at the end of the
experiment there were no cells left attached to the PEI pattern. This was an intriguing
outcome as it suggested that lack of sufficient nutrient diffusion or the shearing of neurites
led to their retraction / delamination. Further investigation into different hydrogel fabrication
techniques may help in increasing the probability of the gel flap not fracturing from the rest
of the gel and possibly elongating neurons. Primary cortical neurons were generously
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donated by the Hewett lab. These neurons are multi-polar neurons. Growing these neurons
along a protein pattern forced them to extend neurites along two directions. However the
density of neurites that reach the edge of the glass slides could be improved by using dorsal
root ganglion (DRG) explants. The benefit of using DRG‟s over primary neurons is their
direct clinical relevance. DRG‟s are routinely used to study peripheral nerve system
neuropathies (7). The density of neurites emanating from the explant are significantly greater
compared with primary cortical neurons. The main advantage that DRG‟s would provide is
culture longitivity due to presence of support cells and microglia. The primary cortical
neurons were ready to be used around day 6 post seeding and the optimal shelf life was 8 to
10 days post seeding.

To be considered as a suitable actuator material for axonal stretching, the biomaterial
should be able to produce shrinkage at rates that can sustain development of neo-axoplasm.
Thus while selecting the compositions which would be feasible candidates, the rate of the
shrinkage and profile of shrinkage are more critical than the net magnitude of shrinkage. We
conclude that among the compositions tested here, 60 mg/ml HAGMa crosslinked with 4:1
PEGDa and 70 mg/ml HAGMa crosslinked with 1:1 PEGPLADa were the best compositions
with the potential to be used as axonal stretch growth actuators. The ability to shrink in a
controlled fashion as a response to a trigger made this network system an addition to a
special class of polymers known as polymeric actuators.

There are several successful examples of polymeric actuator materials in the literature
which have applications ranging from coatings on medical devices, artificial muscles, to drug
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delivery vehicles (8-10). Each of these materials has a trigger that causes a change in shape
or volume that is exploited for the desired application. These triggers are generally a change
in temperature, electric field, or ionic balance. The success of a polymer actuator is judged on
time of response, the magnitude of the contractile force, and the actuation strain. Almost all
of the electroactive polymers (EAP) have a response rate that would be unsuitable for
sustained stress application problems such as stretching axons. Uragami and co-workers
synthesized a semi-interpenetrating network (semi-IPN) hydrogel containing both grafted
antigens and their corresponding specific antibodies (11). An antigen-antibody semi-IPN
hydrogel was prepared by the copolymerization of the vinyl (rabbit IgG), acrylamide, and
N,N-methylenebisacrylamide (MBAA) as a cross-linker in the presence of the polymerized
goat anti-rabbit (GAR) IgG. Antigen-antibody binding reaction caused the formation of
cross-links within the polymer. Free antigens were then added to the solution around the
hydrogel creating competition between the grafted antigens leading to a decrease in crosslinking density. This caused an increase in swelling of the hydrogel. This increase in swelling
was reversible. By removing the hydrogel from the antigen solution and washing, the
polymer would return to approximately its original volume. This change in volume caused
shrinking of the hydrogel as well as change in permeability of the hydrogel. The authors used
the hydrogel as a selective permeable membrane for transport of drugs, however there is
potential for use as a mechanical actuator. This gel could be implanted in the nerve gap and
subsequently triggered to shrink after sufficient time has been provided for neurite ends to
attach. There are however some operational disadvantages in the actuation mechanism that
may limit its applicability beyond serving as a selective permeable membrane. The main
advantage our hydrogel networks have over the networks synthesized by Uragami and
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coworkers is the feasibility of the concept to be implemented in vivo. Maintaining the
concentration of the free antigen in a hostile injury environment filled with debris clearing
macrophages would be extremely difficult. On the other hand, shrinking a crosslinked
HAGMa hydrogel by cleaving the network using hyaluronidase or via hydrolysis or both is
much more realistic for in vivo application.

Recently a novel crosslinked hydrogel system has been described by Lin et al. and
Chippada et al. (1, 12). A DNA crosslinked hydrogel was fabricated that demonstrated
potential to be used for stretching axons. The DNA-crosslinked polyacrylamide gels have the
ability to contract or swell by the addition of crosslinks or removal of strands respectively.
The tendency of these loosely crosslinked gels to contract as their crosslink density was
increased is a novel technique to generate a force. The dynamic modulation of the stiffness of
the hydrogels by addition of crosslinks caused the tissue scaffold to shrink and this could
potentially be used to exert traction on the emerging neurites and physically expand the
tissue. The force potential was measured by two techniques that used linear elasticity
principles. The force generated by the DNA crosslinked gel per unit length was
approximately equal to 1050 pN/μm, at room temperature testing conditions, which is in the
range reported by Heidemann and coworkers (13) for successful axonal stretching. However
the potential of the DNA crosslinked gels as axonal stretch inducers is vastly reduced by the
fact that the force potential drops almost three times at 37°C. The HAGMa hydrogels
described here generated forces ranging between 600 nN/µm and 2300 nN/µm. Despite the
fact that these values are significantly higher than those reported in the axonal stretch
literature, it is important to note that the literature values are for the stresses a single neurite
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can successfully sustain to elongate. It is known that a bundle of neurites can sustain stretch
rates that are 100 times more than what a single neurite can sustain (14). We could draw a
parallel analogy and expect that a neurite bundle may be able to sustain higher stretch forces
as well.

Thus except for the DNA crosslinked polyacrylamide hydrogels there is an absence of a
polymer system that can successfully demonstrate controlled slow transformation that could
be exploited for actuation purposes. EAP‟s and SMP‟s have been designed to exhibit multifunctionality in terms of biocompatibility, biodegradability, quick transitioning / shape
changing phenomenon, and mechanical tunability (15). The transformation of the SMP
networks after the transition temperature is reached is very rapid, usually ranging between
1.8% to 5% per minute depending on the size of the monomer used to form the crosslinked
network (9, 10, 15). Thus there is an alarming absence of slow transforming (shrinking)
polymer actuators. The polymer system discussed in this dissertation is the first of its kind.
We have been able to demonstrate controlled slow shrinkage of the hydrogel network via two
different mechanisms of degradation that is sustained for at least two days. We admit that
there is still potential room for optimization; however this network system fills a void that is
present in the current available polymeric actuator materials by creating a new class of
biologically relevant slow actuators.

6.2. Limitations of the polymer system: We demonstrated that a novel hyaluronic acid based
network system can be designed to shrink along a preferred axis of the sample. All but one
composition of the gel produced shrinkage rates that are compatible to be used for the
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application of stretching axons (14, 16, 17). The shrinkage however could only be sustained
for three days at the most. Despite the fact that this hydrogel system is unique, this short
duration of shrinkage is a potential drawback. Optimizing this gel system will further
increase the applicability of the hydrogel. High degree of derivatization of HA at the (COOH) groups may have reduced the number of available sites for cells to bind. An
alternative strategy that has been described in literature is covalently binding the
methacrylate moiety to the (-OH) groups. HA esterification with methacrylic anhydride can
be performed in ice cold water at pH 8 for 24 hours to obtain methacrylated HA (18). This
photoactive HA polymer can then be crosslinked with PEGDa and PEGPLADa to form
hydrogels as described in earlier sections. Having the (-COOH) groups free may increase the
number of viable sites for cell surface receptors and improve cell binding. Moreover we can
further enhance the binding potential of the gels by covalently adhering small peptide
molecules. Carrying on with the theme of improving the neurite binding probability, DRG
explants can be cultured on a PEI microcontact printed glass slide. Using the hydrogels
described above along with the DRG explants in the axonal elongation device might provide
the best chance of successfully stretch elongating the axons. The following sections describe
a few future investigations that may help further improve our understanding of the polymer
network system and prolong the shrinkage magnitude and duration.

6.3. Further variables to investigate: Some of the variables that can affect the extent of
molecular orientation but were not investigated as part of this dissertation include molecular
weight of the HA chains, injection flow rate prior to crosslinking, and pH similar to the
injury site.
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6.3.1.

Increasing the molecular weight of HA: Degradation caused the shear aligned HA
chains to recoil and release the stored retractive stress. The magnitude of the
retractive stress in the network is dependent on how long the HA chain was i.e. the
molecular weight of HA. For the PEGPLADa crosslinked composition we observed
that increasing the ratio of the crosslinker caused phase separation of the solution.
Increasing the molecular weight of HA might allow us to reduce the final
concentration of HA in the solutions at the same time maintaining viscosity
conditions necessary for getting relaxation time greater than crosslinking time.
Besides this possible advantage, higher molecular weight would increase the
magnitude of retractive stress that can be stored in the crosslinked network.

6.3.2. Flow rates: The shear thinning property of HA molecule made it possible for us to
shear align some of the molecular chains and store retractive stress in the network
via rapid crosslinking. We maintained the injection rate at 0.5 ml/min. The effect of
varying the flow rate of the pre-crosslinking solution on the degree of molecular
orientation and the effective magnitude of retractive stress in the crosslinked
network will be a valuable addition to our knowledge of this polymer system in
order to increase the applicability of the hydrogels as mechanical stimulators for
axonal elongation.
6.3.3. Varying pH during degradation: The pH that was maintained during both
enzymatic and hydrolytic degradation was neutral. The enzyme hyaluronidase is at
optimum activity at neutral pH. However following nervous system injuries, the pH
at the site of injury has been observed to be slightly acidic on account of the
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immune system response. It will be critical to understand how the shrinkage profile
is affected at varying levels of acidic pH values ranging between neutral and 3.

6.4. Swelling studies for PEGPLADa crosslinked hydrogels: The current testing protocol
followed during the shrinkage study of the hydrolytically degraded hydrogels involved
swelling the hydrogel for two hours at 4°C prior to any testing. This was done to minimize
any hydrolysis and allow for swelling. However there is not sufficient evidence that the gel
reached equilibrium swelling. To understand the equilibrium swelling and if and how it
affected the shrinkage profile observed for the PEGPLADa crosslinked hydrogels, the
following set of experiments should be explored.

A long term swelling study at room temperature and 4°C should be performed to
understand the swelling behavior of the hydrogel. At least three samples of the PEGPLADa
crosslinked gels should be weighed every hour and a profile of swelling ratio vs time should
be established. Simultaneously a shrinkage assay should be performed by completely getting
rid of the two hour swelling duration. Instead, the sample can be subjected to 37°C
conditions straightaway after the crosslinking process and images of the sample captured at
intervals of one hour. The normalized sample length vs time profile will show how the
sample swells, when it reaches equilibrium swelling, and when the shrinkage starts and stops.
Also, the samples will be taken to complete or near complete hydrolytic breakdown. The
expected outcome profile may show initial swelling followed by shrinkage and maybe
another swelling cycle when the shrinkage stops and hydrolysis increases capacity of the gel
to absorb water.
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6.5. Viscosity measurement to determine mechanism of hydrolytic degradation driven
shrinkage: The shrinkage observed for the PEGPLADa crosslinked hydrogels that were
exposed to 37°C was rapid. The mechanism we posit for shrinkage is hydrolysis driven
cleavage of the crosslinks that permit recoiling of the HA chains. The initial rapid shrinkage
observed is confusing since the hydrolysis process is described to be a slow process. To
investigate further what is actually happening in the hydrogels we can measure overtime the
viscosity of the solvent that the gels are degraded in. The main degradation byproducts of the
gel hydrolysis that have the potential to increase viscosity of the degradation solvent are PEG
and HAGMa. The smaller PEG molecule is more likely to be diffused out before
considerable degradation would enable the large HAGMa molecule to escape. HAGMa will
have a greater effect on the viscosity as compared to PEG. With a sensitive setup (GPC or
Ubbelohde capillary viscometer) the viscosity of the degradation solvent could be measured.
Standard curves for both the components at various concentrations would allow us to
determine which component is diffusing out of the gel and at what time along the
degradation process. Correlating this data with the shrinkage profile would help us formulate
a hypothesis and possibly explain the true mechanism of shrinkage and the rapid nature of
the shrinkage.

6.6. Hydrogel fabrication techniques: New strategies in hydrogel fabrication can be explored to
improve probability of neuronal ends crossing the interface and binding to the hydrogel.
Figure 6.1 shows a couple of strategies worth exploring. Creating a ramp [6(a)] for the
neuronal ends to adhere to instead of presenting them with an interface in the form of a wall
might compel them to traverse the interface successfully. Crosslinking a gel with aligned
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channels fabricated by implementing the principles used in fabricating foams would produce
substrates could improve the cell-gel interaction at the interface. The idea is once again the
same of replacing the gel wall at interface with a more inviting gel interface.

Fig. 6.1. Schematics showing alternative fabrication strategies to create a better hydrogel-cell
interface. (a) Gel crosslinked as a wedge on the glass slide with the tapering edge at the
interface. (b) Hydrogel with aligned hollow channels.
6.7. Double crosslinking: The shrinkage profile we obtained for the compositions tested were
unimodal; meaning there wasn‟t as second stint of sample shrinkage after the shrinkage
plateaued. It would be an added advantage to have multiple levels of shrinkage. This could
be achieved by crosslinking the hydrogels twice either using same crosslinker or different
crosslinkers. Figure 6.2 shows schematic for a proposed method to achieve that. A precrosslinking solution containing HAGMa and a crosslinker would be injected in to the glass
mold and rapidly crosslinked. Then a slight extensional pressure would be applied via a
vacuum line connected to the mold. While this pressure exists another solution containing
crosslinker and photoinitiator will be pipetted at the end across from the vacuum port. The
pressure might facilitate in slightly stretching the crosslinked gel as well as diffusion of the
second crosslinker. The mold would be exposed to UV source to crosslink a second time.
191

Degradation of such a double crosslinked hydrogel could increase the duration of shrinkage
as well as introduce multiple levels in the shrinkage profile.

Fig. 6.2. Schematic showing the proposed double crosslinking method. For the first stage of
crosslinking the pre-crosslinking solution is injected into mold and rapidly crosslinked. Then
a slight pressure will be created using vacuum line and the second=d crosslinker is
introduced followed by UV exposure.

6.8. Magnetic bead study: Magnetic beads have been employed to study tractional behavior and
microrheology of a variety of cell lines. The technique utilizing magnetic beads to study
microrheology was pioneered half a decade earlier by Crick and Hughes (19). Since then it
has been improved upon by introduction of beads smaller than 5 µm which has enabled
researchers to study the viscoelastic properties of the cytoplasm once the beads were
phagocytized. Sackmann et al. (19) have developed a magnetic bead microrheometer capable
of generating forces in the nano-newton range on supermagnetic and ferromagnetic beads
with diameters smaller than 5 µm. This technique could be used to further understand and
test the axon-hydrogel interface. The device that was built to test the interface had its
limitations. The magnetic beads can be modified so as to covalently bind a thin layer of
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hyaluronic acid hydrogel. The beads could then be introduced in a well containing primary
neurons that have been cultured on a microcontact printed PEI pattern along the axonal end.
The size scale match between the axonal ends and the beads would be a definite advantage
over the glass slide interface tested earlier as it would give us a chance to position them at
neurite ends and test the direct bond between the neurite end and the gel. Using appropriate
calibrations the beads could be moved in desired directions at speeds coinciding with the
shrinkage rate of the hydrogel composition coated on them. Thus we may be better able to
study and quantify the strength of the bond between the growth cone of the axon and the
hydrogel and the effect of applying the mechanical stimulation on the stretch growth of the
axons.
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APPENDIX
7.1. NMR of Hyaluronic acid molecule modified with 10X glycidyl methacrylate
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7.2.

NMR of pre-dialysis and post-dialysis HAGMa solution
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7.3.

Measuring sample dimensions using Image J

1.

The sample images were captured using an iPhone camera from a fixed distance.

2.

A reference scale was placed underneath the wells before imaging the samples as
shown below.

3.

The images were opened in Image J and the measuring tool was calibrated using the
reference scale present in the image.

4.

The sample dimensions were measured at least 3 times and the average value was
reported as the actual dimension of the sample.
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7.4.
1.

Analysis of birefringence spectra
The spectrum obtained from the optical spectrophotometer gets stored as an excel
file. The first column being the wavelengths and the second is the intensity data.

2.

Select the data between 480nm and 700nm. Using the dark and bright reference
spectra, normalize the intensity spectrum using the formula given below.
𝑇=

3.

𝐼 − 𝐼0
𝐼𝑑 − 𝐼0

Next construct a column using the standard equation using an arbitrary retardance
value. Perform non-linear regression to fit the actual data with the standard equation
to find the best fit and extract the retardance value.

7.5. Activation of glass slides for crosslinking hydrogel
Chemical activation of the glass coverslip is done following the procedure used by Pelham
and Wang.
Reagents:


Coverslips, square (No. 1, 18 x 18mm; Fisher)
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0.1N NaOH



3-Aminopropyltrimethoxysilane (Sigma Aldrich)



0.5% Glutaraldehyde in Phosphate buffered saline (PBS) (Polysciences, Inc.)

Procedure:
1. Pass the coverslips briefly through the flame of the Bunsen burner.
2. Pipette out 100ul of 0.1N NaOH on the coverslip and smear it across the surface of the
coverslip till it forms a layer. Aspirate the excess after 5 minutes and air dry the
coverslip. The coverslip surface should be covered with a film of dried NaOH. Mark the
untreated surface with a marker.
3. Pipette 100-200ul of 3-aminopropyltrimethoxysilane evenly on the treated side of the
glass surface with the Pasteur pipette. Allow the coverslip to sit for 4 minutes.
4. Soak the treated side of the coverslip with deionized (DI) water and let it sit for 5
minutes. Rinse thoroughly with DI water and air dry.
5. Transfer the coverslips into petri dishes, treated side up, and cover the surface with 0.5%
glutaraldehyde. Incubate at room temperature for 20-30 minutes.
6. Wash the coverslip extensively with DI water and then let it air dry. The treated
coverslips should be used for gel attachment within 48 hours after activation.

7.6.Activation of top glass slides: Chemical activation of the glass coverslip is done
following the procedure suggested by the manufacturer.
Reagents:


Coverslips, square (No. 1, 22 x 22mm; Fisher)



0.1N NaOH
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SurfaSil Siliconizing Fluid (Pierce Biotechnology)



Acetone



Methanol

Thorough cleaning of glassware ensures maximum coating. Clean glassware before siliconizing.
Use of acid or base to prepare glassware etches glass and exposes more sites with which the
siliconizing agent can react.
1. Clean glassware with standard laboratory cleaner.
2. Thoroughly rinse glassware with DI water to remove residue. Dry the surface in an
oven at 200°C for at least 15 minutes. Multiple layers of silane can form on the glass
surface if water is not completely removed.
SurfaSil Siliconizing Fluid: Immersion Technique:
1. Dilute SurfaSil Siliconizing fluid in a non-polar organic solvent such as acetone.
Working concentration is 10% volume to volume.
2. Completely immerse the coverslip to be coated in the diluted SurfaSil Solution for at
least 5-10 seconds. Agitate the solution to ensure a uniform coat. A thin film will
immediately coat the object's surface.
3. Rinse the coverslip with acetone.
4. Rinse the coverslip with methanol. This rinse is required to prevent interaction of the
SurfaSil Coating with water and thus, reversing siliconization.
5. Air-dry the object for 24 hours or heat at 100°C for 20-60 minutes.
6. SurfaSil Siliconizing Fluid evolves HCl as a by-product during coating. Use a fume
hood and vented explosion-proof ovens.
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7.7. MC3T3 Fibroblast cell culture
MC3T3 fibroblast cell lines are good models for studying in vitro osteoblast differentiation,
particularly ECM signaling. They have behavior similar to primary calvarial osteoblasts. They
need to be grown and expanded in culture until they reach confluence and then passaged 2-3
times before using them for cell culture experiments.
Following is the procedure for culturing undifferentiated cells:
1. Remove a vial of stored MC3T3 cells from the liquid N2 tank. A vial should have
approximately 1x106 cells in 1mL of media.
2. Rapidly thaw the vial of cells by placing it in your palm for about 5 minutes.
3. Once thawed, transfer the aliquot into a 15mL conical tube and add 9mL of
culture medium.
4. Form a pellet of cells by spinning them down in a centrifuge at 1000 RPM for 5
minutes. This is to remove the DMSO used during cryopreservation.
5. Remove the supernatant and resuspend the cell pellet in 10mL of fresh culture
medium. Transfer this solution to a T-75 flask (75mm2) and place the flask in the
incubator at 37°C with 5% CO2. Change media every alternate day until cells
reach confluence. Once the cells reach about 80% confluence they are ready to be
passaged. Cells usually split 1:3.
Materials:
 1X Trypsin EDTA
 1X PBS
 Cell Culture Medium
 2, T-75 flasks
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Procedure:
1. Aspirate the culture medium from the T-75 flask that needs to be passaged.
2. Add 10mL of 1X PBS and gently tap the flask. This is done to remove dead and
poorly attached cells. Aspirate off the PBS and add 1mL of 1X trypsin.
3. Make sure to cover the entire surface of the flask with trypsin. Put the flask into
the incubator at 37°C for 3 minutes.
4. Add 9mL of culture media and rinse the cells off of the flask. When most of the
cells are off the flask, suck up all of the media and transfer it to the 15mL conical
tube.
5. Add 7mL of fresh media in 2 new T-75 flasks as well as in the flask from which
we passaged cells.
6. Spin down the cells in the conical tube in the centrifuge for 5 minutes at 1000
RPM. Aspirate the supernatant and resuspend the pellet of cells in 10mL of fresh
culture media.
7. Add 3mL of media and cells to each of the T-75 flasks. Place all the three flasks
in the incubator. Change media every alternate day until cells are needed for
passaging or cryopreservation.

MC3T3 Fibroblast Media
Media Constituents


Advanced Minimum Essential Medium AMEM



Fetal Bovine Serum (FBS)



Penicillin Streptomycin Glutamine (PSG)
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Remove FBS and PSG from freezer and thaw to room temperature.
For making 200ml media
20ml of FBS
2ml PSG
178ml AMEM

7.8. Hemocytometry
A hemocytometer is used for counting cells. Remove the hemocytometer, clean with DI
water and 70% Ethanol, dry thoroughly and assemble it for counting cells.

1. Obtain 10ul of the sample of the cell suspension in media and dispense it onto the
hemocytometer
2. Focus on the grid under the microscope and count cells in 16 boxes at 4 corners of the
hemocytometer (16 boxes x 4 squares = 64 boxes).
3. Divide the total number of cells from 64 boxes by four to get the number of cells per
square.
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4. Multiply the number of cells/square by 10,000 to get the number of cells/mL of media
5. Multiply number of cells/mL by the total amount of media you have (about 10mL) to
get the total number of cells in your media.
6. For freezing or splitting cells you normally need about 1x106 cells in 1mL of media,
so you divide 1x 106 by the number of cells/mL to get the amount of media that needs
to be removed to get 1x106 cells

Example:
200 cells were counted in the 64 boxes
200 cells/4 = 50 cells/square
50 cells/square x 10,000 = 500,000 cells/mL
500,000 cells/mL x 10 = 5,000,000 cells in total suspension of media
We need 1x106 cells, thus
1x106/ 500,000 cells/mL = 2mL of cell-suspension contains 1 million cells
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Thus we extract 2mL of cell-media suspension for the process we need to perform.

7.9. Cryopreservation of cells
PC12 cells can be cryopreserved and stored for future usage. The method for preserving cells is
called cryopreservation. After passaging cells when all three T-75 flasks are confluent and you
do not need all the cells we can freeze them down.
1. Follow steps 1-4 from the cell passaging procedure stated earlier for two T-75
flasks.
2. Pipette out 10ul of media and cells onto the hemocytometer to count the number
of cells. We want to freeze down around 1x 106 cells in 1mL.
3. Pellet down the cells in the conical tube using the centrifuge for 5minutes at 1000
RPM. Aspirate off the supernatant and resuspend the pellet of cells in 10 mL of
1X PBS.
4. Spin down the cells again for 5 minutes in the centrifuge, and resuspend the pellet
of cells in 10 mL of fresh culture media containing 10% dimethyl sulfoxide
(DMSO), a cryopreservative.
5. Aliquot out 1mL of media containing about 1x 106 cells into 2mL cryovials. Put
the vials in Mr. Frosty which is filled with 250 mL of isopropyl alcohol and leave
them for 24 hours in the -80°C freezer for controlled freezing (1°C/min).
6. Remove Mr. Frosty from the freezer and store the vials in the liquid nitrogen tank
(-120°C) for future use.
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7.10. Primary Cortical Neuron Media
Media constituents:


B-27 supplement



L-Glutamine



Penicillin/ Streptomycin



Neurobasal Media

Remove the B-27 supplement, L-glutamine, and penicillin/streptomycin from the freezer and let
it thaw.
For making 200mL of Neurobasal media add:
4 mL of B-27 supplement
1mL of L-glutamine
2mL of Penicillin/ Streptomycin (1:100 dilutions)
193 mL of Neurobasal Media
The media can be stored in the refrigerator at 4°C until required.

7.11. Live –Dead Assay
1.

Wash the cells prior to the assay to remove or dilute serum esterase activity
generally present in serum-supplemented growth media (serum esterases could
cause some increase in extracellular fluorescence by hydrolyzing calcein AM).
Wash adherent cells gently with 500–1,000 volumes of Dulbecco‟s phosphatebuffered saline (D-PBS)

2.

Remove the LIVE/DEAD® reagent stock solutions from the freezer and allow
them to warm to room temperature.
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3.

Add 20 μL of the supplied 2 mM EthD-1 stock solution (Component B) to 10 mL
of sterile, tissue culture–grade D-PBS, vortexing to ensure thorough mixing. This
gives an approximately 4 μM EthD-1 solution.

4.

Combine the reagents by transferring 5 μL of the supplied 4 mM Calcein AM
stock solution (Component A) to the 10 mL EthD-1 solution. Vortex the resulting
solution to ensure thorough mixing.

5.

The resulting approximately 2 μM Calcein AM and 4 μM EthD-1 working solution
is then added directly to cells. The final concentration of DMSO is ≤ 0.1%, a level
generally innocuous to most cells.

6.

Note that aqueous solutions of Calcein AM are susceptible to hydrolysis (see
Storage and Handling of Reagents). Aqueous working solutions should therefore
be used within one day.

7.

Incubate the cells for 30–45 minutes at room temperature. A shorter incubation
time may be used if the dye concentrations or incubation temperature are
increased.

7.12. 4% Paraformaldehyde
Paraformaldehyde is used for fixing cells once the experiment is complete.
Media Constituents:


Monobasic Sodium Phosphate Anhydrous (Soln. A) (0.2M)



Dibasic Sodium Phosphate Anhydrous (Soln. B) (0.2M)



Paraformaldehyde granules



NaOH (1M)
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For making 500mL of solution, dissolve 24 grams of monobasic sodium phosphate anhydrous in
1000mL of DI water (soln A). Dissolve 28.4 grams of dibasic sodium phosphate anhydrous in
1000mL of DI water (soln B). Dissolve 20 grams of paraformaldehyde granules in 250mL DI
water at 55-60°C while adding 10-15 drops of 0.1M NaOH to it until solution is clear. For the
500mL of 4% paraformaldehyde solution, take a 500 mL glass bottle and from the above
prepared solutions add 250mL of paraformaldehyde solution, 47.5mL of solution A and 202.5
mL of solution B. This will yield a 4% fixing solution which should be stored in the refrigerator
at 4°C until needed.

7.13. Microindentation Device


Fill the liquid cell with either DI water or PBS. Load the sample into the test setup.



Get the sample close to the tip.



Switch on the power supply (First Elenco then Topward)



Press the “Acquire” button to check if all sensors are in proper range. (refer table for
trace information)



Press “Stop acquire”.



Enter the file name (“_filename”), scan dimensions, and indent spacing. (select linear
profile if testing gradient samples)



Enter the maximum load to be reached in uN .



Press “Snap location”. Enter number of indents in the manual over ride box if you
intend to perform a specific number of indents.



Press “Scan” button.



A message box pops up after the test is finished.
209

Trace color

Description

DVRT voltage (has to between -1 to +1
Yellow

volt. If voltage >2 volts tip might be in
contact with sample or cantilever is bent
towards the DVRT

Green

Z – LVDT voltage (has to be between 5
& 6 volts for optimal performance)

Pink

Displacement LVDT (has to be between 3 & 1 volts for best performance)

Red
X motor LVDT voltage

Blue
Y motor LVDT voltage
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#

Button Name

Description

1

Acquire

On clicking this control button the strip chart above the button will
acquire and show the current voltages on the various LVDT
sensors and the DVRT

2

Stop Acquire

On clicking this control button the strip chart above the button will
stop acquiring the current voltages on the various LVDT sensors
and the DVRT

3

Current status

It displays the current voltage state of the sensors. (refer the table

Voltage Chart

1)

Test status Voltage

This chart displays the DVRT voltage Vs displacement LVDT

Chart

voltage during the test.

5

Test area dimension

Enter the length and breadth of the region you wish to test.

6

Indent Spacing

Enter the distance between two indent locations. Minimum

4

distance being 2 times radius of the tip.
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7

Linear scan select

On checking this box the test will be done in a straight line across
the sample as per the dimensions entered in 5

8

Snap Location

This control takes a snapshot of the voltages at the start of test.
The test is run comparing these conditions as baseline.

9

Scan

Clicking this control starts the test

10

Reset

Click this button at the end of test to get the system back to pretest conditions

11

Filename

The format for entering the filename is “_name_date”. The
underscore is important as the test is automated and the software
increments the counter and every indent is stored as a separate file
automatically. Always remember to check he write to file box

12

Manual Over ride

Enter the number of indents if you wish to indent at fewer
locations than calculated by the program.

213

************Code for microindenter************
Option Strict Off
Option Explicit On
Imports Excel = Microsoft.Office.Interop.Excel
Public Class StressRelax
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const
Const

z_down As Short = 1 'assign integers to these actions
z_up As Short = 2
y_front As Short = 3
y_back As Short = 4
x_left As Short = 5
x_right As Short = 6
x_left1 As Short = 7
x_right1 As Short = 8
y_back1 As Short = 9
z_down1 As Short = 10 'assign integers to these actions
z_up1 As Short = 11
x_right2 As Short = 12
x_left2 As Short = 13
y_front2 As Short = 14
y_back2 As Short = 15

Dim gbWriteHeader As Boolean
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim

vdif As Object
lconst As Object
dconst As Object
ldconst As Object
ifile As Short
teststart As Object
maxload As Object
testend As Object
indentnum As Object

Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim

vdata As Object
label As Single
Voltage1 As Object
Voltage2 As Object
Voltage3 As Object
z As Object
i As Object
i1 As Object
j1 As Object
j As Object
bv As Object
t As Object
vqdata As Object
vwdata As Object
vedata As Object
vzdata As Object
vddata As Object
nvdata As Object
nvddata As Object
zv As Object
dzv As Object
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Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim

zref As Object
zdata As Object
zddata As Object
zdata0 As Object
zddata0 As Object
ldata0 As Object
lndata As Object
zcoord As Object
xcoord As Object
ycoord As Object
maxindents As Short
maxindents1 As Short
maxindents2 As Short
totalindents As Short
totalindents1 As Short
indentlocationx As Object
indentlocationy As Object
progress As Short
progressincr As Short
Llocation As Short
Blocation As Short
XL As Short
XXL As Short
YL As Short
YYL As Short
XXLmax As Short
YYLmax As Short

Dim
Dim
Dim
Dim

fs As Object
fc As Object
order As Object
ldata1 As Object

Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim
Dim

ltempdata As Object
ltempdata2 As Object
dtempdata As Object
ltempdata3 As Object
dtempdataX As Object
ltempdataX As Object
dtempdata3 As Object
imax As Object
ldata(9000000) As Object
ddata(9000000) As Object
load_ldata(9000000) As Object
unload_ldata(9000000) As Object
load_ddata(9000000) As Object
unload_ddata(9000000) As Object
disp(9000000) As Object
load1(9000000) As Object

Private Sub DaqTaskComponent1_DataReady(ByVal sender As System.Object,
ByVal e As ContinuousAcquire.DaqTaskComponentDataReadyEventArgs) Handles
DaqTaskComponent1.DataReady
Dim acquiredData() As NationalInstruments.AnalogWaveform(Of Double) =
e.GetData
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WaveformGraph2.PlotWaveforms(acquiredData)
End Sub
Private Sub DaqTaskComponent1_Error(ByVal sender As System.Object, ByVal
e As NationalInstruments.DAQmx.ComponentModel.ErrorEventArgs) Handles
DaqTaskComponent1.Error
'TODO: Handle DAQ errors.
Dim message As String = e.Exception.Message
MessageBox.Show(message, "DAQ Error", MessageBoxButtons.OK,
MessageBoxIcon.Warning)
End Sub
Private Sub AcquireVoltages_Click(ByVal sender As System.Object, ByVal e
As System.EventArgs) Handles AcquireVoltages.Click
DaqTaskComponent1.StartRead()
End Sub
Private Sub StopAcquireVoltages_Click(ByVal sender As System.Object,
ByVal e As System.EventArgs) Handles StopAcquireVoltages.Click
DaqTaskComponent1.StopRead()
End Sub
Private Sub Button1_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs)
Dim up((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
up(0) = -3
Pointout_XmotorComponent1.Write(up)
End Sub
Private Sub Pointout_XmotorComponent1_Error(ByVal sender As
System.Object, ByVal e As
NationalInstruments.DAQmx.ComponentModel.ErrorEventArgs) Handles
Pointout_XmotorComponent1.Error
'TODO: Handle DAQ errors.
Dim message As String = e.Exception.Message
MessageBox.Show(message, "DAQ Error", MessageBoxButtons.OK,
MessageBoxIcon.Warning)
Pointout_XmotorComponent1.StopTask()
End Sub
Private Sub start_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles start.Click
indentlocationx = 0
indentlocationy = 0
If CheckBox2.Checked = True Then
linearscan()
Else
squarescan() 'add creep call here
End If
MsgBox("Test Done
End Sub

Press Reset")
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Private Sub masterreset_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles masterreset.Click
vqdata = Pointread_ZlvdtComponent1.Read
vwdata = Pointread_YlvdtComponent1.Read
vedata = Pointread_XlvdtComponent1.Read
zcoord = -1
xcoord = 0.2
ycoord = 3
If vqdata(0) > zcoord Then
Run((z_down1)) 'move the stage toward z down (see section Run for
detail)
Else
Run((z_up1)) 'move the stage toward z up (see section Run for
detail)
End If
If vedata(0) < xcoord Then
Run((x_left2)) 'move the stage left (see section Run for detail)
Else
Run((x_right2)) 'move the stage right (see section Run for
detail)
End If
If vwdata(0) < ycoord Then
Run((y_back2)) 'move the stage back (see section Run for detail)
Else
Run((y_front2)) 'move the stage front (see section Run for
detail)
End If
MsgBox("Master Reset Done")
End Sub
Private Sub halt_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles halt.Click
Dim hlt((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt(0) = 0
Pointout_ZmotorComponent1.Write(hlt)
Dim hlt1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt1(0) = 0
Pointout_YmotorComponent1.Write(hlt1)
Dim hlt2((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt2(0) = 0
Pointout_XmotorComponent1.Write(hlt2)
End Sub
Private Sub yback_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles yback.Click

217

Run((y_back)) 'move the stage toward y back (see section Run for
detail)
End Sub
Private Sub xright_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles xright.Click
Run((x_right)) 'move the stage toward x right (see section Run for
detail)
End Sub
Private Sub xleft_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles xleft.Click
Run((x_left)) 'move the stage toward x left (see section Run for
detail)
End Sub
Private Sub yfront_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles yfront.Click
Run((y_front)) 'move the stage toward y front (see section Run for
detail)
End Sub
Private Sub zdown_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles zdown.Click
Run((z_down))
End Sub
Private Sub zup_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles zup.Click
Run((z_up))
End Sub
Private Sub NumericEdit3_AfterChangeValue(ByVal sender As System.Object,
ByVal e As NationalInstruments.UI.AfterChangeNumericValueEventArgs)
End Sub
Private Sub NumericEdit2_AfterChangeValue(ByVal sender As System.Object,
ByVal e As NationalInstruments.UI.AfterChangeNumericValueEventArgs)
End Sub
Sub Run(ByRef RunMode As Single) 'this section defines motion for the 3D
stage x(right,left), y(front,back),and z(up,down)
Dim zdata As Object
Dim zdata0 As Object
Dim ydata As Object
Dim ydata0 As Object
Dim xdata As Object
Dim xdata0 As Object
Dim nvdata As Object
Select Case RunMode
Case z_down
vdata = Pointread_ZlvdtComponent1.Read
zdata0 = vdata
zdata = zdata0
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Do While System.Math.Abs(zdata(0) - zdata0(0)) <
(Gauge1.Value * 0.7918)
nvdata = Pointread_ZlvdtComponent1.Read
zdata = nvdata
Dim
stgdwn((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgdwn(0) = -5
Pointout_ZmotorComponent1.Write(stgdwn)
Loop
Dim
stgdwn1((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgdwn1(0) = 0
Pointout_ZmotorComponent1.Write(stgdwn1)
Case z_up
vdata = Pointread_ZlvdtComponent1.Read
zdata0 = vdata
zdata = zdata0
Do While System.Math.Abs(zdata(0) - zdata0(0)) <
(Gauge1.Value * 0.7918)
nvdata = Pointread_ZlvdtComponent1.Read
zdata = nvdata
Dim
stgup((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgup(0) = 5
Pointout_ZmotorComponent1.Write(stgup)
Loop
Dim
stgup1((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgup1(0) = 0
Pointout_ZmotorComponent1.Write(stgup1)
Case x_right
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While System.Math.Abs(xdata(0) - xdata0(0)) <
(Gauge1.Value * 0.0946)
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stgrt((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgrt(0) = 5
Pointout_XmotorComponent1.Write(stgrt)
Loop
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Dim
stgrt1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgrt1(0) = 0
Pointout_XmotorComponent1.Write(stgrt1)
Case x_left
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While System.Math.Abs(xdata(0) - xdata0(0)) <
(Gauge1.Value * 0.0946)
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stglft((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft(0) = -5
Pointout_XmotorComponent1.Write(stglft)
Loop
Dim
stglft1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft1(0) = 0
Pointout_XmotorComponent1.Write(stglft1)
Case y_front
vdata = Pointread_YlvdtComponent1.Read
ydata0 = vdata
ydata = ydata0
Do While System.Math.Abs(ydata(0) - ydata0(0)) <
(Gauge1.Value * 0.0853)
nvdata = Pointread_YlvdtComponent1.Read
ydata = nvdata
Dim
stgfrnt((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgfrnt(0) = -5
Pointout_YmotorComponent1.Write(stgfrnt)
Loop
Dim
stgfrnt1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgfrnt1(0) = 0
Pointout_YmotorComponent1.Write(stgfrnt1)
Case y_back
vdata = Pointread_YlvdtComponent1.Read
ydata0 = vdata
ydata = ydata0
Do While System.Math.Abs(ydata(0) - ydata0(0)) <
(Gauge1.Value * 0.0853)
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nvdata = Pointread_YlvdtComponent1.Read
ydata = nvdata
Dim
stgbk((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk(0) = 5
Pointout_YmotorComponent1.Write(stgbk)
Loop
Dim
stgbk1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk1(0) = 0
Pointout_YmotorComponent1.Write(stgbk1)
Case x_left1
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While System.Math.Abs(xdata(0) - xdata0(0)) <
((NumericEdit_indentspacing.Value / 100) * 0.0946)
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stglft((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft(0) = 10
Pointout_XmotorComponent1.Write(stglft)
Loop
Dim
stglft1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft1(0) = 0
Pointout_XmotorComponent1.Write(stglft1)
Case x_right1
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While System.Math.Abs(xdata(0) - xdata0(0)) <
((NumericEdit_indentspacing.Value / 100) * 0.0946)
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stgrt((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgrt(0) = -10
Pointout_XmotorComponent1.Write(stgrt)
Loop
Dim
stgrt1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
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stgrt1(0) = 0
Pointout_XmotorComponent1.Write(stgrt1)

Case y_back1
vdata = Pointread_YlvdtComponent1.Read
ydata0 = vdata
ydata = ydata0
Do While System.Math.Abs(ydata(0) - ydata0(0)) <
((NumericEdit_indentspacing.Value / 100) * 0.0853)
nvdata = Pointread_YlvdtComponent1.Read
ydata = nvdata
Dim
stgbk((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk(0) = 10
Pointout_YmotorComponent1.Write(stgbk)
Loop
Dim
stgbk1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk1(0) = 0
Pointout_YmotorComponent1.Write(stgbk1)
Case z_down1
vdata = Pointread_ZlvdtComponent1.Read
zdata0 = vdata
zdata = zdata0
Do While zdata(0) > zcoord
nvdata = Pointread_ZlvdtComponent1.Read
zdata = nvdata
Dim
stgdwn((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgdwn(0) = -5
Pointout_ZmotorComponent1.Write(stgdwn)
Loop
Dim
stgdwn1((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgdwn1(0) = 0
Pointout_ZmotorComponent1.Write(stgdwn1)
Case z_up1
vdata = Pointread_ZlvdtComponent1.Read
zdata0 = vdata
zdata = zdata0
Do While zdata(0) < zcoord
nvdata = Pointread_ZlvdtComponent1.Read
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zdata = nvdata
Dim
stgup((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgup(0) = 5
Pointout_ZmotorComponent1.Write(stgup)
Loop
Dim
stgdwn1((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgdwn1(0) = 0
Pointout_ZmotorComponent1.Write(stgdwn1)
Case x_right2
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While xdata(0) > xcoord
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stgrt((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgrt(0) = -10
Pointout_XmotorComponent1.Write(stgrt)
Loop
Dim
stgrt1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgrt1(0) = 0
Pointout_XmotorComponent1.Write(stgrt1)
Case x_left2
vdata = Pointread_XlvdtComponent1.Read
xdata0 = vdata
xdata = xdata0
Do While xdata(0) < xcoord
nvdata = Pointread_XlvdtComponent1.Read
xdata = nvdata
Dim
stglft((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft(0) = 10
Pointout_XmotorComponent1.Write(stglft)
Loop
Dim
stglft1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stglft1(0) = 0
Pointout_XmotorComponent1.Write(stglft1)
Case y_front2
vdata = Pointread_YlvdtComponent1.Read
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ydata0 = vdata
ydata = ydata0
Do While ydata(0) > ycoord
nvdata = Pointread_YlvdtComponent1.Read
ydata = nvdata
Dim
stgfrnt((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgfrnt(0) = -10
Pointout_YmotorComponent1.Write(stgfrnt)
Loop
Dim
stgfrnt1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgfrnt1(0) = 0
Pointout_YmotorComponent1.Write(stgfrnt1)

Case y_back2
vdata = Pointread_YlvdtComponent1.Read
ydata0 = vdata
ydata = ydata0
Do While ydata(0) < ycoord
nvdata = Pointread_YlvdtComponent1.Read
ydata = nvdata
Dim
stgbk((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk(0) = 10
Pointout_YmotorComponent1.Write(stgbk)
Loop
Dim
stgbk1((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As Double
stgbk1(0) = 0
Pointout_YmotorComponent1.Write(stgbk1)

End Select
End Sub
Private Sub getcoordinates_Click(ByVal sender As System.Object, ByVal e
As System.EventArgs) Handles getcoordinates.Click
' get the current location of the tip w.r.t stage and use as origin
value
zcoord = -1
xcoord = 0.2
ycoord = 0.6
maxindents2 = ((NumericEdit_scanlength.Value * 1000 /
NumericEdit_indentspacing.Value))
NumericEdit_linearindents.Value = maxindents2
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Llocation = NumericEdit_scanlength.Value * 1000 /
NumericEdit_indentspacing.Value
Blocation = NumericEdit_scanbreadth.Value * 1000 /
NumericEdit_indentspacing.Value
maxindents = Llocation * Blocation
NumericEdit_squareprofile.Value = maxindents
MsgBox("Do you want to proceed with the test?")
MsgBox("Press Start button")
End Sub
Private Sub linearscan()
progress = 0
indentnum = 0
totalindents = 0
XL = (Llocation - Llocation)
YL = Llocation
' scanning in x direction
If CheckBox1.Checked = True Then
maxindents1 = NumericEdit_override.Value
Else
maxindents1 = maxindents2
End If
'progressincr = 100 / maxindents1
Do While totalindents < (maxindents1)
If CheckBox2.Checked = True Then
Do While indentnum < ((maxindents2)) ' defining number of
indents per scan line
Scannsave()
'ProgressBar1.Value = progress
indentlocationx = indentlocationx + 1
vzdata = Pointread_ZlvdtComponent1.Read
XL = XL + 1
ScatterGraph2.PlotXYAppend(XL, YL)
If vzdata(0) > zcoord Then
Run((z_down1)) 'move the stage toward z down (see
section Run for detail)
Else
Run((z_up1)) 'move the stage toward z up (see section
Run for detail)
End If
Run((x_right1)) 'move the stage and sample toward x left
(see section Run for detail)
bv = 0
While bv < 2000 ' 120 sec pause to lets ripples settle
bv = bv + 1
End While
bv = 0
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Loop
indentnum = 0
End If
Loop
End Sub
Private Sub squarescan()
Dim marker As Object
progress = 0
indentnum = 0
marker = 0
totalindents = 0
XXL = ((Llocation - Llocation) + 1)
XXLmax = Llocation
YYLmax = Blocation
YYL = Blocation + 1
Dim pointer As Object = 0
'progressincr = 100 / maxindents
If CheckBox1.Checked = True Then
maxindents1 = NumericEdit_override.Value
Else
maxindents1 = maxindents
End If
' scanning in x direction
Do While totalindents < maxindents1
If marker = 0 Then
Do While indentnum < ((maxindents2)) ' defining number of
indents per scan line
indentlocationx = indentlocationx + 1
If XXL > XXLmax Then
pointer = 1
YYL = YYL - 1
XXL = XXL - 1
End If
If XXL < 2 Then
pointer = 0
YYL = YYL - 1
End If
Scannsave()
'ProgressBar1.Value = progress
ScatterGraph2.PlotXYAppend(XXL, YYL)
If pointer = 0 Then
XXL = XXL + 1
Else
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XXL = XXL - 1
End If
vzdata = Pointread_ZlvdtComponent1.Read
If vzdata(0) > zcoord Then
Run((z_down1)) 'move the stage toward z down (see
section Run for detail)
Else
Run((z_up1)) 'move the stage toward z up (see section
Run for detail)
End If
Run((x_right1)) 'move the stage and sample toward x left
(see section Run for detail)
bv = 0
While bv < 2000 ' 120 sec pause to lets ripples settle
bv = bv + 1
End While
bv = 0
Loop
marker = 1
indentnum = 0
End If
Run((y_back1)) 'move the stage and sample toward y back away from
user(see section Run for detail)
indentlocationy = indentlocationy + 1
If marker = 1 Then
Do While indentnum < (maxindents2) ' defining number of
indents per scan line
indentlocationx = indentlocationx - 1
If XXL > XXLmax Then
pointer = 1
YYL = YYL - 1
XXL = XXL - 1
End If
If XXL < 2 Then
pointer = 0
YYL = YYL - 1
End If
Scannsave()
'ProgressBar1.Value = progress
ScatterGraph2.PlotXYAppend(XXL, YYL)
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If pointer = 0 Then
XXL = XXL + 1
Else
XXL = XXL - 1
End If
vzdata = Pointread_ZlvdtComponent1.Read
If vzdata(0) > zcoord Then
Run((z_down1)) 'move the stage toward z down (see
section Run for detail)
Else
Run((z_up1)) 'move the stage toward z up (see section
Run for detail)
End If
Run((x_left1)) 'move the stage and sample toward x right
(see section Run for detail)
bv = 0
While bv < 2000 ' 120 sec pause to lets ripples settle
bv = bv + 1
End While
bv = 0
Loop
marker = 0
indentnum = 0
End If
Loop
End Sub
Private Sub Scannsave()
fs = 100
fc = 1
order = 1
ltempdata = Pointread_dvrtComponent1.Read
ldata0 = ltempdata
lndata = ldata0
i = 0
j = 0
t = 0
dconst = NumericEdit_dconst.Value 'microns/volt
ldconst = NumericEdit_ldconst.Value / NumericEdit_gain.Value
'microns/volt
lconst = NumericEdit_lconst.Value / NumericEdit_gain.Value
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Do While lndata(0) < (ldata0(0) + (NumericEdit_maxload.Value) / (1000
* lconst)) ' micro newton
Dim stgdwn((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) 1) As Double
'stgdwn(0) = -3
stgdwn(0) = -2.5
Pointout_ZmotorComponent1.Write(stgdwn)
ltempdata2 = Pointread_dvrtComponent1.Read
lndata = ltempdata2
ldata(i) = lndata(0)
load_ldata(i) = ltempdata2
dtempdata = Pointread_displlvdtComponent1.Read
ddata(i) = dtempdata(0)
load_ddata(i) = dtempdata
ScatterGraph1.PlotXYAppend(ddata(i), ldata(i)) 'plot the acquired
data on trace monitor
i = i + 1
j = j + 1
t = t + 1
Loop
i1 = i
j1 = 0
bv = 0

Dim stg((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
stg(0) = 0
Pointout_ZmotorComponent1.Write(stg)
vddata = Pointread_ZlvdtComponent1.Read
zddata0 = vddata
zddata = zddata0
dconst = NumericEdit_dconst.Value 'microns/volt
ldconst = NumericEdit_ldconst.Value / NumericEdit_gain.Value
'microns/volt
lconst = NumericEdit_lconst.Value / NumericEdit_gain.Value
'highlight from here to get rid of pause for stress relaxation
' While bv < (holdtime.Value * 9000)

'1500 = 10 sec

'Dim stg9((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
'stg9(0) = 0
'Pointout_ZmotorComponent1.Write(stg9)

229

'ltempdata2 = Pointread_dvrtComponent1.Read
'lndata = ltempdata2
'' ldata(i) = lndata(0)
'load_ldata(i) = ltempdata2
'dtempdata = Pointread_displlvdtComponent1.Read
'ddata(i) = dtempdata(0)
'load_ddata(i) = dtempdata
'ScatterGraph1.PlotXYAppend(ddata(i), ldata(i)) 'plot the acquired
data on trace monitor

' bv = bv + 1
'i = i + 1
'j = j + 1
'gbWriteHeader = True
'End While

'i1 = i
'j1 = 0
'bv = 0
'highlight till here to get rid of pause for stress relaxation
dconst = NumericEdit_dconst.Value 'microns/volt
ldconst = NumericEdit_ldconst.Value / NumericEdit_gain.Value
'microns/volt
lconst = NumericEdit_lconst.Value / NumericEdit_gain.Value
Do While System.Math.Abs(zddata(0) - zddata0(0)) <
((NumericEdit_pullup.Value / 100) * 0.7918) 'telling z-motor to move up
integer*100 microns
nvddata = Pointread_ZlvdtComponent1.Read
zddata = nvddata
Dim stg1((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1)
As Double
'stg1(0) = 3
stg1(0) = 2.5
Pointout_ZmotorComponent1.Write(stg1)
''highlight from here for stress relaxation
ltempdata = Pointread_dvrtComponent1.Read
ldata(j) = (ltempdata(0) - 0.0953)
unload_ldata(j1) = ltempdata
dtempdata = Pointread_displlvdtComponent1.Read
ddata(j) = dtempdata(0)
unload_ddata(j1) = dtempdata
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ScatterGraph1.PlotXYAppend(ddata(j), ldata(j)) 'plot the acquired
data on trace monitor
j = j + 1
j1 = j1 + 1
t = t + 1
gbWriteHeader = True
''highlight till here for stress relaxation
Loop
Dim stg2((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
stg2(0) = 0
Pointout_ZmotorComponent1.Write(stg2)
' bfldata = CWDSP1.BwLPF(ldata, fs, fc, order) ' butterworth
filtering load data for an order n
' bfdata = CWDSP1.BwLPF(ddata, fs, fc, order)
' load_bfdata = CWDSP1.BwLPF(load_ldata, fs, fc, order)
'unload_bfdata = CWDSP1.BwLPF(unload_ldata, fs, fc, order)
'time1.Value = t
imax = j
ifile = FreeFile()
If CheckBox3.Checked = True Then
FileOpen(ifile, "D:/Mesomechdata/" & totalindents &
inputfilename.Text & ".csv", OpenMode.Append)
End If
For i = 0 To (j - 1)
WriteLine(ifile, ddata(i), ldata(i))
Next i
FileClose(ifile)
ltempdata(0) = 0
dtempdata(0) = 0
Dim hlt((Pointout_ZmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt(0) = 0
Pointout_ZmotorComponent1.Write(hlt)
Dim hlt1((Pointout_XmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt1(0) = 0
Pointout_XmotorComponent1.Write(hlt1)
Dim hlt2((Pointout_YmotorComponent1.NumberOfChannelsToWrite) - 1) As
Double
hlt2(0) = 0
Pointout_YmotorComponent1.Write(hlt2)
indentnum = indentnum + 1
totalindents = totalindents + 1
progress = progress + progressincr
End Sub
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Private Sub Baselinecollection_Click(ByVal sender As System.Object, ByVal
e As System.EventArgs) Handles Baselinecollection.Click
ifile = FreeFile()
If CheckBox3.Checked = True Then
FileOpen(ifile, "D:/Mesomechdata/" & inputfilename.Text & ".csv",
OpenMode.Append)
End If
For i = 0 To 10000
ltempdataX = Pointread_dvrtComponent1.Read
dtempdataX = Pointread_displlvdtComponent1.Read
WriteLine(ifile, dtempdataX(0), ltempdataX(0))
Next i
FileClose(ifile)
MsgBox("Baseline collected")
End Sub

Private Sub NumericEdit_pullup_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_pullup.AfterChangeValue
End Sub
Private Sub NumericEdit_dconst_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_dconst.AfterChangeValue
End Sub
Private Sub Form1_Load(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles MyBase.Load
End Sub
Private Sub NumericEdit_scanlength_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_scanlength.AfterChangeValue
End Sub
Private Sub NumericEdit_lconst_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_lconst.AfterChangeValue
End Sub
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Private Sub NumericEdit_ldconst_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_ldconst.AfterChangeValue
End Sub
Private Sub NumericEdit_maxload_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_maxload.AfterChangeValue
End Sub
Private Sub NumericEdit_gain_AfterChangeValue(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit_gain.AfterChangeValue
End Sub
Private Sub Pointread_dvrtComponent1_ReadCompleted(ByVal sender As
System.Object, ByVal e As
ContinuousAcquire.Pointread_dvrtComponentReadCompletedEventArgs) Handles
Pointread_dvrtComponent1.ReadCompleted
End Sub
Private Sub Label23_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles Label23.Click
End Sub
Private Sub NumericEdit2_AfterChangeValue_1(ByVal sender As
System.Object, ByVal e As
NationalInstruments.UI.AfterChangeNumericValueEventArgs) Handles
NumericEdit2.AfterChangeValue
End Sub
End Class

Mesoindenter calibration
The custom built indentation system has following components that need to be calibrated in
order to measure the modulus accurately;


X & Y motor stage LVDT‟s



Stage displacement LVDT
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Z displacement LVDT



Cantilever (load) calibration

The calibration should be done in the order given below.
Materials:


Dial gauge



2 x Digital multimeter (DMM)

Displacement LVDT Calibration:


Place the dial gauge such that the measuring pin rests on the stage.



Connect the DMM between terminal 28 and ground (GND) on the SCB 68 board.



Press the master reset button on the GUI. Note the reading on the dial gauge in
inches and the DMM reading. Dial gauge reading changes in steps of 0.001
inches. E.g. if the arrow is at 2 and goes down by 2 marks  1.998.



Now move the stage in steps of 100 microns using the software till the DMM
reading goes to 10 volts.



Convert the dial gauge readings from inches to microns and plot displacement vs
voltage and find the slope of the linear regression for the curve (µm/V).



Repeat it a couple of times and average the values to get the “dconst”.

Z LVDT calibration:


Placement of the dial gauge is same as the previous calibration. DMM is now
connected between pin 68 and GND.
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Follow the same procedure as the displacement LVDT calibration and find the
slope of the linear regression line. This is “zconst”.

Load calibration:


Remove the tip from the cantilever and flatten out any bumps in cantilever caused
during removal of the tip.



Invert the Z stage such that the tip face of the cantilever faces the ceiling.



Connect the DMM between the actual DVRT output voltage and not the amplified
voltage and GND.



Measure weights of paper disks punched out of standard bond paper in grams.
Now place the disks one by one on top of each other every time noting the
voltage. Calibrate for a change of 0.5 volts.



Plot the Load vs. Volt (mN/volt) curve and get slope of the linear regression
which gives you the load constant “lconst”.

7.14. Force measurement device


Based on the stiffness of the sample, select aluminum cantilever of appropriate
dimension.



Glue the sample on one end to the cantilever and other end to the adjustable stage.



Pipette a few drops of PBS around the sample and gently move the stage to test if the
sample is not glued to the base. Add PBS to submerge the sample and the DVRT.



Enter the duration of the test in mins and the voltage on the smaller Elenco voltage
supply. This is a backup to verify the signal captured is of the DVRT.



The design schematics of the device are shown below.
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Button #

Name

1

Graph 1

2

Test duration

3

Bias voltage value

4

File name

5

Write to file

6

Acquire

7

Start test

8

Graph 2
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Description
Displays the live force voltage
signal
Enter the total duration of test in
minutes
Voltage from the elenco bioa
power supply
Enter the file name starting with
“_”
Select this to ensure the file gets
created
This button will activate graph 2
and show the raw voltage level
Pressing this button will start
data acquisition
Shows the raw voltage level

************Code for Force measurement device***********
Public Class Form1
Dim dvrtdata As Object
Dim dvrtdata1 As Object
Dim dvrttempdata As Object
Dim dvrtRawdata As Object
Dim dvrtRawdata1 As Object
Dim dvrtRawtempdata As Object
Dim datapoint As Object
Dim biasvoltage As Object
Dim i As Object
Dim p As Object
Dim k As Object
Dim ifile As Short
Dim stopwatch As New Stopwatch()
Dim elapsedTime As Object
Dim elapsedTimeArray(90000) As Object
Dim dataArray(90000) As Object
Dim dataArrayRaw(90000) As Object
Dim datapointnumber(90000) As Object
'Private Sub Switch1_StateChanged(ByVal sender As System.Object, ByVal e
As NationalInstruments.UI.ActionEventArgs) Handles Switch1.StateChanged
'Try
'If Switch1.Value Then
' DaqTask2Component1.StartRead()
'Else
'
DaqTask2Component1.StopRead()
'End If
'Catch ex As NationalInstruments.DAQmx.DaqException
'MessageBox.Show(ex.Message, "DAQ Error", MessageBoxButtons.OK,
MessageBoxIcon.Warning)
'Switch1.Value = False
'End Try
'End Sub
' Private Sub DaqTaskComponent1_DataReady(ByVal sender As System.Object,
ByVal e As DaqApplication1.DaqTask2ComponentDataReadyEventArgs) Handles
DaqTask2Component1.DataReady
'Dim acquiredData() As NationalInstruments.AnalogWaveform(Of Double) =
e.GetData
'WaveformGraph1.PlotWaveforms(acquiredData)
'End Sub
Private Sub Start_Test_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles Start_Test.Click
'Stopwatch timer starts when the DVRT begins reading data'
stopwatch.Start()
datapoint = 0
i = 0
k = 1
p = 0
'Stopwatch elapsed time is read'
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elapsedTime = stopwatch.Elapsed.TotalSeconds
'The DVRT reads data as long as the elapsed stopwatch time that was
just read is within the amount of time entered by user'
While elapsedTime <= (testduration.Text * 60)
elapsedTime = stopwatch.Elapsed.TotalSeconds 'Stopwatch elapsed
time is read'
'DVRT data is recorded along with elapsed time approximately
every second'
If ((elapsedTime > (0.99 * k)) AndAlso (elapsedTime < (1 * k)))
Then
elapsedTime = stopwatch.Elapsed.TotalSeconds 'elapsed time
recorded'
If (p = 4) Then
dvrttempdata = DVRT_pointread.Read 'DVRT data recorded'
dvrtRawtempdata = RawDVRT_pointread.Read 'RawDVRT data
recorded'
biasvoltage = biasvolt.Value
dvrtdata = dvrttempdata
dvrtRawdata = dvrtRawtempdata
dataArray(i) = (dvrtdata(0) / 22.55) + biasvoltage 'Array
records all DVRT data'
dataArrayRaw(i) = dvrtRawdata(0) 'Array records all DVRT
data'
datapointnumber(i) = datapoint
elapsedTimeArray(i) = elapsedTime 'Array records all
elapsed time data'
'collected DVRT and elapsed time data are graphed on the
user interface'
ScatterGraph2.PlotXYAppend(elapsedTimeArray(i),
dataArrayRaw(i))
p = 0
i = i + 1
End If
k = k + 1
p = p + 1
End If
datapoint = datapoint + 1
elapsedTime = stopwatch.Elapsed.TotalSeconds
'Stopwatch elapsed time is read so it can be used in the while
loop'
End While
stopwatch.Stop() 'At the end of collection, stopwatch is stopped and
reset to 0'
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stopwatch.Reset()
'Write to file'
ifile = FreeFile()
If CheckBox1.Checked = True Then
FileOpen(ifile, "D:/Mesomechdata/" & filename.Text & ".csv",
OpenMode.Append)
End If
For i = 0 To (i - 1)
WriteLine(ifile, elapsedTimeArray(i), dataArray(i),
dataArrayRaw(i))
'Written file closed/saved and user is alerted of test end'
Next i
FileClose(ifile)
MsgBox("Test Done. File is saved")
datapoint = 0
i = 0
End Sub
Private Sub CheckBox1_CheckedChanged(ByVal sender As System.Object, ByVal
e As System.EventArgs) Handles CheckBox1.CheckedChanged
End Sub
Private Sub Label2_Click(ByVal sender As System.Object, ByVal e As
System.EventArgs) Handles Label2.Click
End Sub
Private Sub DVRT_pointread_ReadCompleted(ByVal sender As System.Object,
ByVal e As DaqApplication1.DaqTask1ComponentReadCompletedEventArgs) Handles
DVRT_pointread.ReadCompleted
End Sub
Private Sub DaqTask2Component1_ReadCompleted(ByVal sender As
System.Object, ByVal e As
DaqApplication1.DaqTask2ComponentReadCompletedEventArgs) Handles
DaqTask2Component1.ReadCompleted
End Sub
Private Sub RawDVRT_pointread_ReadCompleted(ByVal sender As
System.Object, ByVal e As
DaqApplication1.DaqTask3ComponentReadCompletedEventArgs) Handles
RawDVRT_pointread.ReadCompleted
End Sub
End Class
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7.15. Mechanical stretch device
The device design is shown below. The GUI is provided free by the manufacturer of the stepper
motor. The unit containing the temperature control PID (Gilbert Lab) is the only floating piece of
equipment. Check availability before planning experiment. Perform the following steps in the
same order as below to effectively get the device operational.


Make sure all the power cables are disconnected.



Place the device on the vibration isolation table on a paper towel mat to soak media if
any leak occurs.



Connect the Serial cable from the temperature control PID to the device and power the
controller.



Next switch on the PID supply (red button) which will turn the display on which
should show the current and desired temperatures.



Turn the 5% CO2 tank regulator on. It should be set to 4-5 psi for the output valve
pressure. This should provide a CO2 flow of 2 bubbles / second. Insert the tube into
the port on the device after confirming steady flow of CO2.



Next connect the motor control cable to the motor controller module.



Connect the 20V 3A supply cable to the controller.



Connect the USB to RS485 adapter to the PC and plug the other end of RS485 into the
motor controller module. Turn power on for the power supply.



Click on the “CRK motion creator” icon on the desktop to launch the GUI.



Select the proper COM port (Currently set to 3) and that should connect the device to
the PC.



The GUI should read connected for both port and motor.
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Use the following steps to calculate the parameters to feed into the GUI to control the motor
speed.

Move distance revolutions in Rev = Move distance / (Diameter * 3.14)
Operating Pulses (DIS) = Revs * (pulses/rev)
Pulse speed = Operating pulses / (positioning time – Acceleration time)
TA = Acceleration time
TD = Deceleration time
For micro-stepping function make sure to select “High Res” and gear ratio as “25” in the system
config tab. For further information check out the live demos on the website for Oriental Motor
Corp.
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7.16. Microcontact printing of proteins using PDMS stamp
Materials:


Silicon master



Sylgard™ 184 (Dow Corning)



Acetone



Methanol



Clean the silicon master with acetone and methanol to remove any residues.



Dry the silicon master in a vacuum over at 100° C for 15 min.



Mix the resin and curing agent in the ratio of 10:1 by volume using a spatula and

Method:

then carefully sonicate the mixture to remove the air bubbles making sure the
mixture does not contact water at any time.


Pour this mixture on the silicon master and place it in the vacuum oven at 100° C
for 1 hr.



Remove the chip from the oven and cool it to room temperature and peel the
silicone stamp off the master.

The steps performed to print the protein pattern on to the substrate are illustrated in Figure
below.


The stamps were sonicated in 70% ethanol for 30 minutes and dried under a
stream of nitrogen gas.



A 10 µg/mL laminin solution was poured onto the stamp and the inking process
was carried out for 30 minutes.
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The excess protein solution was washed off and the stamps were dried under a
stream of nitrogen gas and quickly brought into contact with the pre-desiccated
flat surface of the polyacrylamide samples. The efficiency of pattern transfer
decreases with an increase in the time between drying and stamping.



The stamps were kept in contact with the polyacrylamide sample surface for 10
minutes and then peeled off.



Pattern integrity was verified using fluorescent light microscopy as the protein
was tagged with FITC.

Laminin solution

PDMS Stamp
15um

15um

5um

Substrate
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